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It is estimated that this year more than 200,000 women in the United States will 
be diagnosed with breast cancer. Treatment for most occurrences of breast cancer will 
often include surgical removal of the tumorigenic tissue, resulting in a soft tissue defect 
within the subcutaneous tissue of the skin.  Post-surgical reconstruction methods are 
often sought by patients to restore the aesthetic function of the breast via cellular or non-
cellular methods; however, because of complications associated with currently used 
methods for breast reconstruction, researchers are investigating tissue engineering 
methods to produce viable autologous adipose tissue for breast reconstruction.   
Previous research in our laboratory has focused on the development of an 
injectable composite system for breast reconstruction that uses injectable microcarrier 
beads as support scaffolds for cellular growth.  In vitro and in vivo studies of this system 
have shown that the polymeric microcarriers not only support cellular attachment, but 
also facilitate proliferation and differentiation of adipose cells, and yield biocompatible 
tissue response in an i  vivo host.   Successful clinical implementation of this system, like 
many other adipose tissue engineering methods, has been limited by an inability to 
engineer adipose tissue of sustained volume long-term.  It is hypothesized that more 
optimal in vitro culturing methods for adipose cells could yield populations of fat cells
capable of differentiating to adipocytes and retaining their capacity for lipid-filing over 
time.  The goal of this work, therefore, was to evaluate specific factors that influence 
adipose cell differentiation in an attempt to create a more succe sful injectable composite 
system for breast reconstruction.  While adipogenesis is influenced by many factors, for 
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this work, we investigated two specific areas: 1) the influence of adipose cell-mammary 
epithelial cell interactions and 2) the influence of fatty acids on adipose cell 
differentiation in vitro.    
A series of conditioned media studies were first performed to deermine how 
adipogenesis of primary adipose cells from bovine, murine, and human tissue samples 
was influenced by mammary epithelial cell-conditioned media.  Depending on the source 
of conditioned media and the species of adipose cell, adipose cell differentiation was 
either positively or negatively influenced by the conditioned media as evidenced by 
increased or decreased triglyceride production and lipid accumulation in the two-
dimensional cultures.  Characterization of the components of the conditione  media 
samples showed that mammary epithelial cell-conditioned media contains measurable 
quantities of factors that influence adipogenesis.     
To investigate the influence of fatty acids on adipose cell differentiation, a series 
of studies were performed to identify an optimal concentration of fatty acid and an 
optimal culture time for supplementing adipose cells with a fatty cid that would 
stimulate fatty acid uptake and subsequent lipid filling of the cells.  Exogenous fatty acids 
in cell culture medium were found to influence adipogenesis.  Microcarrier beads 
containing fatty acids were then manufactured and used in three-dimnsional cell culture 
experiments to determine if microcarrier beads could be used for fatty acid delivery while 
simultaneously supporting adipose cell growth and differentiation.   
Results of the studies performed in this work suggest that fatty acids as well a 
specific factors produced by mammary epithelial cells will influence adipogenesis, 
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suggesting that these factors may be used to enhance the in vitro culturing of adipose 
cells for the injectable composite system.  Methods to more optimally culture the adipose 
cells in vitro could be used to identify strategies that could then reduce the concerns of 
tissue resorption and volume-reduction that have limited the success of breast tissue 
engineering strategies clinically.  Ideally, the incorporation of fatty acids and/or cellular 
components into the injectable composite would allow immediate delivery of a cellular 
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Many methods for post-surgical reconstruction of breast tissue following tumor 
resection exist. There are, however, complications associated with these methods which 
influence the successful reconstruction of the patients’ breast tissue.  For this reason, 
researchers are investigating strategies to engineer adipose tissu  that would allow 
autologous, natural tissue sources to be used for breast reconstruction.  To date, the 
successful implementation of these methodologies into clinical practice has been limited 
primarily because researchers have yet to develop methods that yield sufficiently 
vascularized large volumes of tissue that remain viable and retain volume over time.   
 Previous work in our lab has focused on the development of an injectable 
composite system for breast reconstruction that uses injectable microcarrier beads as 
support scaffolds for cellular growth.  In vitro and in vivo studies of this system have 
shown that the polymeric microcarriers not only support cellular attchment, but also 
facilitate proliferation and differentiation of adipose cells, and yield biocompatible tissue 
response in an in vivo host.  While these results have been promising there are still facets 
of this system that must be further understood to successfully engineer adipose tissue 
using this system.  The long-term goal of this work, therefore, is to evaluate factors that 
modulate adipogenesis for breast tissue engineering.  
To accomplish the goals set forth for this project, five specific aims were 
identified:   
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1. Investigate the relationship between mammry epithelial cells and primary 
adipose cells in two-dimensional (2-D) culture 
2. Evaluate adipose cell behavior in three-dimensional (3-D) cultures with 
mammary epithelial cells 
3. Evaluate the influence of exogenous fatty acid on adipose cell 
differentiation in 2-D in vitro cultures 
4. Evaluate the influence of 3-D fatty acid-loaded substrates on adipose cell 
differentiation 
5. Evaluate fatty acid influence on adipose cell-breast cancer cell interactions 
in vitro 
The studies in Aim 1, as detailed in Chapter 2, were designed to investigat  the 
relationship between mammary epithelial cells and primary adipose cells in 2-D culture.  
In long-term application of our proposed system, beyond the scope of this research, 
adipose cells will be implanted into the mammary microenvironment which largely 
consists of mammary epithelial cells.  It is therefore important to understand the influence 
that mammary epithelial cells have on adipose cell behavior.  To evaluate this 
relationship, conditioned media from mammary epithelial cells was used in the culture of 
primary adipose cells from bovine, murine, and human tissue samples.  Three types of 
conditioned media were used for analysis, and the influence of each type on adipose cell 
behavior was evaluated to determine if there was any differenc in ell behavior, and if 
so, if it was dependent on the cell or medium species.  Additionally, the influence of 
conditioned media on adipose gene expression was assessed, and the conditioned media 
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components were assessed with an adipokine protein array and ELISAs specific for TGF-
β and PAI-1.   
The Aim 2, as detailed in Chapter 3, was conducted to evaluate the behavior of 
adipose cells co-cultured with mammary epithelial cells in a 3-D environment.  This work 
evaluated the effect of culturing primary human adipose cells on polymer microcarriers, 
made of a chitosan-gelatin blend, in conjunction with human mammary epithelial cells.  
This in vitro study allowed us to observe how adipose cell viability and differentiation 
were influenced by 3-D conditions and served as an indicator of how cells included in the 
injectable composite system might behave in vivo.   
The studies performed to address Aim 3, as detailed in Chapter 4, wee designed 
to evaluate the influence of exogenous fatty acids on adipose cell behavior in 2-D 
cultures.  The breast microenvironment is very complex by nature.  Th  large presence of 
adipose tissue in the breast means that there are also factors, such as fatty acids, released 
by fat tissue, that are present within the breast.  We hypothesized that supplementation of 
adipose cell cultures with fatty acids would enhance the lipid-fill ng capacity of adipose 
cells for breast tissue engineering, such that the cells would retain volume over time.   
Aim 4 studies, as described in Chapter 5, evaluated the influence of 3-D fatty 
acid-loaded polymer substrates on adipose cell behavior.  One advantge of the injectable 
composite system is the ability to tailor the polymeric microca rier for multiple uses.  In 
addition to serving as cellular supports, the microcarriers can serve as delivery vehicles 
for growth factors, drugs, media supplements, or in this case, fatty acid delivery.  Aim 4 
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studies included devising methods of sterilely producing chitosan-gelatin microcarriers 
loaded with linoleic acid.     
Aim 5 studies, as described in Chapter 6, include the evaluation of fatty acid 
influence on adipose cell and breast cancer cell interactions in vitro.  Fatty acids present 
in the body have been shown to influence the behavior of both normal and cancerous 
cells.  The addition of fatty acids to the bead component of our injectabl  composite 
systems lead us to wonder, if by chance there were residual cancer cells within a post-
surgical patient, how the addition of fatty acids would influence the beavior of cancer 
cells.  Additionally, fatty acids have been shown to influence the effectiveness of cancer-
treating drugs.  Here, we evaluated the influence of fatty acid supplemented beads on 
breast cancer cell behavior.  Chitosan-gelatin beads with and without ncorporated fatty 
acids produced and cultured with human primary adipose cells.  These cellular 
microcarriers were co-cultured with MCF-7 breast cancer cells and then treated with an 







1.1 Clinical Significance 
Cases of traumatic injury, congenital defect, or tumor resection often result in soft 
tissue defects, where loss or removal of volumes of adipose tissue, within the 
subcutaneous layer of skin, results in alterations of the skin’s normal contour [1].  Soft 
tissue defects are repaired clinically using plastic and reconstructive procedures to restore 
the missing volume of adipose tissue.  Clinical procedures used to repair such defects 
include autologous fat tissue grafts and tissue flap transfers, implants, or injectable fillers 
that reconstruct and fill the void space.  While many options for sot ti sue reconstruction 
are used in clinical application, there is, however, not one strategy that is useful for the 
wide range of defects that may exist.  Additionally, the methods currently used for soft 
tissue reconstruction are limited in their success due to complications, such as tissue 
resorption, resulting in loss of tissue volume over time [1-6]. Research rs are therefore 
working to develop methods for engineering autologous adipose tissue that may be used 
to fill soft tissue defects. 
Breast cancer is one of the most commonly diagnosed cancers amongwomen in 
the United States.  For many women undergoing surgical treatments for his disease, 
some form of reconstructive procedure is subsequently performed to restore the aesthetic 
function of the breast. In the case of tissue-based reconstruction options, autologous fat 
tissue transplantation has been largely unsuccessful as a means for breast reconstruction.  
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To date, tissue engineering strategies have led to the development of various methods that 
appear to be promising starting points for researchers working to successfully engineer 
autologous adipose tissue for breast reconstruction.  The structural and functional 
complexity of the human breast, however, has limited progress developing a successful 
means for engineering breast tissue. This dynamic organ is comprised of multiple tissue 
types and their associated secretory factors that play key roles in the developmental 
processes of the breast throughout the stages of female maturation [7]. The complexity of 
the breast must therefore be considered when investigating strategies for engineering 
breast tissue; however, a complete understanding of the specific interactions that occur 
between the stromal cells and epithelial cells of the breast remains limited.   
 
1.2 Anatomy and Structure of the Human Breast 
The female mammary gland or breast is composed of two primary tissue types: 
epithelial tissue and stromal tissue.  The epithelial tissue of the breast is primarily 
glandular tissue that plays a role in lactation and milk production.  The stromal tissue of 
the breast consists primarily of adipose tissue and its associated v scular network.  The 
tissue of the breast lies over the pectoral or chest muscle of the body and typically 
extends from the collarbone to the breastbone midway of the sternum [8, 9].   
Structurally, the breast is divided into 15 to 20 sections called lobes(Figure 1.1).  
At the extension of these lobes are lobules with acini that produce milk during lactation. 
The lobes are interconnected by thin tubes called ducts that function to transport the 
produced milk from the lobules to the nipple of the breast. Within the space  between the 
3 
 
lobular and ductal structures is stromal tissue which provides the structural framework 
and support for the breast. 
 
 
Figure 1.1: The structural anatomy of the human breast which is made up primarily of 
epithelial and stromal tissues [10]. 
 
Adipose tissue fills the interstitial spaces and provides the most significant 
proportion of the breasts’ volume, accounting for approximately one-third of the breasts’ 
volume at specific stages of female maturation [11-16]. The breasts are connected 
systemically to other parts of the body via its associated vascular network and the 
lymphatic system [17].  The primary source of blood supply to the breast is from the 
internal mammary artery, accounting for approximately 60%; however, th  mammary 
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branch of the thoracic artery provides an additional 30% of blood to the breast [8].  Veins 
of the breast drain into the internal mammary vein, which is the primary vein that 
facilitates blood flow from the breast [15].  The lymphatic vessels carry lymph fluid, or 
cellular waste, away from the breast.  Most lymphatic vessels in the breast connect to the 
axillary nodes.  Lymph fluid drains from the breast to the axillary nodes first and then 
second to the internal mammary nodes. The internal mammary lymph nodes are located 
within the chest, and the supraclavicular or infraclavicular nodes are located around the 
collar bone and connect to the breast.  The connection of the breasts to the lymphatic 
system is important to note because the spreading of metastatic breast cancers often 
occurs via the lymphatic vessels to the lymph nodes [15, 17]. 
 
1.3 Normal Development of the Female Breast 
The human breast is a dynamic organ that undergoes morphological and 
developmental changes throughout the stages of female maturation, as shown in Figure 
1.2 [15, 18]. Changes in the size, shape, and function of the breast occur in response to 
puberty, pregnancy, lactation, and menopause. The most significant changes in growth of 
the breast, however, occur following puberty [17].  Following birth, the mam ry gland 
is composed primarily of adipose tissue, with small ductal structures p esent forming 
breast tissue that remains immature until the onset of puberty.  At puberty, growth of the 
breast, signified by increased cellular growth of the epithelial ducts, is stimulated by the 
hormones estrogen and growth hormone produced by the ovaries and pituitary gland, 
respectively [7]. In addition to increased deposition of adipose tissue n the breasts, the 
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ducts stretch, elongate, and become more branched, creating a more defined ductal 
network [8, 19-23]. The formation of lobules at the end of the ducts also occurs.  As the 
female ages, during the course of menstruation, the growth of a mature network of ducts 
and lobules is formed, with slight growth apparent until approximately ge 35 when the 




Figure 1.2: The mammary gland undergoes morphological and structural changes 
throughout its normal developmental stages (Adapted from [24]). 
 
While a mature network of ductal and lobular structures is formed over tim , 
complete development of the breast tissue does not occur unless pregnancy a d childbirth 
are experienced [8, 25].  Growth of the mammary gland is stimulated by production of 
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progesterone hormones during pregnancy.  During pregnancy, significant exte sion and 
branching of the breast ductal system, accompanied by growth of glandular tissue, leads 
to maximal development of the breast whereby the lobules increase in both size and 
number.  Systemic reproductive hormones, specifically progesterone and prolactin, 
stimulate the expansion and differentiation of the mammary epithelium into milk-
producing cells [7].  Lactation, or the production of milk, is the point where the breast 
reaches its complete functional capacity due to these functional changes of the glands, 
which now secrete milk.  Following lactation, the breast undergoes involution, a 
regression of the tissue most notably caused by a collapse or folding f lobular structures 
and a narrowing of the ducts.  A similar type of tissue remodeling is observed following 
menopause when hormones levels, particularly estrogen levels, decrease and glandular 
tissue atrophies, leaving larger proportions of fat tissue, stromal connective tissue, and 
skin [8, 9, 15, 19-22, 25]. 
 
1.4 Breast Cancer Development and Tumor Progression 
Healthy cells in the body undergo a balanced, controlled pattern of growth; both 
signals that promote cell growth and signals that limit cell growth remain in balance with 
each other for ordered proliferation and, ultimately, differentiation of cells.  When this 
balance is interrupted, the cells will become cancerous [26, 27].  Cancers of the body 
occur when cells abnormally divide and proliferate outside the body’s normal control.  
Cancerous cells often result from DNA damage that leads to constitutively activated 
oncogenes (genes that initiate cell proliferation and differentiation) and inactivated tumor 
7 
 
suppressor genes (genes that inhibit growth and progression in the cell cycl ).  Tumor 
formation, or tumorigenesis, occurs when the cells cluster together to fo m large masses 
which or may not be malignant.  Benign tumors are not cancerous, however, malignant 
tumors are cancerous and may metastasize to other parts of the b dy other than the point 
of origin.  Malignant cancers that metastasize are more seriou  in nature because of their 
invasive phenotype. 
Breast cancer is the form of cancer where cells in the breast tissue, typically 
epithelial cells of the breast, divide and grow abnormally [28].  The initiation of breast 
cancer is thought to result from uncontrolled cell proliferation and/or an error in the 
apoptotic events of breast cells, often the result of genetic damage or alteration.  Breast 
cancer risk factors include gender, age, weight, family history, child-bearing history, 
environmental factors such as smoking or radiation, and genetic predisposition [20, 29].   
Genetic predisposition for breast cancer, where a genetic mutation is inherited 
from a parent, is correlated to 10-20% of breast cancer cases [10, 30].  The most 
commonly inherited mutation predisposing women to breast cancer is of the breast cancer 
1 and breast cancer 2, BRCA1 and BRCA2 genes, respectively.  Both BRCA1 and 
BRCA2 are tumor suppressor genes that normally aid in controlling cell growth and cell 
death by preventing cells from growing abnormally [10, 31]. Each person has two 
BRCA1 (one on each chromosome #17) and two BRCA2 genes (one on each 
chromosome #13); however, when an altered or mutated copy of either the BRCA1 or 
BRCA2 gene is present the risk for cancer increases; specifically, an individual with a 
BRCA1 or BRCA2 mutation carries a 36-85% lifetime risk for developing breast cancer 
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[32].  Genetic testing of women with a family history of breast cancer may reveal one of 
the several hundreds of mutations observed in this gene.  A positive test for these 
mutations may allow women to actively monitor their breast healt in an effort to quickly 
find a breast cancer should it arise. 
The majority of breast cancers originate in the ducts of the breast (85%), while 
others typically originate in the lobules [33].  The progression of breast cell growth from 
a normal to cancerous state is a multistep process that does not occur in a defined length 
of time.  A normal duct of the breast epithelium is composed of epithelial c lls (bilayer of 
inner luminal epithelial cells for milk production and an outer layer of myoepithelial cells 
for milk ejection) along the fully intact basement membrane of the duct [28].  The 
progression of breast cancer begins with a hyperproliferation of cells known as 
hyperplasia.  The epithelial cells still appear normal in structu e; however, they begin to 
divide uncontrollably resulting in more cells within the duct.  The next stage of cancer 
progression is known as atypia.  At this stage, the epithelial cells begin to look “atypical” 
or slightly abnormal upon microscopic examination.  This condition is often diagnosed as 
benign, however, the patient may still be diagnosed as precancerous, indicating that they 
may have a high likelihood of developing cancer later [31, 34].  The next stage of cancer 
progression is described as in situ carcinoma.  The epithelial cells have grown to an 
obviously abnormal appearance.  Additionally, they are fast-growing, so much so that 
they have begun to form clusters within the lining of the duct.  The name for this stage of 
growth, in situ, refers to the fact that the cells are still “in place” within the inside of the 
ducts in this case.  More specifically, this type of cancer is commonly known as ductal 
 
carcinoma in situ (DCIS) because it is localized to the ducts of the br ast.  The other 
common type of in situ carcinoma is known as lobular carcinoma 
it is localized in the lobules of the breast [31, 33 4]. The final stage of breast cancer 
progression is known as invasive cancer.  In this stage, the abnormal cells of the duct, 
which were once localized within the duct, have begun to infiltrate or metastasize into the 
surrounding normal breast tissue.  Degradation of the ductal basement membrane, often 
attributed to increased levels of enzymes that degrade the extracellular matrix, allows 
cancerous cells to travel to other parts of the body via the blood vessels or the lymphatic 
vessels [31].  This type of invasive cancer is regaded as very serious because of its 
likelihood of spreading to other organs like the liver, lungs, brain and bones
 
Figure 1.3: A schematic of breast cancer tumor progression demonstrates cellular 
behavior and transformation from a normal breast to the most aggressive disease state. 
(Adapted from [31, 34]). 
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1.5 Surgical Treatment of Breast Cancer and Breast Reconstruction 
The course of treatment recommended for patients with breast cancer will vary 
from patient to patient, and depends on several factors, including the stage of the cancer, 
whether or not it is benign or malignant, the tumor size, and whether it is in situ or 
invasive.  For breast cancer patients, there are several courses f tr atment available, 
including therapeutic options such as chemotherapy, radiation, and hormone therapy, 
and/or surgical options, such as lumpectomy and mastectomy. Oftentimes, however, for 
many patients the course of treatment will include a combinatio  of one or more surgical 
or therapeutic options. 
Surgical options for breast cancer treatment include lumpectomies, where only the 
affected breast tissue and an immediate surgical margin of tissue are removed (breast-
conserving), and mastectomies, where the entire area of breast tissue is removed.  The 
basic lumpectomy procedure is referred to as a partial or segmental lumpectomy.  
Additionally, this procedure may include an axillary lymph node dissection, where the 
lymph nodes are removed and subsequently evaluated to identify if the specific cancer 
has metastasized.  A simple or total mastectomy procedure involves removal of the entire 
breast, and may sometimes be performed as a preventative measure for women with a 
high risk of developing breast cancer.  A modified radical mastectomy is a procedure that 
involves removal of the entire breast along with the lymph nodes; it is of en performed in 
the case of large invasive cancers [10, 13, 33-35]. 
For many patients undergoing surgical treatment for breast cancer, some form of 
reconstructive procedure is often sought.  Restoration of the natural function of the breast 
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tissue is typically not the primary goal in reconstruction; rather, restoring the aesthetic 
function of the breast is largely desired to minimize the anxiety and negative 
psychological feelings associated with the disfigurement caused by the large amount of 
tissue lost [35-39].  Reconstructive procedures are thus used to restore the symmetry of 
the breast by recreating a breast mound that is similar in size, shape, contour, and position 
to the opposing breast [40]. 
In 2008, more than 4.9 million reconstructive procedures were performed in the 
United States. Approximately 79,458 of those procedures were breast reconstruction 
procedures performed for women [41].  As is the case with the numero s types of breast 
cancers and the courses of treatments that vary from patient to patient, there are 
numerous reconstruction options that may be used, with no one method ideal for all 
patients.  For each specific patient, there are several factors that must be taken into 
consideration before the ideal reconstruction method is selected.  These factors include 
the timing of the reconstructive procedure (immediate or delayed post-mastectomy), the 
patient’s overall health condition, the patient’s course of cancer treatment, and the 
presence of necrotic tissue or scarring resulting from mastectomy procedures [10, 40, 42, 
43].  Reconstruction options for breast cancer patients include both acellular and cellular 
options, summarized in Table 1.1, all of which have associated disadvantages and 
complications. 
Acellular options include breast prostheses that may be worn outside the body to 
provide the appearance of natural breast tissue when worn beneath clothing.  Other 
acellular reconstruction options include breast implants and tissue expanders.  Oftentimes 
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a tissue expander is implanted into the breast area behind the pectoralis muscle of the 
chest and later filled or expanded to a sufficient volume that will restore the body’s 
symmetry.  The expansion process typically occurs over the course f veral weeks 
using a valve system that was implanted subcutaneously along with the expansion 
implant [43].   Breast implants are typically made of a silicone shell, and are often filled 
with saline or silicone gel, providing a structure that fills the void area. Patients that wear 
some form of prosthetic device outside the body are often limited in their physical 
activity due to its movability, and their appearance may seem distorted at times.  The 
complications associated with the use of breast implants, particul ly silicone breast 
implants, are largely known.  Breast implants require a subsequent surgery for 
implantation, subjecting the patient to further trauma.  They have also been shown to 
mask the recurrence of breast tumors, and have led to a condition known as capsular 
contracture, where the scar tissue capsule that forms around the implant contracts and 
results in a hardened breast [37, 38, 40, 44]. 
Cellular reconstruction methods often consist of the use of autologous tiss e flaps 
which are taken from the abdomen, back, thigh, or other area of the pati nt and 
transplanted to the effected breast area [37, 38, 40, 42, 44-47].  Removal of a large 
portion of tissue, including skin, fat, and musculature, from a site on the body may lead 
donor site morbidity and a weakening of its surrounding musculature [3, 38, 48].  The 
vascular network of the transplanted tissue is also disturbed, resulting in tissue necrosis 
due to lack of sufficient nutrient transport.  These procedures are also highly invasive and 
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costly for patients.  Other cellular options for reconstruction include fat pad or fat tissue 
transfers, and collagen injections [3, 49, 50].   
 
Table 1.1: Summary of Breast Reconstruction Methods [45, 47, 48, 51]  
Non-Cellular Methods for Breast Reconstruction 
Method Description 
Breast Prostheses 
External reconstruction method where artificial breast form is worn outside 
the body to return the aesthetic function of the breast. 
Tissue Expanders 
Balloon-like device placed beneath skin immediately following 
mastectomy.  Commonly followed by saline injections to fill expander. 
Implants:  
 Silicone Gel 
More permanent device, commonly inserted into expanded area after 
removal of tissue expander.  Provides a more natural feel compared with 
saline. 
 Saline 
More permanent device, commonly inserted into expanded area after 
removal of tissue expander.  (Salt water). 
Cellular Methods for Breast Reconstruction 
Method Description 
Collagen Injections 
Collagen is injected with a small needle into the desired area (bovine r 
autologous collagen). 
Fat Pads/Fat Tissue 
Transfers 
Harvesting of fat tissue from one area of the body and transferring to the
breast area for use during reconstruction. 
Tissue Flaps:  
 TRAM  
Transverse Rectus Abdominis Myocutaneous flap-Oval or elliptical shaped 
patch of skin, fat, and muscle from the abdomen is used to create a new 
breast. 
 LD Flap 
Latissimus Dorsi Myocutaneous flap-Flap of skin and muscle removed 
from the back and transferred to the front of the chest where it is used to 
create a new breast or a covering for an implant. 
 DIEP Flap 
Deep Inferior Epigastric Perforator flap-Skin, fat, and blood vessels 
dissected through the abdominal muscle so that muscle is left intact to 
alleviate post-op pain after reconstruction. 
 SIEA 
Superficial Inferior Epigastric Artery flap-Uses lower abdominal skin and 
fat, without disturbing the muscles or abdominal wall, during 
reconstruction. 
S-Gap 
Superior Gluteal Artery Perforator flap-Skin, fat, and blood vessel flap 
taken from the gluteus maximus muscle of the buttock, transferred to the 
internal mammary vessels, and then shaped into a breast. 
Gluteal Free  
Flap taken from the lower buttock that requires the sacrifice of only a 
small amount of the gluteus maximus muscle. 
Anterolateral Thigh  




Because the volume of the breast is composed primarily of adipose tissu , adipose 
tissue is logically recommended to be used for reconstructing the breasts and to repair 
other forms of soft tissue defects [5].  Adipose tissue is found all over the human body, 
often in excess amounts that may be obtained through processes such aliposuction, and 
transplanted to where the volume is needed. This idea of autologous fat graft 
transplantation seems logical in its approach of replacing fat with fat, but the ac ual use of 
this transplantation technique has not been consistently successful in patients [4, 52].  
When autologous fat tissue is transplanted from one location to a defect site, or the site 
where reconstruction must occur, the primary result is significa t resorption of the 
transplanted tissue over time, so that 40-60% of the graft volume is lost.  One proposed 
reason for this resorption is that there is not sufficient revascul rization of the tissue once 
it is transplanted to its new location [1, 4, 38].  The fat grafts never reach sufficient 
vascularity, so blood flow at their center is not adequate for long-term survival of the 
tissue, and often leads to tissue resorption [5].  Tissue engineering st ategies are thus 
being investigated to develop new, alternative methods for breast tissue reconstruction 
[53, 54]. 
 
1.6 Tissue Engineering for Breast Reconstruction 
Tissue engineering methods are being used to develop a wide range of tissues, 
including bone, skin, cartilage, vascular, and adipose tissues [55].  Because adipose tissue 
provides the most significant portion of the breast’s volume, it is suggested for use as the 
cellular basis for tissue engineering strategies used for breast reconstruction and other 
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soft tissue defects. The development of tissue engineered adipose tissue would provide 
replacement tissue that is similar in texture and shape as autologous breast tissue.  With 
the numerous complications associated with the currently employed breast reconstruction 
methods, the development of tissue engineered adipose tissue would significantly impact 
not only the field of breast reconstruction, but the field of plastic surgery in general.  
Tissue engineered adipose tissue has the potential to provide reconstru tion options that 
are natural and autologous, i.e., using the patient’s own healthy cels. Additionally, the 
advent of minimally-invasive technologies, enhanced by tissue engineering strategies, 
could provide reconstruction options better-suited for breast cancer patients.  Minimally 
invasive, tissue engineered strategies could effectively reduce post-surgical trauma that 
patients would endure from the typically used open procedures required for breast 
implant insertion or tissue flap replacements [56]. 
 
1.7 Factors Influencing Success of Breast Tissue Engineering  
 Tissue engineering methods typically involve the use of a cellular source, a 
support structure or scaffold to facilitate cellular growth, and specific factors that 
promote the growth of the cells of interest.  For successful incorporation of a tissue 
engineered device into a patient’s body, the implant must respond favorably to the 
microenvironment into which it is placed without eliciting a negative cellular response 
that could be detrimental to that patient’s health.  For this reason, when approaching the 
task of developing tissue engineered options for any tissue or organ type, it is essential to 
understand the behavior of that specific tissue type and the factors that the implant would 
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be subjected to upon implantation.  More specifically, when developing strategies for 
breast tissue engineering, an understanding of the physical properties of the human breast 
and of the normal mammary microenvironment is necessary.   
 
1.8 Influence of the Mechanical Properties of Mammary Tissue 
 As a soft tissue, the normal mammary gland’s mechanical properties may be 
characterized as non-linear, anisotropic, and viscoelastic by nature.  By definition, a 
material is non-linear when its viscosity exhibits a non-constant response to strain (non-
constant coefficient of viscosity).  Anisotropy refers to a material whose stiffness 
depends on the direction of load application; while, viscoelasticity refers to a material 
whose stiffness depends on the rate of strain application [9, 57].  Additionally, normal 
mammary tissue has been characterized as rubber-like due to its almost incompressible 
nature [9, 57, 58].  These characteristics of mammary tissue are dependent on age, water 
content, lipid content, temperature, and disease-state of the tissue specimen used for 
analysis [9].  The precise makeup of the tissue components, i.e. distribut on of ductal 
structures within the stromal network, will also influence the spcific mechanical 
properties of mammary tissue [57, 59].  
Further characterization of mammary tissue has included identifying and 
quantifying specific mechanical properties of the key tissue components that make up 
breast composition.  Numerous studies to determine the elastic modulus and the strength 
of selected tissues of the breast have been performed, as knowledge of the elastic 
properties of breast tissue may be used for modeling of tissue dynamics and for imaging 
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of the tissue to detect malignancies [58-61].  Three of the mostpredominant types of 
tissue that make up the mammary gland are skin, glandular tissue, and adipose tissue.  
Reports indicate that the elastic modulus of skin is between 200-3000 kPa and its ultimate 
tensile strength is approximately 20 MPa [9].  The elastic modulus for normal glandular 
tissue has been reported as between 2-66 kPa [60, 62]; while the elastic modulus for 
mammary adipose tissue, characterized as white adipose tissue, ha been reported as 0.5-
25 kPa [59, 62-66].  Some reports have indicated that normal glandular tissue is 5-50 
times stiffer than adipose tissue, which is attributed to the higher lipid and water weight 
of the adipose tissue that influences the modulus according to the appli d strain rate [9, 
67].   
When considering the mechanical properties of the mammary gland, it is also 
important to account for the diseased state of tissue.  In addition to characterization of 
normal mammary tissue, researchers have also investigated the mechanical properties of 
malignant mammary tissue samples.  The mechanical properties of cancerous tissues 
have been shown to have an increased stiffness when compared to normal tissue samples; 
this has been thought to be an indicator of not only the presence of tumorogenic tissue, 
but also an indicator of the cancer stage and level of tumor progression.  Evaluation of 
fibroadenomas (non-cancerous breast lumps) showed the fibroadenomas to be four times 
stiffer than normal tissue, while cancerous tissue was up to seven times stiffer than 
normal mammary tissue [58, 61].  Others, however, have reported that the s iffness of 
breast cancers may differ in stiffness from surrounding tissues by as much as 90-fold [61, 
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68], in which case a significant increase in tissue stiffness would readily signal presence 
of non-healthy tissue that should be evaluated. 
For breast tissue engineering strategies, it is therefore ss ntial to understand and 
consider these physical properties of normal and cancerous mammary tissue, specifically 
when selecting materials as cellular support scaffolds.  Scaffolds f r adipose tissue 
engineering have typically been designed for restoration of tissue volume, as opposed to 
the restoration of tissue function.  Accordingly, the scaffolds should ideally restore the 
aesthetic function of the tissue by imparting a soft, smooth feel closely resembling that of 
natural tissue.  The rigidity and stiffness of scaffolds used for adipose tissue engineering 
is therefore one property that must be considered.  Consideration should be given not 
only to the aesthetic requirements of a breast reconstruction option, but also to the 
specific requirements for culturing cells for use in an autologous option [69-72].  An 
ideal scaffold should meet the aesthetic requirements while also providing a surface that 
will permit and promote cellular attachment.  Preadipocytes, the cells most commonly 
used for breast tissue engineering strategies, are anchorage-dependent cells; that is, they 
require a relatively stiff surface on which to adhere in order for proliferation and 
differentiation to occur [1, 4, 44, 73].  Coupling of these two ideas has proven a 
significant undertaking for researchers, as numerous materials wth varying physical 
properties have been considered for adipose tissue engineering methods useful for breast 
reconstruction [2].  Of the implantable materials that are available for use in tissue 
engineering, those most widely used are porous biodegradable polymers, which include 
poly-L-lactide, polyglycolide, and copolymers of the two [36, 55].  Injectable hydrogels, 
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such as alginate, chitosan, etc. appear to have the ideal characteristics for use specifically 
in breast tissue regeneration.  Studies have been conducted using calcium alginate gels, as 
well as hyaluronic acid gels, where the interactions of preadipocytes with the gel material 
have been investigated [3, 4, 37]. 
 
1.9 Influence of the Mammary Microenvironment 
 Not only must the mechanical and physical properties of the breast b  accounted 
for when developing tissue engineering strategies, but the breasts’ normal 
microenvironment should be considered.  As previously described, the mammary gland 
largely consists of glandular tissue embedded within a network of str mal tissue 
comprised of adipose tissue and fibrous connective tissue [8, 9, 15, 18, 74].  Epithelial 
cells, adipocytes, and fibroblasts are therefore the most prevalent cell types present within 
the mammary gland.  Accordingly, the interaction between the epithelial c lls and the 
stromal cells within the normal mammary microenvironment is of significant interest 
because the hormonal regulation of cellular processes that occur during mammary gland 
development, such as cell differentiation, ductal elongation, and ductal branching 
morphogenesis, are dependent on the cooperative interaction of epithelial and stromal 
cells of the breast [18, 75-78]. This premise, that the relationship between mammary 
epithelial cells and stromal cells significantly impacts mammary development, is widely 





Mammary Gland Extracellular Matrix (ECM) and Epithelium 
 Structurally, the cross-section of the human mammary gland, as shown in Figure 
1.4, reveals a bi-layered epithelium consisting of the inner-most luminal epithelial cells 
and outer-most myoepithelial cells [76, 77, 80, 81].  The luminal epithelial c lls are so-
termed because they form the lumen of the mammary gland.  Adjacent to the luminal 
epithelial cells is a thin layer of myoepithelial cells that comprises the glandular 
epithelium.  The glandular epithelium lies directly above the basement embrane of the 
mammary gland, which is structurally a thin layer of extracellular matrix sheets that 
consists primarily of collagen type IV, entactin, perlecan (heparan sulfate proteoglycan), 
and laminin [82-84].  The primary functions of the basement membrane are as a 
mechanical barrier separating the epithelium from its surrounding stroma and as a support 
structure, anchoring the epithelium to its underlying connective tissue. The main 
structural component of the fibroblastic connective tissue forming the stroma around the 





Figure 1.34: Structural components of the cross-section of the human mammary gland.  
Adapted from references [76, 77, 81, 85] 
 
 The stromal cell-epithelial cell relationship within the mammary gland has been 
proven to be most important for regulating epithelial cell differentiation and for 
modulating ductal morphogenesis in vivo [18, 86, 87].  This point is evidenced by the 
need for stromal fibroblasts and/or ECM components, such as collagen, to be present 
when culturing epithelial cells for modeling purposes in vitro [25, 79, 81, 83].  Three-
dimensional (3-D) models of mammary organogenesis and carcinogenesis are widely 
used for evaluating normal and cancerous mammary cell behavior in vit o.  However, in 
order to develop 3-D models that possess organized ductal and acinar structures similar in 
morphology to native mammary tissue, it has been shown that epithelial cel s must be co-
cultured with either stromal fibroblasts, or within collagen gels, or within laminin-rich 
Matrigel [81-83, 88, 89].  This relationship between the ECM stromal factors and the 
22 
 
epithelium must be taken into account when developing breast tissue engineering 
methods.  Many breast tissue engineering strategies are based on the idea of culturing 
adipose cells on scaffolds made of some absorbable material that is subsequently 
implanted or injected into a previously cancer-stricken patient.  It is therefore essential 
that the selected materials not emit any by-products that may cause disruption to the 
behavior of the native epithelial cells upon implantation.  Scaffolds made of collagen, for 
example, have been widely used for tissue engineering applications because collagen 
degrades enzymatically, and may be processed into a variety of shapes and forms (sheets, 
sponges, injectable microspheres, etc.) [6, 44, 71, 90-94].  Because collagen has been 
shown to play an important role in the behavior of the mammary epithelium, implanted 
collagen-based scaffolds would have to be closely observed for any disruptive signals 
that could be delivered to native epithelial cells and cause cancer re urrence or other 
immunogenic complications.  Researchers using scaffolds made of any ther ECM-based 
components would similarly need to consider any effect that the ECM scaffolding would 
have on surrounding epithelium tissue within the breast [95].     
 
Adipose Tissue Composition 
Comparisons of the human mammary gland to the mouse mammary gland are 
largely found within the literature, as the mouse mammary gland has been widely used to 
understand mammary development and to model developmental processes of th  breast 
[15, 74, 76, 77, 79].  While many similarities exist between the mouse and the human 
mammary gland, these two systems  are considered histologically different [15, 74, 95].  
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The mouse mammary epithelium is surrounded predominantly by adipose tissu , while 
the human mammary epithelium has been shown to be more closely associated with the 
fibrous connective tissue of the stroma [15, 74, 96-99].  This has led some researchers to 
theorize that the relationship between mammary epithelia and adipose tissu  within 
humans is not as significant as the epithelial-fibrous stromal relationship, however, the 
mere presence of large adipose tissue deposits within the human breast suggest otherwise.  
Identified as an endocrine organ capable of secreting hormones and factors proven to 
influence epithelial cell behavior, the adipose tissue influence on the mammary 
environment cannot be ignored [23, 100-102]. 
Adipose tissue is a highly specialized connective tissue found in two forms: 
brown and white, which function as a heat source for the body and as an energy storage 
source within the body, respectively [100].  White adipose tissue is the specific type 
found within the mammary gland.  The primary cellular component of white adipose 
tissue is a collection of lipid-filled cells, adipocytes, held togeher by collagen fibers. 
Other cellular components contained in adipose tissue are stromal-vascular cells 
including smooth muscle cells, endothelial cells, fibroblasts, blood cells, and 
preadipocytes, which account for one-to two-thirds of adipose tissue composition [37, 
103-107]. Autologous fat tissue obtained through liposuction and aspiration procedures 
has been considered for breast tissue reconstruction; however this method has been 
unsuccessful in restoring tissue volume due to insufficient angiogenesis of the tissue and 
the inability of easily-damaged adipocytes to maintain the desired volume in vivo [5, 38, 
44, 69]. Preadipocytes, precursor cells committed to the adipocyte lineage are contained 
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within the stromal-vascular fraction of enzymatically digested tissue. Preadipocytes are, 
however, deemed more advantageous as a cell source than mature adipocytes because 
they are easily cultured, easily expanded, and easily obtained.  They are capable of both 
proliferating to yield larger cell numbers, and of differentiating to form the tissue of 
interest [5, 38, 44, 104, 108].   
Long thought to be solely an energy storage locale for the body, adipose tissue 
has now become recognized as an endocrine or secretory organ within the body.  
Adipocytes are capable of secreting many proteins and cytokines (termed adipokines) 
that may influence the behavior of other cells within the body [109-111].  Factors 
secreted from adipocytes have been categorized by function as influencing ECM 
development, cell metabolism, immunological function or other processes within the 
body [109].  More specifically, evaluation of the mammary extracellular and intracellular 
components of mammary adipose tissue has yielded an extensive listing of proteins found 
within in mammary adipose tissue [112].  From this comprehensive lit of growth factors 
and cytokines, investigators hope to further understand the relationship that exists 
between mammary epithelial and adipose cells.  With such a large deposit of adipose 
tissue within the human breast it seems highly probable that a close paracrine relationship 
between mammary epithelial and adipose cells exists [113].  Many sources have listed 
factors generally secreted by adipose cells [109].  When consideri g b east tissue 
engineering applications, however, it is necessary to identify factors secreted from 
adipocytes that may have some direct influence on epithelial cel behavior.  Table 1.2 
lists adipocyte-secreted factors that have been proven to influence pithelial cell 
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behavior.  Knowledge of these factors and their role in influencing epithelial cell 
behavior should be taken into account when developing adipose tissue engineeri 
strategies, as the inclusion or omission of one or more of these factors could yield 
improved breast tissue engineering options. Additionally, knowledge of adipocyte-
secreted factors that also have exhibited roles in tumor progression, such as matrix 
metalloproteinases (MMPs), could yield information regarding mammary tumor 
formation [114, 115]. 
Preadipocytes and adipocytes have commonly been used as the cellular basis for 
adipose tissue engineering strategies in breast reconstruction [90, 116].  Additional 
attempts toward developing breast tissue engineering strategies hav  included the use of 
mammary epithelial cells co-cultured with adipose cells, since these are two of the most 
prevalent cell types present within the breast and it is documented in he literature that 
there exists an adipose cell-epithelial cell relationship within the breast [85, 117].   
 
Table 1.2: Adipocyte-Secreted Factors that Influence Epithelial Cell Behavior 
Factor Reference(s) 
Estrogen [85, 100] 
Glucocorticoids [85, 100, 112] 
Insulin-like Growth Factor-1 (IGF-1) [96] 
Transforming Growth Factor (TGF-
β) 
[85, 100, 118] 
Fibroblast Growth Factor (FGF) [96, 112] 





 Investigation of the relationship between adipose cells and epithelial c ls has led 
to the conclusion that adipose cells promote functional differentiation of epithelial cells, 
characterized by casein production and milk protein synthesis [119].  Attempts to co-
culture mammary epithelial cells and adipocytes within a collagen el yielded cellular 
clusters containing structures resembling the ductal structures of the breast [120].  
Similarly, co-cultures of preadipocytes with mammary epithelial cells on 3-D silk 
scaffolds also resulted in cellular structures appearing to undergo uctal morphogenesis 
[102]. Analysis for functionality in these cases was not conducted, so it i  not known 
whether functional breast tissue was produced or not [102, 120].  For further 
development of breast tissue engineering strategies, the use of co-cultures of mammary 
epithelial cells and adipose cells seems promising; however, studie  further evaluating 
that specific relationship are limited.  The paucity of research could possibly be attributed 
to the difficulties in maintaining mature adipocytes in culture. Due to their buoyant 
nature, the lipid-filled cells float in culture so proliferation is limited and cells may not be 
readily available.  Additionally, breast tissue engineering methods based on co-cultures 
of mammary epithelial and adipose cells may not be of greater interest because of the use 
of epithelial cells.  The majority of breast cancers originate wi hin the ducts of the breast 
(85%), often the result of some abnormality of the ductal epithelial cells [33, 85].  The 
use of epithelial cells for breast tissue reconstruction options should be carefully 
considered as one would not want to introduce altered epithelial cells with the potential to 
become cancerous into a former cancer patient.  As such, many str tegies are therefore 
directed toward the use of adipose cells in breast tissue reconstruction. 
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 Of additional interest to the discussion of adipose tissue influence o  the 
mammary microenvironment is the role of fatty acids within the br ast.  Dietary fatty 
acids have been identified within deposits of mammary tissue in the body, the 
measurement of which has been determined to be useful as a biomarker of dietary fatty 
acid intake by individuals [121-126].  Within the literature, it is well-documented that 
there is conflicting opinion regarding the influence of dietary ftty acids on the behavior 
of breast cancer cells, whereby specific fatty acids have been shown to act as anti-cancer 
agents (eicosapentaenoic acid, EPA, and docosahexaenoic acid, DHA), while others have 
been considered cancer promoting agents (linoleic acid and arachidonic acid) in certain 
instances [122, 123, 127-136].  Numerous epidemiological, experimental, and ecological 
studies have been conducted to evaluate the relationship between dietary fatty acids and 
breast cancer risks [126, 129, 135-142].  Analysis of normal breast tissue samples, i.e. 
those that are identified as free of tumorigenic cells, has shown that the fatty acids found 
most commonly in the highest concentrations within samples are oleic, palmitic, linoleic, 
and stearic acids [133, 143]. In the case of cancerous mammary tissuesamples, 
investigation of fatty acids contributing to cancer growth or inhibition has led to the 
concept that increased levels of linoleic acid and arachidonic acid are associated with 
increased risk of breast cancer [127, 128, 133, 144], while increased levels of α-linolenic 
acid, EPA, DHA, and conjugated linoleic acid are associated with decreased risk of breast 
cancer occurrence [127, 128, 131, 133, 145].  Table 1.3 summarizes, to date, the 
influence of investigated fatty acids on breast cancer cell behavior.   
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It was shown that preadipocytes supplemented with oleic acid accumulated large 
amounts of cytoplasmic lipid fairly rapidly in vitro [146].  Furthermore, the addition of 
linoleic acid to the culture medium of preadipocyte cells result d in significant lipid 
accumulation within the cells [147].  The influence that specific fatty acids will have on 
epithelial cells of the breast should therefore be considered when developing breast 
reconstruction strategies.  The release of fatty acids from adipose cells may influence cell 
proliferation and other cellular processes within the mammary gland [96, 97].  More 
specifically, it has been suggested that extracellular supplementation of adipose cells with 
fatty acids [127, 148] could promote and facilitate the lipid filling of those fat cells used 
in breast tissue engineering applications [149-151].  One limiting factor to providing 
patients with an autologous engineered breast tissue option has been the inability to 
maintain a stable volume of adipose tissue long-term.  With the inclus on of fatty acids 
that will aid in facilitating lipid filling of the cells, it is feasible that this addition will in 
turn aid in maintenance of overall implant volume in vivo while promoting increased 
adipose cell size through increased lipid accumulation.  It is therefor  essential to 
understand the role that specific fatty acids possibly play as either breast cancer 
promoters or as breast cancer inhibitors—the inclusion of a poorly selected fatty acid 




Table 1.3: Fatty Acid Influence on Breast Cancer Cell Behavior 
Fatty Acid   
Common Name Shorthand Cell/Tissue Type 
Influence on Cell 
Behavior* 
Reference(s) 














Monounsaturated Fatty Acids (ω-9) 






Polyunsaturated Fatty Acids (ω-3) 
α-Linolenic (ALA) 18:3, n-3 
Human mammary 
tissue 
























22:5, n-3    
Polyunsaturated Fatty acids (ω-6) 















[127, 128, 148, 
160] 
[161] 
Arachidonic 20:4, n-6 
Human mammary 
tissue 
Promote [127, 148, 156] 















*The influence of each specific fatty acid on cellular behavior was determin d to either 
“inhibit” tumor cell proliferation and/or metastasis, “promote” tumor cell proliferation; 




1.10 Research Aims 
Previous research in our laboratory has been focused toward the development and 
optimization of an injectable composite system for breast tissue reconstruction, shown in 
Figure 1.5, [163, 164].  The system is comprised of cells seeded on biodegradable beads 
of an injectable size; these cellular constructs are then mixed with a degradable hydrogel 
delivery medium, resulting in a composite that may be injected into a patient through a 
syringe at the defect site.  In vitro studies using 3T3-L1 preadipocyte cells cultured on 
various surfaces showed that the selection of injectable bead chemistry and topography, 
with and without therapeutic components, may be used to influence cellular 
differentiation.  Preadipocyte cells were cultured in vitro on highly porous gelatin beads 
and relatively smooth polylactide beads.  Assays to measure lipid production and to 
evaluate the genes expressed by the cells revealed that the scaffold material and/or 
surface topography did influence cell attachment, lipid production, and gee expression 
[165].  Additionally, in vivo studies in a large animal model demonstrated the efficacy of 
the composite system.  Implantation of cellular and acellular injectable composite 
constructs within a bovine animal model revealed that the selected bead materials were 






Figure 1.5: The injectable composite system for breast tissue reconstruction has been 
evaluated; however, further improvements on the system are necessary. 
 
 While these previous results are promising, there are still aspects of the injectable 
composite system that require further investigation to yield a more successful implant 
system.  More specifically, this work is designed to answer the following questions 
regarding the injectable composite system: 
1. Is it possible to manipulate isolated adipose cells in vitro to more optimally direct 
their differentiation to mature cells?  
2. Will the inclusion of fatty acids within our cell cultures promote r maintain the 
lipid-filling capabilities of isolated adipose cells in vitro? 
3. What influence will fatty acids have on adipose cell-breast cancer cell interactions 
in vitro? 
To answer these questions, five specific aims, listed in Table 1.4, were outlined.  





Table 1.4 Research Specific Aims 
Specific Aims 
Aim 1:  Investigate the relationship between mammary epithelial cells and 
primary adipose cells in two-dimensional culture 
Aim 2: Evaluate adipose cell behavior in three-dimensional cultures with 
mammary epithelial cells 
Aim 3: Evaluate the influence of exogenous fatty acid on adipose cell 
differentiation in two-dimensional in vitro cultures 
Aim 4:  Evaluate the influence of three-dimensional fatty acid-loaded 
substrates on adipose cell differentiation 
Aim 5: Evaluate fatty acid influence on adipose cell-breast cancer cell 
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THE EFFECT OF MAMMARY EPITHELIAL CELL CONDITIONED MEDIA 





 The development of a clinically translatable method of engineerig adipose tissue 
for breast reconstruction requires investigation of several components.  Adipose tissue 
engineering strategies have involved the use of preadipocytes and adipocytes to restore 
the volume of tissue lost at defect sites.  Mature adipocytes in culture are limited in their 
proliferative capabilities, and are not readily expanded to high numbers or volume [1-3].  
Preadipocytes, which are precursor cells committed to the adipocyte lineage, have also 
been suggested for use in adipose tissue engineering.  Preadipocytes are deemed more 
advantageous as a cell source than mature adipocytes because they are easily cultured, 
easily expanded, and easily obtained.  They are capable of both proliferating to obtain 
larger cell numbers, and of differentiating to form the tissue of interest [4-7].
 The process of adipogenesis or the formation of fat is a multi-step process 
involving the proliferation and differentiation of preadipocytes.  For differentiation of 
preadipocyte cell lines to occur, differentiation inducers consisting of insulin, 
dexamethasone, and 3-isobutyl-1-myethylxanthine (IBMX) are added to the cultures to 
initiate and accelerate the differentiation process [8-14].   The ability to isolate and 
culture primary preadipocytes from several species has been d monstrated.  When 
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studying differentiation of these cells, the use of primary cells offers several advantages.  
Primary preadipocytes can be obtained from adipose deposits in different locations from 
a wide variety of animals in order to glean information about the local behavior and 
environmental conditions of adipose cells and tissues.   
 We hypothesize that if the differentiation of these adipose cells could be 
controlled in vitro, while maintaining the capacity of the cells to proliferate, researchers 
would be able to better dictate how the cells will behave once implanted into the body, 
and would be able to produce large volumes of adipose tissue from a small nu ber of 
retrieved cells.  The interaction of mammary stromal and epithelial c lls has been widely 
investigated in studies of normal mammary development; the two cell types work 
together during processes of ductal expansion and alveolar development. It is therefore 
logical that, because these two cell types are found in close pr ximity in normal tissue, a 
co-culture is necessary in order to engineer new tissue for breast reconstruction.  That is, 
there is likely some signaling or cross-talk that exists between these cell types, such that a 
co-culture of the two would prove advantageous.  Because most occurrences of breast 
cancer originate in the epithelial cells of the breast ducts, it may not be advantageous to 
implant epithelial cells simultaneously with adipose cells for breast tissue regeneration.  
Rather, exposure of the adipose cells, pre-implantation, to mammary epithelial cells could 
provide a stimulus in vitro, which would influence adipose differentiation once 
implanted. 
 Previous studies were conducted to evaluate the effect of mammary epithelial 
cells on the differentiation of cells of the adipose lineage.  D1 cells, mouse bone marrow 
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stromal cells, are mesenchymal cells that are capable of differentiating to bone, cartilage, 
and fat cells when cultured in medium with an appropriate stimulus.  When cultured with 
medium conditioned from MACT (bovine mammary epithelial) cells, the diff rentiation 
of the D1 cells was inhibited, even in the presence of adipogenesis differentiation 
inducers.  Additionally, once the cells were cultured in normal medium with 
differentiation inducers, the inhibition of differentiation was reversed, and the cells 
differentiated as normal [15].   
As cells are grown in culture they produce cytokines and other factors that are 
expressed in the conditioned media.   In the previously described studies, he behavior of 
adipose cells, when cultured with conditioned medium from mammary epithelial c ll 
cultures, was shown to vary depending on the specific type of conditione medium used 
to treat the adipose cells.  To better understand the outcome of the conditioned medium 
studies, it was necessary to identify any specific factors pre ent in the conditioned 
medium that could potentially inhibit or facilitate adipogenesis. 
Numerous cytokines, growth factors, and other chemical compounds have been 
shown to influence adipogenesis.  One of the most widely produced cytokines is 
transforming growth factor-β (TGF-β).  TGF-β exists in three isoforms, TGF-β1, TGF-
β2, and TGF-β3, which are produced and secreted by many cell types, and thus plays 
multiple roles in physiological functions of the body, including immunological and 
inflammatory processes, and regulation of cellular differentiation.  For example, TGF-β 
has been shown to be produced by chondrocytes and osteoblasts, and is a promoter of 
chondrogenic differentiation [16].  The role of TGF-β in epithelial cell-mesenchymal cell 
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interactions has also been noted; both epithelial and mesenchymal cells produce TGF-β.  
Additionally, TGF-β has been shown to play a role in the functional development of 
epithelial tissues, such as the lungs, kidneys, and breasts, where TGF-β functions as a key 
regulator in ductal growth and formation [17].  Further evaluation of the li erature reveals 
that TGF-β has been identified as an inhibitor of adipogenesis.  Early studies conducted 
by Torti and coworkers showed that the addition of either TGF-β1 or TGF-β2 to 
differentiated adipose cells resulted in a decrease in adipogenic g e expression and, as a 
result, inhibited adipogenesis [18].  The function of TGF-β to inhibit adipogenesis has 
also been correlated to decreased levels of PPARγ and C/EBPα, transcription factors that 
are known to be critical for adipogenesis [10, 19, 20].  
In addition to TGF-β, plasminogen activator inhibitor-1 (PAI-1) has been 
identified as a protein produced by adipose tissue that acts in an autocrine manner to 
modulate adipogenesis [21].   PAI-1 is a serine protease inhibitor that inhibits 
plasminogen activation and fibrinolysis in vivo.  PAI-1 is secreted by endothelial cells, 
vascular smooth muscle cells, and adipocytes.  As a key regulator of fibrinolysis and 
thrombus formation, increased levels of PAI-1 have also been associated w th increased 
risk for cardiovascular diseases and diabetes [22].  Further correlati n has also been 
drawn to link high levels of PAI-1 in obese mice and humans to insulin res stance; since 
insulin is a known modulator of adipogenesis, it is suggested that PAI-1 may also 
influence adipocyte differentiation [22-28].  Liang and coworkers showed that 
overexpression of PAI-1 inhibited adipogenesis of 3T3-L1 preadipocytes and reduced 
PPARγ and C/EBPα transcription factors, while inhibition of PAI-1 promoted 
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adipogenesis [21].  PAI-1 has also been associated with TGF-β, as TGF-β has been used 
to stimulate PAI-1 production in 3T3-L1 mouse preadipocytes and human adipose tissue 
explants [23, 29].   
Studies were conducted in order to: 1) determine what effect mammary epithelial 
cell conditioned medium would have on primary adipose cells in vitro, 2) determine if the 
influence of the conditioned medium on adipogenesis was species-dependent or 
independent, and 3) characterize the components of each type of conditioned medium.     
 
2.2 Materials & Methods 
Methodologies were first determined to successfully isolate populations of 
primary adipose cells from bovine, murine, and human tissue samples.  Isolated cells 
were then cultured in vitro with specified conditioned media (Table 2.1) to determine the 
effects on cell differentiation.  Additionally, analyses of specific factors present within 
each type of conditioned medium were performed to determine if any similarities could 
be identified among the media types and the medium effect on cell behavior.  Enzyme-
linked immunosorbent assays (ELISAs) specific for TGF-β and PAI-1 were conducted to 
determine if any measurable quantities of the factors were prsent within each medium 
sample.  Additionally, a protein array was used to identify cytokines specific for 
adipocytes and adipokines present in the conditioned media samples.  This information 
was then used to draw comparisons between the components of each conditioned medium 




Table 2.1: Tissue Samples and Cell Lines for Cellular Studies 
Species of Fat Tissue Primary 
Culture 
Complementary Mammary 





Primary Adipose Cell Isolation & Characterization 
Cell Isolation 
Procurement of human tissue samples for this work was approved by the 
Greenville Hospital Systems Institutional Review Board (IRCOR #Pro00002270) and the 
Clemson University Institutional Biosafety Committee (#IBC2009-15).  Bovine tissue 
samples were obtained from cattle at a local slaughterhouse, whil murine tissue samples 
were obtained from mice at the Clemson University Godley Snell animal research 
facility.  An enzymatic digestion procedure, detailed in Appendices A, B, and C, was 
used to isolate the primary adipose cells from samples of fresh bovine, murine, and 
human adipose tissue.  Briefly, following collection of the samples, the tissue was 
processed under sterile conditions in a SterilGARD III Advance laminar flow Class II 
Biological Safety Cabinet (The Baker Company, Sanford, ME).  The tissue samples were 
rinsed with sterile transport medium, consisting of Hank’s Balanced Salt Solution (Gibco, 
Invitrogen, Carlsbad, CA) supplemented with 1% antibiotic-antimycotic (AA) (Gibco, 
Invitrogen, Carlsbad, CA) and 0.2% fungizone (Gibco, Invitrogen, Carlsbad, CA).  
Samples were rinsed by pipetting transport medium over the tissue samples twice. Tissue 
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samples were then minced by cutting the tissue into small pieces with sterile disposable 
scalpels (BD, Franklin Lakes, NJ); the pieces were incubated in a collagenase digestion 
solution for 1 hour at 37°C in a rotating water bath (Thermo Scientific Lab-Line, 
Waltham, MA) at 100rpm.  Following digestion of the tissue, the lysate was filtered using 
a 1000-µm nylon mesh (Small Parts Inc., Lexington, KY) placed over a sterilized glass 
funnel (Pyrex®, Corning, Corning, NY).  The filtrate was centrifuged for 10 minutes at 
1000rpm using an Allegra 6R centrifuge (Beckman Coulter, Brea, CA) to separate the 
sedimented stromal-vascular cells, consisting primarily of preadipocytes, from the fatty 
and aqueous layers of the solution.  The resulting preadipocyte cells were seeded in T-25 
culture flasks (Corning, Corning, NY) with Dulbecco’s Modified Eagle’s Medium 
(DMEM) (Gibco, Invitrogen, Carlsbad, CA) supplemented with 1%  AA, 0.2% 
fungizone, 0.4% Insulin-Transferrin-Sodium Selenite (ITS) medium supplement (Sigma, 
St. Louis, MO), and 10% fetal bovine serum (FBS) (Mediatech, Herndon, VA). Culture 
flasks were incubated at 37°C with 5% CO2.  This procedure was used for all tissue 
types; however, digestion of the human tissue samples also included a st p to lyse red 
blood cells contained within the tissue lysate. 
 
Cell Culture 
Isolated primary cells were seeded in 12-well culture plates (Corning, Corning, 
NY) and grown to confluence.  At confluence, an adipogenic differentiation cocktail was 
added to the cells to assess differentiation to mature fat cells.  The adipogenic cocktail 
was prepared by adding 1mL 5mM 3-isobutyl-1-methylxanthine (IBMX) (Sigma, St. 
57 
 
Louis, MO), 100µL 10mg/mL insulin (Sigma, St. Louis, MO), and 2µL 1mg/mL 
dexamethasone (Sigma, St. Louis, MO) to every 10mL of DMEM culture medium.  A 
volume of 2mL of adipogenic cocktail was added to each well.  Cells were cultured with 
the adipogenic cocktail for 7 days, after which time cellular differentiation was assessed. 
 
Qualitative Microscopy 
Representative cellular morphology for cells isolated from each tissue type was 
evaluated.  Light microscopic images of cells during culture were captured using an 
Axiovert 135 inverted microscope (Zeiss, Thornwood, NY) fitted with a ProgRes™ C10 
Plus color digital camera (Jenoptik Optical Systems, Jupiter, FL) and ProgRes Capture 
Pro 2.6 imaging software (Jenoptik Optical Systems, Jupiter, FL). 
 
S-100 Staining 
The presence of S-100 protein was detected by staining using a Mouse ABC 
Staining System kit (Santa Cruz Biotechnology, Santa Cruz, CA).  Briefly, the culture 
medium was aspirated from the well plates and the cells were rins d twice with 
phosphate buffered saline (PBS; Sigma, St. Louis, MO).  The cells wre then fixed in 
10% Neutral Buffered Formalin (NBF) (Fisher Chemicals, Fair Lwn, NJ) for 1 hour at 
room temperature. The NBF was removed from the wells and the cells were rinsed again 
with PBS.  A volume of 1mL of 1% hydrogen peroxide diluted in PBS was added to each 
well for 10 minutes at room temperature.  The hydrogen peroxide was aspirated from the 
wells and the cells incubated with 1.5% blocking serum for 1 hour at room temperature 
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on an orbital shaker.  The blocking serum was aspirated from the wells and 200µL of anti 
S-100 protein primary antibody (Millipore, Billerica, MA) was added to the wells and 
incubated for 30 minutes at room temperature on an orbital shaker.  The primary antibody 
was removed and samples washed three times with PBS.  The secondary a tibody, 
provided in the kit, was added to the wells and incubated for 30 minutes at room 
temperature on an orbital shaker (IKA Works, Wilmington, NC).  The secondary 
antibody was removed and samples washed three times with PBS.  The AB enzyme 
reagent was added to the wells and incubated for 30 minutes at room temperature.  The 
AB enzyme reagent was removed and the samples washed three times with PBS.  Three 
drops of peroxidase substrate were added to the wells for 10 minutes at room 
temperature.  The excess peroxidase substrate was blotted from the wells and the 
presence of S-100 protein, indicated by brown staining within the cells, was imaged using 
an inverted microscope and imaging software. 
 
Oil Red O (ORO) Staining 
Cell culture medium was aspirated from well plates and the cells were rinsed 
twice with sterile PBS.  The cells were fixed with 2mL of 10% NBF overnight.  An ORO 
stock solution was prepared by dissolving 0.5g ORO powder (Sigma, St. Louis, MO) in 
100mL isopropanol (Fisher Scientific, Fair Lawn, NJ).  An ORO working solution was 
prepared by mixing 60mL of ORO stock solution with 40mL deionized water and stirring 
for 30 minutes.  A volume of 500µL of the working solution was added to each well and 
incubated for 15 minutes at room temperature.  Following incubation, the wells ere 
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rinsed three times with fresh deionized water.  After decanting the excess water, the red-
stained lipid was imaged using an inverted microscope and imaging software. 
 
Total Triglyceride Measurement 
Cell culture medium was aspirated from well plates and the cells rinsed twice 
with sterile PBS.  After subjecting the cells to three freeze-thaw cycles, 1mL of 1% 
Triton X-100 (Sigma, St. Louis, MO) was added to each well and the cells were 
incubated for 30 minutes at room temperature.  Standard glycerol solutions of 
concentrations ranging from 0 to 200µM glycerol were prepared by dissolv ng glycerol 
(#G7793, Sigma, St. Louis, MO) in deionized water.  Following incubation, he cells 
from each well were collected with the Triton X-100 solution into microcentrifuge tubes 
(Fisher Scientific, Fair Lawn, NJ) and centrifuged for 10 minutes a  3000rpm.  A volume 
of 100µL of each sample and standard was pipetted into the wells of a 96-well plate 
(Corning, Corning, NY) in triplicate.  A volume of 100µL of Infinity™ Triglyceride 
Reagent (Thermo Fisher Scientific, Waltham, MA) was added to each well and incubated 
for 15 minutes at room temperature.  The absorbance was read at 490nm on a icroplate 
reader (BioTek Instruments, Inc., Winooski, VT). 
 
Statistical Analysis 
Statistical analyses of triglyceride data for preliminary characterization were 
performed using a paired t-test with significance level of p<0.05 (n=3).  Graphical error 
bars represent the standard error of the mean.   
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Conditioned Media Influence on Adipose Cell Behavior 
Conditioned Media Collection 
MACT cells (CRL-10274, ATCC, Manassas, VA) were cultured in T-150 flasks 
(Corning, Corning, NY) with 15mL of DMEM (ATCC, Manassas, VA) until confluence.  
The MACT culture medium consisted of 500mL DMEM supplemented with 10% FBS, 1% 
AA, and 0.2% fungizone.  MACT conditioned medium (MACT-CM) was collected every 2–
3 days from confluent MACT cells; the medium was stored at 4˚C if designated for use 
within the week or -20°C if intended for later use.  Immediately b fore medium changes, the 
MACT-CM was warmed to 37˚C and centrifuged at 1000 rpm for 5 minutes to collect 
residual cellular debris.   
NMuMG cells (CRL-1636, ATCC, Manassas, VA) were cultured in T-150 flasks 
with 15mL of DMEM (ATCC, Manassas, VA) until confluence.  The NMuMG culture 
medium consisted of 500mL of DMEM supplemented with 10% FBS, 2% AA, 0.2% 
fungizone, and 0.l% insulin.  NMuMG conditioned medium (NMuMG-CM) was colle ted 
every 2–3 days from confluent NMuMG cells; the medium was stored at 4˚C if designated 
for use within the week or -20°C if intended for later use.  Immediat ly before medium 
changes, the NMuMG-CM was warmed to 37˚C and centrifuged at 1000 rpm fo  5 minutes 
to collect residual cellular debris.   
MCF10A cells (CRL-10317, ATCC, Manassas, VA) were cultured in T-150 
flasks with 15mL of Mammary Epithelial Cell Growth Medium (MEGM) (Lonza, 
Walkersville, MD) until confluence.  The MCF10A culture medium consisted of 500mL 
MEGM supplemented with the contents of one MEGM bullet kit consisting of 2mL 
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bovine pituitary extract, 0.5mL human epidermal growth factor, 0.5ml hydrocortisone, 
0.5mL insulin, and 0.5mL gentamicin.  MCF10A conditioned medium (MCF10A-CM) 
was collected every 2-3 days from confluent MCF10A cells; the medium was stored at 
4˚C if designated for use within the week or -20°C if intended for late use.  Immediately 
before medium changes, the MCF10A-CM was warmed to 37°C and centrifuged at 1000 
rpm for 5 minutes to collect residual cellular debris.   
 
Cell Seeding 
Primary bovine, murine, and human adipose cells were isolated from tissue 
samples using the enzymatic digestion procedures as described in Appedices A, B, and 
C.  Each individual cell type was seeded in T-25 culture flasks with 5mL of DMEM 
supplemented with AA, fungizone, ITS, and FBS.  The cells were grown t  confluence, 
and the culture medium was changed every 2-3 days.  At confluence the clls were 
subcultured and grown to confluence in T-150 culture flasks until a sufficient cell number 
was obtained. 
Bovine, murine, and human adipose cells were seeded individually in 12-well culture 
plates at 20% seeding density (7.6x104 cells per well) to evaluate the effect of each type of 
conditioned medium on the adipose cell behavior.  Only cells of passage four or lower were 
used for these studies.  Cells were initially cultured with 2mL DMEM per well until 2 days 
post-seeding.  At that time, the DMEM was removed from the cells and the cells were then 
cultured with 2mL of media according to the conditions shown in Figure 2.1.  The 
adipogenic differentiation cocktail consisted of the following: per 10mls DMEM, 1ml 
 
IBMX + 100µl insulin +2µl dexamethasone.  The cells were cultured under these conditions 
for 14 days, with medium changes every 2
Figure 2.1: The control samples for each cell type w re cultured with DMEM only or 
with an adipogenic differentiation cocktail (AC).  The experimental samples for each cell 
type were cultured with a specified conditioned media, or with the conditioned
combination with the adipogenic cocktail.
 
Metabolic Activity 
Cellular metabolic activity was quantitatively assed using alamarBlue
Viability Reagent (Invitrogen, Biosource International, Camarillo, CA).  The 
alamarBlue® reagent was adde
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-3 days.   
 
 to each well at 10% of the amount of culture medium n 
 




each well (200µl added to the 2mL in each well).  Well plates were incubated for 3 hours 
at 37°C on a shaker plate.  Following incubation, 150µl of the reaction solution was 
removed from each well of the cell culture plates to corresponding wells of a black-
walled, clear-bottom 96-well microplate (Corning, Corning, NY) to assay the 
fluorescence of samples resulting from the reduction of the dye by metabolically active 
cells, as visualized by a color change from blue to pink.  Samples were assessed using a 
Fluoroskan Ascent FL microplate reader (Labsystems, Finland) with fluorescence 
excitation wavelength of 544nm and emission wavelength of 590nm.   
 
RNA Isolation  
Samples of ribonucleic acid (RNA) were isolated from cells cultured at each 
condition.  The culture medium was aspirated from the wells of the culture plates and the 
cells were rinsed with 1mL of sterile PBS.  The RNA was isolated from the samples 
using the reagents and instructions supplied in an RNeasy Mini Kit (QIAGEN, Valencia, 
CA) (Appendix D).  The cell membranes of the cell samples were directly lysed by 
adding 600µL of Buffer RLT to the wells of the culture plates.  The samples were 
incubated at room temperature in the Buffer RLT for 15 minutes.  Each s mple was then 
homogenized by pipetting the lysate onto a QIAshredder spin column inserted into a 2ml 
collection tube.  The tubes were centrifuged for 2 minutes at 13,000 rpm.  Following 
centrifugation, 600µL of 70% ethanol was added to the homogenized lysateof each 
sample and mixed well.  Following transfer of the samples to RNeasy mini columns, the 
samples were subjected to a series of wash and centrifugation steps.  To elute the RNA 
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sample, 50µL of RNase-free water was added to the RNeasy columns and the samples 
were centrifuged for 1 minute at 13,000 rpm.  The elution step was repeated and the 
sample RNA was collected in a 1.5ml collection tube.  The final volume of each RNA 
sample was 100µL.  All samples were stored at -80°C. 
 
Analysis of RNA Concentration and Purity  
The concentration and purity of the isolated RNA samples were measured using 
the Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., San Jose, CA), RNA 6000 
Nano Assay Kit (Agilent Technologies, Inc.), RNA 6000 Ladder (Ambion, Inc., Austin, 
TX), RNA 6000 Nano LabChip® (Caliper Technologies Corp., Mountain View, CA), 
and 2100 Expert Software (Agilent Technologies, Inc.) (Appendix E).  Prepared samples 
were loaded on the LabChip®, placed in the Bioanalyzer, and analyzed using the 
Eukaryote Total RNA Nano program from the 2100 Expert software to determine the 
concentration of the RNA sample (reported as ng per mL), the RNA integrity number, 
and the 28s:18s ribosomal ratio.   
 
Real Time Quantitative RT-PCR  
Three genes were selected to assess the differentiation of the isolated cells.  
Primers specific for the following genes were used in the RT-PCR analysis: peroxisome 
proliferator activator receptor-gamma (PPAR-γ), adipocyte-specific fatty-acid-binding 
protein-2 (aP2), and beta-actin (β-actin).  PPAR-γ and aP2 were selected to identify cells 
in the early and late stages of adipocyte differentiation; and β-actin was used as the 
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housekeeping gene.  Primers specific for each species of cells and accession numbers for 
the mRNA sequences for each specified gene are listed in Table 2.2.  The primer pairs for 
each gene were ordered from Integrated DNA Technologies (IDT) (Coralville, Iowa).   
Real-time, one step RT-PCR was performed using the Quantifast™ SYBR® 
Green RT-PCR kit (Qiagen).  RNA samples, primers, and components of the RT-PCR kit 
were maintained on ice during the reaction setup.  Template RNA samples were diluted 
to a working concentration of 10ng/uL and primers were diluted to 25µM.  Sample 
reactions were prepared according to the table shown in Appendix F.  No Template and 
Minus-RT control samples were prepared for each set of reactions by adding RN-ase free 
water to the reaction tubes instead of template RNA or the RT mix, respectively.  All RT-
PCR reactions were performed using a Rotor-Gene RG-3000 light cycler (Corbett 
Research, Sydney, Australia) equipped with Rotor-Gene 6.1 software (Corbett Research).   
The comparative Ct or delta-delta Ct (∆∆Ct) method was used to determine the 
relative expression level for each gene of interest using β-actin as the reference gene.  










Table 2.2 RT-PCR Primers 
Bovine Sequence Accession No. 
β-actin 
 
Fwd:  5’-CTCTTCCAGCCTTCCTTCCT-3’ 





Fwd:  5’-CGCACTGGAATTAGATGACAGC-3’ 





Fwd:  5’-AGGTACCTGGAAACTTGTCT-3’ 
Rev:  5’-GACAACGTATCCAGCAGAA-3’ 
X89244 
Murine Sequence Accession No. 
β-actin 
 
Fwd:  5′-TGGAATCCTGTGGCATCCATGAAAC-3′  





Fwd:  5′-ACTGCCTATGAGCACTTCAC-3′  





Fwd:  5′-GAATTCGATGAAATCACCGCA-3′  
Rev:  5′-CTCTTTATTGTGGTCGACTTTCCA-3′ 
NM024406 
Human Sequence Accession No. 
β-actin 
 
Fwd:  5′-TGACGGGGTCACCCACACTGTGCCCATCTA-3′  





Fwd:  5′-AGACAACAGACAAATCACCAT-3 ′   





Fwd:  5′-TGCAGCTTCCTTCTCACCTTGA-3′  
Rev:  5′-TCCTGGCCCAGTATGAAGGAAATC-3′ 
NM001442 
 
∆Ct(Control) = Ct(Target) – Ct(Reference)   Equation 2.1 
∆Ct(Sample) = Ct(Target) – Ct(Reference)   Equation 2.2 
∆∆Ct = ∆Ct(Sample) = ∆Ct(Control)   Equation 2.3 
Relative Expression = 2-∆∆Ct    Equation 2.4 
Where: Control = Control sample condition 
 Sample = Experimental sample condition 
 Target = Gene of interest (i.e., aP2 or PPAR-γ) 




SAS 9.2 (Cary, NC) statistical software was used to compare the ffect of each 
conditioned medium on cellular metabolic activity and triglyceride production.  
Statistical analyses were performed using a general complete block design with three 
replicates per treatment, randomly assigned to each cell type.  Follow-up analyses were 
conducted using Fisher’s Protected Least Significant Differenc (LSD).  Observations 
with standardized residuals more than two standard deviations from the mean were 
excluded from the analysis.  A significance level of p<0.05 (n=3) was used for all 
comparisons.  Graphical error bars represent the standard error of the mean. 
 
Conditioned Media Characterization 
Conditioned Media Collection 
MACT cells were cultured in T-150 flasks with 15mL of DMEM until confluence.  
The MACT culture medium consisted of 500mL DMEM supplemented with 10% FBS, 1% 
AA, and 0.2% fungizone.  MACT conditioned medium (MACT-CM) was collected from 
confluent MACT cells; aliquots of the medium were assayed immediately. 
NMuMG cells were cultured in T-150 flasks with 15mL of DMEM until 
confluence.  The NMuMG culture medium consisted of 500mL DMEM supplemented 
with 10% FBS, 2% AA, 0.2% fungizone, and 0.l% insulin.  NMuMG conditioned 
medium (NMuMG-CM) was collected from confluent NMuMG cells; aliquots of the 
medium were assayed immediately. 
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MCF10A cells were cultured in T-150 flasks with 15mL of MEGM until 
confluence.  The MCF10A culture medium consisted of 500mL MEGM supplement d 
with the contents of one MEGM bullet kit consisting of 2mL bovine pituitary extract, 
0.5mL human epidermal growth factor, 0.5ml hydrocortisone, 0.5mL insulin, and 0.5mL 
gentamicin.  MCF10A conditioned medium (MCF10A-CM) was collected from 
confluent MCF10A cells; aliquots of the medium were assayed immediately. 
 
TGF- β 1 ELISA 
The amount of TGF-β1 present within samples of each type of conditioned 
medium was determined using a Multispecies TGF-β1 quantitative sandwich ELISA kit 
(Invitrogen, Camarillo, CA).  Conditioned medium samples were collected from 
confluent cultures of cells and centrifuged for 10 minutes at 1000 x g. A volume of 
0.05mL of extraction solution was added to 0.25mL of each sample in microtubes and 
incubated for 30 minutes at 4°C.  Reagents and standard solutions were prepared 
according to the standard protocol.  A volume of 200µl of standards and extract d 
samples were added to wells of the microplate.  Biotinylated anti-TGF-β1 solution in the 
amount of 50µl was added to each well; the plate was covered and incubated for 3 hours 
at room temperature.  The solutions were aspirated from the wells and the plate was 
rinsed four times with wash buffer.  A volume of 100µl of streptavidin-HRP working 
solution was added to the wells and then incubated for 30 minutes at room temperature.  
Following aspiration of the solution and washing of the plate, 100µl of stabilized 
chromogen was added to each well and the plate was incubated for 30 minutes at room 
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temperature in the dark.  Stop Solution in the amount of 100µl was added to each well 




The amount of PAI-1 present within samples of each type of conditi ed media 
was determined using a PAI-1 quantitative sandwich ELISA kit (AssayPro, St. Charles, 
MO).  Conditioned medium samples were collected from confluent cultures of cells and 
centrifuged for 10 minutes at 2000 x g.  A volume of 1.5mL of the supernatant was 
collected in microtubes for the assay.  Reagents and standard solutions were prepared 
according to the standard protocol.  Standards and samples in the amount of 50µl of were 
added to wells of the microplate, pre-coated with a polyclonal antibody specific for PAI-
1, and incubated for 2 hours at room temperature.  The microplate was washed five times 
with wash buffer, after which 50µl of Biotinylated PAI-1 Antibody was added to each 
well and incubated for 1 hour at room temperature.  After washing te microplate with 
wash buffer, 50µl of streptavidin-peroxidase conjugate was added to each well and 
incubated for 30 minutes at room temperature.  The plate was washed wit  wash buffer 
and then 50µl of chromogen substrate was added to each well and incubated for 10 
minutes.  A volume of 50µl of Stop Solution was added to each well and the absorbance 
of samples and standards was read at 450nm on a microplate reader (BioT k Instruments, 




Adipokine Protein Array  
Further characterization of the components within each conditioned medium 
sample was performed using an Adipokine Antibody Array (Raybiotech, Norcross, GA).  
This commercially available kit was used for simultaneous detection of the presence of 
multiple adipose-related cytokines, including TGF-β and PAI-1 among others (Figure 
2.2).  Conditioned medium samples were collected from confluent cultures of cells and 
stored at -20°C.  To conduct the assay, the samples were thawed at room temperature and 
centrifuged for 10 minutes at 2000 x g.  A volume of 1.5mL of the supernatant was 
collected in microtubes for the assay.  Reagents were prepared according to the standard 
protocol.  Assay membranes provided in the kit were placed into individual wells of an 
eight-well tray.  A volume of 2mL of 1X Blocking Buffer was added to each well and the 
membranes were incubated for 30 minutes at room temperature.  Following incubation, 
the buffer was removed and 1mL of sample medium was added to the individual wells.  
The membranes were then incubated at 4°C overnight.  The next day, the sample was 
removed from each well and the membranes were washed according to the 
manufacturer’s protocol.  A volume of 1mL of biotin-conjugated antibodies provided in 
the kit were added to each membrane and incubated for 2 hours at room temperature.  
After washing each membrane, 2mL of diluted HRP-conjugated streptavidin was added 
to each membrane and incubated for 2 hours at room temperature.  After washing the 
membranes, 500uL of detection buffer was pipetted onto each membrane and incubated 
for 2 minutes at room temperature.  The excess detection buffer was drained from the 
membrane and the signals on the membrane were detected using the chemiluminesence 
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filters of a MultiImage™ Light Cabinet (Alpha Innotech Corp., San Leandro, CA).  The 
relative intensity of the resulting signals was determined and quantified using 
AlphaEase® FC FluoroChem™ SP software, version 4 (Alpha Innotech Corp.).   
 
 
Figure 2.2: Function of the Adipokine Antibody Array (Raybiotech) 
 
Statistical Analysis 
Statistical analyses of quantitative data from the ELISA assays were performed 
using a paired t-test with significance level of p<0.05 (n=3).  Graphical error bars 





Primary Adipose Cell Isolation & Characterization 
Cell Morphology and S-100 Staining 
The representative cell morphology for the isolated bovine, murine, and human 
cells was imaged as shown in Figure 2.3 A-C.  The bovine, murine, and human cells wer  
stained for S-100 protein following the initial isolation.  As shown in Figure 2.3 D-F, the 
bovine, murine, and human cultures all contained cells that stained positively for the S-




Figure 2.3: Representative cellular morphology (A-C) and staining of S-100 protein (D-




Oil Red O Staining 
Addition of the adipogenic cocktail confirmed that the isolated adipose cells were 
capable of differentiating to mature adipocytes.  Samples of bovine, murine, and human 
cells were stained with ORO following culture with the adipogenic cocktail for up to 14 
days.  Control samples of each cell type, grown in DMEM only, without an adipogenic 
cocktail, were stained with ORO for comparison.  Staining of the control cell samples 
reveal a minimal presence of lipid, indicated by limited amounts of red staining within 
the bovine, murine, and human cells shown in Figure 2.4 A-C.  Staining of cells cultured 
with the adipogenic cocktail reveal a larger number of red-stained cells, exhibiting large, 
intracellular lipid droplets within the bovine, murine and human cells, as hown in Figure 
2.4 D-F.  The lipid within the murine and human cells (Figure 2.4 E-F), however, 
appeared to be larger in size and more uniformly defined than that detected within the 
bovine cells. 
 
Total Triglyceride Content 
Measurable quantities of triglyceride were detected within samples of the isolated 
bovine, murine, and human cells grown in DMEM culture medium.  As shown in Figure 2.5, 
measurement of the total triglyceride concentration within the bovine, murine, and human 
cells (n=3 per condition), following culture with the adipogenic cocktail, showed that the 
triglyceride content within the cells significantly increased (p<0.05) with the addition of the 
cocktail, indicating that the cells were actively differentiating in the presence of the 




Figure 2.4: Staining of control samples, cultured in DMEM without an adipogenic cocktail 
revealed minimal presence of lipid (A-C). ORO staining of intracellular lipid within bovine, 
murine, and human adipose cells following culturing with adipogenic cocktail reveal d the 
presence of large, defined lipid droplets indicating that the cells will differentiate to mature 




Figure 2.5: Measurement of total triglyceride content within cultured cells.  The amount 
of triglyceride within the bovine, murine, and human cells cultured with the adipogenic 
cocktail was significantly higher (p<0.05) than
cultured in the normal DMEM culture medium.  Each data point represents the mean 
value of n=3 samples per condition. Error bars reprsent the standard error of the mean.
 
 
Conditioned Media Influence on Adipose Cell B
Metabolic Activity 
 As shown in Figure 2.6, for the bovine cells in these studies, treatment of the cells 
with MACT-CM, NMuMG
differences in metabolic activity when compared to the respective condi
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different from MACT-CM + AC) (p<0.05).  Addition of the MACT-CM medium alone, 
without the adipogenic cocktail, resulted in a significant increase in metabolic activity 
when compared to the DMEM control sample; however no difference was observed when 
the NMuMG-CM or MCF10A-CM samples were compared to the DMEM control.  
Comparison of the MACT-CM+AC, NMuMG-CM+AC, and MCF10A-CM+AC samples 
to the AC control sample revealed significant differences in metabolic activity for each 
conditioned medium.  
Also shown in Figure 2.6, treatment of the murine cells with MACT-CM, 
NMuMG-CM, or MCF10A-CM did not result in any statistical differences in metabolic 
activity when compared to the respective conditioned media samples combined with the 
adipogenic cocktail (p<0.05).  Addition of the MCF10A-CM medium alone, without the 
adipogenic cocktail, resulted in a significant increase in metabolic act vity of the murine 
cells when compared to the DMEM control; there was no difference when MACT-CM or 
NMuMG-CM samples were compared to the DMEM control.  Comparison of the 
MACT-CM+AC and MCF10A-CM+AC to the AC control sampled revealed significant 
differences in metabolic activity of the murine cells. 
 Treatment of the human cells with the AC media and the MCF10A-CM revealed 
statistically significant decreases in metabolic activity when compared to the respective 
medium sample treated with DMEM (i.e., metabolic activity  of AC was significantly less 
than the DMEM sample, see Figure 2.6) (p<0.05).  There was no significant difference in 
metabolic activity of human cells treated with MACT-CM, NMuMG-CM, or MCF10A-
CM when each was compared to the DMEM control sample.  There was, however, a 
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significant difference between the MACT-CM+AC, NMuMG-CM+AC, and MCF10A-
CM+AC samples when compared to the AC control.   
 Final comparison of the metabolic activity, by cell type, was performed using the 
samples treated with AC to determine the specific effect of the different types of medium 
on each cell type.  Treatment of bovine cells with each conditioned mediu  resulted in 
significantly higher metabolic activity when compared to the AC control.  There was no 
difference in metabolic activity of the bovine cells among the conditi ed media treated 
samples.  Treatment of murine cells with MACT and MCF10A conditioned media 
resulted in significantly higher metabolic activity than the AC control and the NMuMG 
samples.  Treatment of human cells with MACT and NMuMG conditioned mia 














     Bovine Cells          Murine Cells 
 
     Human Cells          Comparison by Cell Type 
 
Figure 2.6: Results from alamarBlue® metabolic activity assay showed that the 
conditioned media used to culture cells influences the metabolic activity in a species-
specific manner. Asterisks (*) indicate statistical differences b tween the specified 
conditions.  Ampersands (&) indicate statistical differences from all other media used to 
treat the bovine cells; “at” (@) and percent (%) symbols denote results that are 
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statistically lower than those obtained from the other media used to treat th  murine 
cells; dollar ($) and pound (#) symbols indicate results that are statistically lower than 
those obtained from the other media used to treat the human cells (p<0.05). Each data 
point represents the mean value of n=3 samples per condition.  Error bars represent the 
standard error of the mean. 
 
ORO Staining 
 Oil Red O staining for intracellular lipid within the bovine adipose cells showed 
very little lipid present within cells treated with DMEM only (Figure 2.7A).  When the 
adipogenic cocktail was added to the bovine cells, differentiation seemed to be induced, 
as evidenced by red-stained lipid droplets within the cells (2.7B).  Treatment of the 
bovine cells with MACT-CM and MACT-CM+AC (2.7C & D) resulted in a large 
presence of lipid droplets within the cells samples.  Treatment of bovine cells with 
NMuMG-CM alone (2.7E) resulted in a smaller amount of lipid than other conditions, 
while the NMuMG-CM+AC samples had more red stained lipid, present in small droplets 
around the cell nuclei (2.7F).  Morphological differences in cell shape were observed in 
cells treated with MCF10A-CM and MCF10A-CM+AC (2.7 G & H); however, treatment 
of bovine cells with MCF10A-CM and MCF10A-CM+AC yielded red-stained lipid 
droplets, indicating that differentiation was occurring.   




Figure 2.7: Oil Red O staining of bovine 
images is 320x. 
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Measurement of the absorbance of the extracted Oil Red O solution was used to 
quantify the lipid content for the bovine cell samples.  As shown in Figure 2.8, a 
significantly larger amount of lipid was measured in the AC sample treated with the 
adipogenic control than that measured in the DMEM-only sample; however, the amount 
of lipid measured in the AC sample was significantly lower than all other samples treated 
with conditioned media in the presence of the adipogenic cocktail (p<0.05).  
Additionally, the samples treated with NMuMG-CM+AC had a significantly higher 
amount of lipid than the samples cultured with NMuMG-CM only (p<0.05).  Treatment 
of the bovine cells with MACT-CM+AC resulted in a significantly greater amount of 
lipid than all other samples treated with conditioned media in combination with the 
adipogenic cocktail (p<0.05).   
Oil Red O staining for intracellular lipid within the murine cells showed small 
lipid droplets stained within the DMEM control sample (Figure 2.9A).  Clearly rounded 
and larger diameter lipid droplets were observed when murine cells were treated with the 
AC medium (2.9B).  Treatment of murine cells with MACT-CM showed dark red-stained 
lipid; however, the shape of the lipid was not as uniform as that stained in the control AC 
samples, suggesting some alteration in cell behavior (2.9C).  When cultured in MACT-
CM+AC, the resulting lipid within the murine cells was rounded and more distributed 
throughout the culture, however, the droplets were smaller in size (2.9D).  Staining of 
cells treated with NMuMG-CM and NMuMG-CM+AC both showed a similar pattern of 
staining, where the brightly stained lipid droplets were smaller in diameter and non-




Figure 2.8: Oil Red O measurements showed that the addition of the adipogenic cocktail 
and conditioned media influences the amount of lipid formed within bovine cells.  
Asterisks (*) indicate statistical differences between the specified conditions.  Pound (#) 
and percent (%) symbols denote results that are statistically lower than all other 
conditions treated with DMEM and conditioned media or AC and conditioned media, 
respectively (p<0.05). “At” (@) symbol denotes results significantly larger than all other 
samples treated with AC and conditioned media (p<0.05).   Each data point represents 





resulted in small lipid droplets dispersed throughout the sample (2.9G).  MCF10A-
CM+AC culture resulted in small intracellular lipid droplets in size; however, the lipid 
appeared more organized around cell nuclei and clearly rounded in shape (2.9H).  The 
extracted Oil Red O solutions for the murine samples of all tretm nt conditions were not 
available for analysis. 
 Oil Red O staining of human cells cultured in DMEM showed small red-stained 
lipid droplets within the cells (Figure 2.10A).  The addition of the adipogenic cocktail to 
human cells resulted in differentiation of the cells, as evidenced by the clearly rounded, 
brightly stained, uniform intracellular lipid seen within the AC samples (2.10B).  
Addition of MACT-CM and MACT-CM+AC to the human cells resulted in a similar 
staining pattern.  The lipid droplets were smaller in size than ose observed in the AC 
samples; however, there was a large amount of staining observed (2.10 C & D).  Staining 
of the human cells treated with NMuMG-CM showed small intracellular lipid droplets 
within the cells (2.10E), while NMuMG-CM+AC yielded a larger amount of stained lipid 
that appeared more disorganized in appearance (2.10F).  When cultured with the 
MCF10A-CM, red stained lipid was observed throughout the culture (2.10G); however, 
there was very little staining within the human cells cultured with MCF10A-CM+AC 
(2.10H).  The extracted Oil Red O solutions for the human samples of all treatment 





Figure 2.9: Oil Red O staining of murine adi
images is 320x. 
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pose cells.  Total magnification for all 
 
 
Figure 2.10: Oil Red O staining of human adipose cells.  Total magnification for all 





Total Triglyceride Measurement 
As shown in Figure 2.11, treatment of the bovine cells with MACT-CM and
NMuMG-CM in the presence of the adipogenic cocktail resulted in sig ificantly higher 
amounts of triglyceride than the respective samples cultured without the adipogenic 
cocktail (i.e., cells treated with MACT-CM+AC had significantly higher total triglyceride 
than those treated with MACT-CM) (p<0.05).  Addition of the MACT-CM media alone, 
without the adipogenic cocktail, resulted in a significant increase in triglyceride when 
compared to the DMEM control samples; however, no difference was observed when the 
results from the NMuMG-CM or MCF10A-CM samples were compared to those from 
the DMEM controls.  Comparison of the results from MACT-CM+AC and NMuMG-
CM+AC samples to those from the AC control revealed significant increases in the 
amount of triglyceride produced in those bovine cells.  
 Also shown in Figure 2.11, treatment of murine cells with each type of 
conditioned medium in the presence of the adipogenic cocktail resulted in significant 
differences in measured triglyceride concentration when compared to their respective 
sample cultured without the adipogenic cocktail.  Addition of the MACT-CM, NMuMG-
CM, and MCF10A-CM media alone, without the adipogenic cocktail, resulted in 
significant differences when compared to the DMEM control sample; total triglyceride 
from the MACT-CM+AC sample was significantly higher than that cultured in DMEM, 
while results from the NMuMG-CM+AC and MCF10A-CM+AC groups were both lower 
than those of the DMEM group.  Comparison of results from the MACT-CM+AC sample 
to that from the AC control sample revealed a significant increase in triglyceride 
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concentration, while the NMuMG-CM+AC and MCF10A-CM+AC samples were 
significantly lower in concentration than the AC control. 
 For the human cells, as shown in Figure 2.11, treatment of the human cells with 
NMuMG-CM+AC resulted in a significantly higher amount of triglyceride when 
compared to the NMuMG-CM sample without the adipogenic cocktail.  Addition of 
MCF10A-CM+AC, however, resulted in a significantly lower amount of triglyceride than 
that found in the MCF10A-CM sample.  When cultured with MACT-CM and NMuMG-
CM, there was a significant increase in triglyceride when compared to theDMEM control 
sample.  Comparison of the NMuMG-CM+AC sample to the AC control reveal d a 
significant increase in triglyceride, while the MCF10A-CM+AC sample was significantly 
lower in concentration than the AC control. 
 Final comparison of the triglyceride concentrations, by cell type, was performed 
using the samples treated with AC to determine the specific effe t of the different types 
of medium on each cell type.  Treatment of the bovine cells with MACT and NMuMG 
conditioned media resulted in significantly higher amounts of triglyceride when 
compared to the AC control.  Type of conditioned medium used to treat th  bovine cells 
resulted in significant differences in triglyceride concentrations. .  Murine cells cultured 
in MACT conditioned media had significantly higher amounts of triglyceride than any 
other conditioned media samples and the AC control.  The murine cells cultured with 





          Bovine Cells          Murine Cells 
 
 Human Cells    Comparison by Cell Type 
 
Figure 2.11: Measurement of total triglyceride content showed that the conditioned 
medium used to culture cells influences the triglyceride produced by a specific species of 
cells. Asterisks (*) indicate a statistical difference between specified conditions.  “At” 
(@), pound (#), and percent (%) symbols denote results that are statistically different 
than the bovine samples treated with AC. Letters a, b, c, and d denote results that are all 
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statistically different from each other. Samples denoted with numbers 1, 2, and 3 are all 
statistically different than the human samples treated with AC (p<0.05). Each data point 
represents the mean value of n=3 samples per condition. Error bars represent the 
standard error of the mean. 
 
amounts of triglyceride than the murine cells treated with MACT conditioned medium 
and the adipogenic cocktail.  Human cells treated with NMuMG conditioned medium had 
significantly higher amounts of triglyceride than those cultured with MACT or MCF10A 
conditioned media, or the adipogenic control.  Additionally, cells treated with MCF10A 




As shown in Figure 2.12A, treatment of the bovine adipose cells with MCF10A-
CM+AC resulted in significantly higher expression of PPAR-γ than treatment of the cells 
with MACT-CM alone (p<0.05).  Treatment of the bovine cells with MACT-CM only 
resulted in significantly higher PPAR-γ expression than that measured in the DMEM-
only control sample (p<0.05).  There were no other significant differences in PPAR-γ 
expression for the bovine cells. 
Treatment of the bovine cells with the adipogenic cocktail, i.e. the AC samples, 
resulted in significantly higher aP2 expression than the cells treated with MACT-
CM+AC, as shown in Figure 2.12B (p<0.05).  Additionally, the bovine cell samples 
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treated with conditioned media without the adipogenic cocktail (MACT-CM, NMuMG-
CM, and MCF10A-CM samples) expressed significantly lower amounts of aP2 than the 
DMEM-only control sample (p<0.05).   
As shown in Figure 2.13A, treatment of the murine cells with the adipogenic 
cocktail resulted in significantly higher PPAR-γ expression than the DMEM only control 
sample (p<0.05).  Additionally, treatment with MACT-CM+AC and MCF10A-CM+AC 
resulted in significantly higher PPAR-γ expression than that measured in cells treated 
with MACT-CM or MCF10A-CM, respectively (p<0.05).  Murine cell samples treated 
with MACT-CM+AC and NMuMG-CM+AC expressed significantly lower amounts of 
PPAR-γ than cells cultured with the AC media alone, or the cells cultured with MCF10A-
CM+AC (p<0.05).   
Treatment of the murine cells with the adipogenic cocktail resultd in 
significantly higher expression of aP2 than that measured in the DMEM control sample, 
as shown in Figure 2.13B (p<0.05).  Treatment of the murine cells with MACT-CM+AC 
and MCF10A-CM+AC resulted in significantly higher expression of aP2 than those cells 
cultured with MACT-CM and MCF10A-CM only, respectively (p<0.05).  The murine 
cells treated with NMuMG-CM+AC expressed a significantly lower amount of aP2 than 





Figure 2.12: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by bovine adipose 
cells. Results are reported as relative expression to β-actin using the ∆∆Ct method. 
Asterisks (*) indicate a statistical difference between specified conditions (p<0.05).  
Percent symbol (%) denotes value statistically different from all other bovine cell 
samples treated with DMEM and the indicated conditioned medium.  Each data point 
represents the mean value of n=3 samples per condition. Error bars represent the 







Figure 2.13: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by murine adipose 
cells. Results are reported as relative expression to β-actin using the ∆∆Ct method. 
Asterisks (*) indicate a statistical difference between specified conditions (p<0.05).  
Percent symbol (%) denotes values statistically different from all other murine cell 
samples treated with AC and the indicated conditioned medium.  Each data point 
represents the mean value of n=3 samples per condition. Error bars represent the 







Figure 2.14: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by human adipose 
cells. Results are reported as relative expression to β-actin using the ∆∆Ct method. 
Asterisks (*) indicate a statistical difference between specified conditions (p<0.05).  
Percent symbol (%) denotes values statistically different from all other human cell 
samples treated with DMEM and the indicated conditioned medium.  Pound (#) and “At” 
(@) symbols denote values statistically different from all other samples treated with AC 
and the specified conditioned medium.  Each data point represents the mean value of n=3 





combination with the adipogenic cocktail (MACT-CM+AC or MCF10A-CM+AC) or 
than cells treated with the adipogenic cocktail (AC) alone (p<0.05). 
 As shown in Figure 2.14A and B, treatment of the human cells with the AC 
samples resulted in significantly higher expression of PPAR-γ and aP2 than cells cultured 
with DMEM alone (p<0.05).  The cells treated with the adipogenic cocktail expressed a 
significantly higher amount of aP2 than all other samples treated with conditioned media 
in the presence of the adipogenic cocktail (p<0.05).  Of the samples cu tured with each 
conditioned medium only, without the adipogenic cocktail, cells treated with MCF10A-
CM expressed significantly higher amounts of PPAR-γ and aP2 than the NMuMG-CM 
samples, MACT-CM samples, and the DMEM control samples (p<0.05).  Additionally, 
human cells treated with MCF10A-CM+AC expressed significantly higher amounts of 
PPAR-γ than the adipogenic control sample and also the MACT-CM+AC and NMuMG-
CM+AC samples (p<0.05).  The cells treated with NMuMG-CM+AC expr ssed 
significantly lower amounts of PPAR-γ than the adipogenic control and also the MACT-
CM+AC and MCF10A-CM+AC samples; however, the NMuMG-CM+AC samples 
expressed significantly higher amounts of aP2 than the MACT-CM+AC and MCF10A-








Conditioned Media Characterization 
TGF- β 1 ELISA 
As shown in Figure 2.15, measurement of the concentration of TGF-β1 present 
within each sample of conditioned medium indicated increased amounts of TGF-β1 in 
MACT-CM and NMuMG-CM when compared to their corresponding base media.  
MCF10A base medium had a significantly higher amount of TGF-β1 than any other 
sample of base medium (p<0.05), and a greater amount of TGF-β1 than the conditioned 
MCF10A medium.  The human mammary epithelial cells, MCF10A cells, produced 




 Measurement of PAI-1 indicated that there was no detectable quantity of PAI-1 in 
any of the samples of base medium (Figure 2.16).  Analysis of the conditioned media 
samples showed that the bovine and human, MACT and MCF10A cells, respectively, 
expressed comparable levels of PAI-1.  The murine cells, the NMuMG cells, however, 






Figure 2.15: Results of the TGF
1 for MACT and NMuMG conditioned media samples, while t e amount of 
MCF10A conditioned medium was lower than that detect d in the base medium. Percent 
symbol (%) indicates statistical difference when comparing MCF10A TGF
concentration with that of 
(p<0.05). Each data point represents the mean value of n=3 samples per condition. The 
standard error of the mean was s
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Figure 2.16: Results of the PAI
in MACT and MCF10A conditioned media than that present in the NMuMG conditioned 
medium (p<0.05).  Percent (%) 
in the NMuMG conditioned media. No measurable quantities of PAI
any of the base medium samples. Each data point repres nts the mean value of n=3 
samples per condition. The standard 
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Adipokine Protein Array  
Evaluation of the adipokine protein array revealed the presence of only one 
adipokine within the media samples.  For each of the fresh media samples and each of the 
conditioned media samples, the same products consistently appeared on each membrane.  
Comparison of the membrane image with the array map, as shown in Figure 2.17, 
showed that vascular endothelial growth factor (VEGF) was the only factor in these 
samples detected by the array.  ELISAs for transforming growth factor-beta (TGF-β) and 
plasminogen activator inhibitor-1 (PAI-1) indicated the presence of those specific factors 
within conditioned media, however, TGF-β and PAI-1 were not detected in samples 
assayed with this array.  Measurement of the density of the resulting products, using the 
imaging software, showed that comparable levels of VEGF were present in each of the 
base medium samples.  There was no difference in the VEGF density of the MACT base 
medium and the MACT conditioned medium.  Likewise, there was no differenc  in the 
VEGF density of the NMuMG base medium and the NMuMG conditioned medium.  
There was a significantly higher VEGF density measured in the MCF10A conditioned 
medium than in the MCF10A base medium (p<0.05).  Additionally, there was no 







Figure 2.17: The resulting image of the adipokine protein arrays showed similar results 
indicating that VEGF was the only adipokine detected within the fresh and conditioned 




Figure 2.18: Results of the adipokine protein array showed comparable levels of VEGF 
in the MACT and NMuMG base media and their respective conditioned media samples.  
Asterisk (*) indicates a significantly higher amount of VEGF in the MCF10A-CM sample 
than that measured in the MCF10A base medium (p<0.05).  Error bars represent the 
standard error of the mean. 
 
2.4 Discussion 
Primary Adipose Cell Isolation & Characterization 
The enzymatic digestion procedure used for isolating primary adipose cells from 
fresh bovine, murine, and human tissue samples yielded a population of cells that could 
be expanded in vitro and used for cellular studies.  Since these cell populations are 
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primary, the composition of the cultures will likely include a heterog neous population 
consisting of the cells normally found in the adipose tissue samples; our methods, 
however, were successful in isolating populations of the stromal cells, including 
preadipocytes, of which we are most interested.  Resulting increases in triglyceride 
concentrations within the cells and presence of intracellular lipid within the primary cells 
treated with the adipogenic cocktail indicate that isolated cells wi  differentiate to mature 
adipocytes that may be useful for our studies. 
 
Conditioned Media Influence on Adipose Cell Behavior 
The relationship between epithelial cells and stromal cells within the breast has 
been investigated in order to determine how these cells interact in normal mammary 
development.  Adipose cells are one of the most populous types of stromal cells present 
within the breast, and as such, the relationship between adipose cells and mammary 
epithelial cells is of interest.  This research is focused on assessing adipose cell behavior 
in response to the presence of mammary epithelial cells.  More specifically, it is of 
interest to identify how adipose cells used for breast tissue engineering applications 
behave in the presence of mammary epithelial cells—do the adipose cells differentiate to 
mature cells, is adipose cell differentiation be delayed or inhibited, or is there no effect on 
the adipose cells?   
 Cell-specific cytokines and proteins are secreted from cells into their surrounding 
culture environment to “condition” the medium.  Since conditioned media contain these 
cell-specific factors, they are often used in biological experiments to determine cellular 
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relationships. It is also widely accepted that adipose tissue is a secretory organ, producing 
factors that will influence the behavior of surrounding cells.  This relationship is 
particularly observed in the breast; however, it is not known how adipose cell behavior is 
affected by factors produced from closely surrounding epithelial cells.  Hirano and 
coworkers demonstrated that conditioned medium from mammary tumor cells enhanced 
adipogenesis of preadipocyte cells in vitro, indicating that a relationship exists between 
cancerous mammary cells and adipose cells [30].  The relationship between normal 
mammary epithelial cells and adipose cells, however, has not been widely investigated. 
To investigate the relationship between adipose cells and normal mammary 
epithelial cells, conditioned media from three types of mammary epithelial cells were 
used to treat primary adipose cells isolated from bovine, murine, and human tissue 
samples. Three different species of cells were used for this analysis to determine if 
similar outcomes were observed from one species to the other, particularly because 
murine animal models are often used for mammary studies, and a bovine animal model 
has been suggested as a potential large-animal model for mammary studies [31, 32].   
Previous studies showed that bovine mammary epithelial cell-conditione media 
inhibited the differentiation of mouse mesenchymal stem cells to adipocytes [15].  In our 
studies, it was determined that conditioned media do influence the behavior of primary 
adipose cells.  Additionally, it was determined that the effect of conditioned media on 
adipogenesis depends on the type of conditioned media with which the cells are cultured.   
In addition to serving as an indicator of metabolic activity, alamarBlue® is also 
deemed an indicator of cell proliferation.  Here, the less metabolic lly active AC control 
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samples for each adipose cell type were likely proliferating at a lower level than those 
treated with conditioned media, because the AC-treated cells were differentiating at a 
higher rate, where proliferation was likely no longer occurring.  Alternatively, the 
addition of conditioned media to cell cultures could, in turn, possibly introduce factors 
that appear to stimulate metabolic activity.  To verify this possibility, analysis of cell 
number for each condition would aid in determining whether the increase in metabolic 
activity for conditioned media treated samples is attributed to actual ell growth and 
proliferation or not. 
Adipose differentiation is characterized by biochemical and morphological 
changes, whereby preadipocyte cells begin to accumulate intracellul r lipid droplets, and 
cell shape changes from a fibroblast-like spindle shape to a rounded shape characteristic 
of mature adipocytes [4, 10, 33, 34].  The enzymatic digestion procedure to isolate cells 
from fresh tissue samples is designed to yield a population of cells consisting primarily of 
preadipocytes.  As a result, it is not surprising to see red-stained lipid droplets within 
cells cultured with DMEM medium, or to detect quantities of triglyceride within those 
cells.  With the addition of the adipogenic cocktail, however, it is expected that 
differentiation of the cells will be induced, resulting in preadipocyte cell maturation.   
Since no significant change in triglyceride content was observed when bovine 
cells were cultured with AC as opposed to DMEM, this adipogenic cocktail may not be 
the most optimal for this cell type.  The role of insulin, dexamethasone, and IBMX in 
stimulating adipogenesis was previously noted [11, 14, 35].  It is, however, key to point 
out that this adipogenic cocktail was optimized for murine preadipocyte cell lines.  For 
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bovine cells, adipogenesis can be stimulated using additional media additives, such as 
thiazolidinediones (i.e., rosiglitazone and troglitazone that are used to treat diabetes) 
which act by binding to PPAR receptors that play key roles in adipogenesis [36, 37].  In 
order to minimize the variables associated with this study, the differentiation cocktail was 
kept constant for all cell types; however, the adipogenesis of the bovine cells may have 
been influenced for this reason. 
As preadipocytes progress through the differentiation process to become mature 
adipocytes, they not only undergo morphological changes, but also undergo changes at 
the genetic level, where genes are expressed at different stages of development.  One 
gene characteristic of cells of the adipose lineage is peroxisome proliferator activator 
receptor (PPAR)-γ, which is expressed early in the differentiation process at low levels 
[10, 38-40].  As adipogenesis progresses, the level of PPAR-γ expression increases [10, 
39, 41].  PPAR-γ belongs to the family of nuclear hormone receptors and is key in the 
induction and maintenance of differentiated adipocytes.  The expression of PPAR-γ 
induces growth arrest and initiates adipogenesis in fibroblast cell lin s [10, 42].  The 
expression of adipocyte-specific fatty-acid-binding protein-2 (aP2) can be detected in 
mature adipocytes [43]; this lipid binding protein is expressed when cells accumulate 
lipid [12, 38, 41, 44, 45].   
RT-PCR was performed to evaluate expression of PPAR-γ and aP2 for the cells 
treated with each type of conditioned medium.  Expression of PPAR-γ by bovine cells 
treated with each medium indicated that the bovine cells are undergoing early 
adipogenesis.  The relatively low level of aP2 expression by the bovine cells indicates 
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that the bovine cells are not in a mature state.  This is also apparent when considering the 
Oil Red O results, where the bovine cells have visible red-stained l pid, but the lipid 
droplets are relatively small (not filling the cell cytoplasm) and not well-defined in shape.   
Evaluation of the RT-PCR results for the murine cells indicated that the cells 
treated with each type of conditioned media are undergoing adipogenesis, as evidenced 
by the increased expression of PPAR-γ and aP2 when compared to the control sample.  
The low expression of PPAR-γ and aP2 observed by the cells treated with NMuMG-CM 
and NMuMG-CM+AC correlate with the lower level of triglyceride measured within 
cells of these conditions when compared to the control samples.  Cells treated with 
NMuMG-CM may express adipogenic markers, but the differentiation of these murine 
cells to mature fat cells appears to be limited in some manner.  Additionally, the 
increased expression of PPAR-γ and aP2 observed in cells treated with MCF10A-
CM+AC suggests that these cells are undergoing adipogenesis and actively maturing. The 
lower level of triglyceride and the minimal staining observed within the cells treated with 
MCF10A-CM+AC may be a result of the buoyant nature of lipid.  Because of its buoyant 
nature, the intracellular lipid of these cells may have been lost to the surrounding culture 
media by the end of the study and therefore not measured in the triglyce ide assay or 
stained by Oil Red O.   
Human cells treated with the adipogenic cocktail expressed high levels of PPAR-γ 
and aP2, indicating that the cells are actively maturing.  When t human cells were 
treated with MACT-CM+AC, there was no difference in the exprssion of PPAR-γ, 
however, the significantly lower level of aP2 in MACT-CM+AC cells when compared to 
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the adipogenic control suggests that the MACT conditioned media may be limiting 
differentiation to mature cells.  Human cells treated with NMuMG-CM+AC expressed 
higher levels of aP2 which coincided with the increased levels of triglyceride measured in 
NMuMG-CM+AC treated cells and indicated a positive influence on adipogenesis.  
Human cells treated with MCF10A-CM+AC expressed higher levels of PPAR-γ, 
suggesting that these cells are actively undergoing adipogenesis, however, the lower 
levels of aP2 accompanied with the low level of triglyceride and minimal Oil Red O 
staining for the MCF10A-CM+AC treated cells suggests otherwis.  These cells may be 
of the adipogenic lineage, but they are not actively maturing, suggesting the combination 
of MCF10A-CM with the adipogenic cocktail may have a negative effect on 
adipogenesis.  
 Table 2.3 shows a summary of the results from these conditioned mediastu ies.  
Based on the triglyceride measurements, the Oil Red O staining, and the gene expression 
data, the overall effect of the conditioned media was designated to have “No effect” on 










Table 2.3: Summary of Conditioned Media Influence on Adipose Cell Behavior 
 Conditioned Media Source 






Bovine + + No Effect 
Murine + - + 
Human - + - 
When compared to the AC control, conditioned media was shown to: 
+ = positively influence adipogenesis 
(Increased triglyceride/lipid  Differentiation promoted) 
 
- = negatively influence adipogenesis 
(Decreased triglyceride/lipid  Differentiation delayed or inhibited) 
 
No Effect = have no effect on adipogenesis 
(Unchanged triglyceride/lipid  Differentiation not affected) 
 
The presence of intracellular lipid was observed within each cell type for each 
condition, as shown by Oil Red O staining and triglyceride measurement.  There were, 
however, differences observed in the quantity of lipid and the lipid shape, distribution, 
and uniformity when the cell samples that were treated with different types of 
conditioned media were compared.  For example, as shown in Table 2.3, treatment of the 
human cells with NMuMG-CM seemed to have a positive effect on adipogenesis based 
on increased aP2 expression and increased triglyceride levels, while the MACT-CM and 
MCF10A-CM seemed to have a negative effect on adipogenesis as reflected by lower 
levels of gene expression and triglyceride.   
 In most instances, similarities in staining patterns and quantity of triglyceride 
could be observed, where samples with more stained lipid also had higher quantities of 
triglyceride.  This was very apparent for the bovine cells when the triglyceride 
measurements were compared to the Oil Red O values.  The greatest amount of 
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triglyceride was measured in the bovine cells treated with MACT-CM and MACT-
CM+AC; likewise, the greatest amount of lipid was measured in the bovine cells treated 
with the MACT-CM and MACT-CM+AC, indicating a positive influence on 
adipogenesis by the MACT conditioned medium.  When the results of the triglyceride 
assay and Oil Red O were compared for bovine cells treated with MCF10A conditioned 
medium, however, it was noticed that there was no difference in the amount of 
triglyceride produced in cells treated with the MCF10A media when compared to the 
adipogenic control, but that there was a significant increase in lipid when cells were 
treated with MCF10A media as opposed to the adipogenic control.   
The variability in the outcome from these studies, however, is obviously a result 
of culturing cells from different species with different types of conditioned media.  It was 
initially expected that, because of the close relationship between adipose and epithelial 
cells within the body, the conditioned medium of a species would not negaively affect, 
delay or inhibit, the differentiation of adipose cells of the same species (i.e., MACT-CM 
from bovine mammary epithelial cells would positively influence bovine adipose cell 
differentiation).  Adipose cells and epithelial cells work together o affect physiological 
development in vivo, however, it was not shown in our studies that the addition of 
conditioned media from one species will always positively influence adipogenesis (e.g. 
increase triglyceride and lipid).  In fact, culture of murine and human cells with 
conditioned mediums from NMuMG and MCF10A cells, respectively, inhibited 
adipogenesis.  Studies by Calvo and coworkers previously showed that mouse ammary 
epithelial cells (NMuMG) produced factors that inhibited adipogenesis of mouse 3T3-L1 
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preadipocytes when co-cultured together, an outcome further confirmed by our studies 
[16, 46].  Additionally, Calvo and Julianelli showed that other epithelial cell types, not 
just mammary epithelial cells, produced factors that inhibited adipogenesis [16].  It is 
therefore likely that enhanced adipogenesis is not observed in these conditioned media 
studies because not all in vivo factors are present.  In addition to adipose and epithelial 
cells, fibroblasts and other cells within the breast work simultaneously for normal 
physiological processes to occur.  Not having each factor present in an in vitro culture 
will likely influence the resulting observations, however, there is still useful information 
obtained from these studies regarding the adipose-mammary epithelial cell re ationship. 
In the case of the bovine cells cultured with MACT-CM, there was increased 
triglyceride and lipid production within bovine adipose cells.  In this instance, it is 
conceivable that the addition of MACT-CM from bovine mammary epithelial cells did 
enhance or facilitate differentiation of the bovine adipose cells.  There was a significantly 
larger amount of lipid measured by the ORO solution for the bovine cells cultured with 
AC as compared with that for DMEM; however, since there was not a significant 
difference in the triglyceride measurement observed between th bovine DMEM and AC 
samples, it was concluded that differentiation, with the specific ad pogenic cocktail that 
was used, did not fully occur. Therefore, the significant increase in lipid and triglyceride 
that was observed from the addition of MACT-CM and MACT-CM+AC to the bovine 
cells is likely due to positive signaling that the MACT conditioned medium is providing 
to the bovine adipose cells, such that adipogenesis occurs even without an appropriate 
adipogenic cocktail.   
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Conditioned Media Characterization 
Results of the TGF-β ELISA indicated that measurable quantities of TGF-β were 
present in each type of base medium and the respective conditioned media samples.  The 
MCF10A base medium had a higher TGF-β concentration than any other base media or 
conditioned media samples.  As shown in Table 2.4, MACT and NMuMG media are 
similar; however, the MCF10A medium is noticeably different.  This difference in media 
components is likely responsible for the difference seen in TGF-β concentration for each 
base medium type.  Additionally, the presence of TGF-β in each base medium is likely 
attributed to the concentration of serum added to the MACT and NMuMG mediu , and 
the bovine pituitary extract added to the MCF10A medium.     
 
Table 2.4: Components of each Mammary Epithelial Cell Base Medium 


















 Mammary Epithelial 
Growth Medium 
(MEGM) (Lonza) 
 Bovine pituitary 
extract 
 Gentamicin 





When considering the results of the conditioned media studies, some correlati n 
with TGF-β concentration may be observed.  The MCF10A conditioned medium had a 
higher concentration of TGF-β than the MACT and NMuMG conditioned media, and the 
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MCF10A medium was shown to have a negative influence on the adipogenic 
differentiation of human cells, and no effect on the bovine cells.  This outcome supports 
previous knowledge of TGF-β as an inhibitor of adipogenesis, as found in the literature 
[18-20].  The lower concentrations of TGF-β were found in MACT and NMuMG 
conditioned media samples, and no effect or a positive effect on adipose cell 
differentiation was observed.  These observations suggest a correlati n between TGF-β 
concentration in the conditioned media samples and adipogenesis, indicating further that 
the influence on adipogenesis by conditioned media may not be species dependent, but 
dependent on specific factors that are found in a conditioned medium sample.   
 While it is known that PAI-1 is actively produced by adipose tissue and other 
vascular cells, there is also evidence to suggest that PAI-1 may be produced by other cell 
types, as quantities of PAI-1 were detected in conditioned medium fro bovine 
mammary epithelial cells by Heegard and coworkers [47].   Results of the PAI-1 ELISA 
showed that there was no measurable quantity of PAI-1 present within any of the base 
medium samples.  There were, however, quantities of PAI-1 detected within conditioned 
media from MACT, NMuMG, and MCF10A cells.  This suggests that PAI-1 is only 
produced in this instance by the cultured mammary epithelial cells, and is not present 
within the serum or any other media additives.  There was no differenc  in the amount of 
PAI-1 produced by the MACT and MCF10A cells, however, the influence of MACT and 
MCF10A conditioned medium on adipogenesis was not the same.  The MACT 
conditioned media has a more positive effect on adipogenesis, resulting in increased 
triglyceride and lipid within bovine and murine cells, while the MCF10A conditioned 
112 
 
media overall had a more negative effect on adipogenesis, resulting in decreased 
triglyceride and lipid within murine and human cells.  The NMuMG conditioned media 
sample had a significantly lower concentration of PAI-1 than the MACT or MCF10A 
samples, and overall the NMuMG conditioned medium increased adipogenesis.  A  
stated in the literature, increased levels of PAI-1 have been associ ted with inhibiting 
differentiation of adipose cells, while lower levels of PAI-1 have be n associated with 
enhancing adipogenesis [23, 29].  Contrary to this idea, though, Scroyen and coworkers 
have suggested that PAI-1 does not play a functional role in murine adipogenesis [48].  
Our results indicate that the exact role of PAI-1 may yet still be unknown, as lower levels 
of PAI-1, such as in the NMuMG medium, did enhance adipogenesis, but higher levels of 
PAI-1 did not conclusively inhibit adipogenesis.   
 VEGF, identified by the adipokine antibody array, was likely expr ssed within 
each of the base medium samples and the conditioned medium samples since it is a 
common factor found in serum, which was added to the base medium, and also produced 
by a number of cell types, including epithelial cells [49, 50].  VEGF is associated with 
angiogenesis, or the formation of new blood vessels and also the migration, and 
proliferation of endothelial cells, smooth muscle cells, and other cell types.  Additionally, 
since adipogenesis is closely associated with angiogenesis and VEGF facilitates 
angiogenesis, the presence of VEGF within the mammary epithelial c ll-conditioned 
media could provide an additional stimulus for enhancing adipogenesis i  vitro [51, 52].   
 It is possible that the levels of PAI-1 and TGF-β were not significant at the time 
the media samples were assayed, and therefore, not detected by he adipokine array.  
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When the conditioned media samples were previously assayed with the ELISAs, the 
media samples were collected and immediately assayed.  The sample  for the protein 
array, however, were collected and frozen at -20○C for approximately 4 weeks before 
assessing with the protein array.  Some degradation of the sample proteins may have 
occurred during this time, resulting in this outcome.  Additionally, it is very likely that 
during the imaging of each array membrane, the images were und rexposed, such that 
any additional products were not visible in the resulting images.  Repeated analysis may 
be necessary with increased exposure time to capture higher resolution images to better 
view resulting products.     
 
2.5 Conclusions 
The results of the S-100 staining, Oil Red O staining, and Total Triglyceride assay 
indicate that we are able to successfully isolate a population of primary bovine, murine, 
and human adipose cells that are capable of differentiating to mature dipose cells when 
cultured with the appropriate stimuli.  These methods for cell isolat on were used to 
obtain cultures of cells used in subsequent cell culture studies for this work. 
 Our studies of the relationship between mammary epithelial cells and adipose 
cells have shown that adipose cell differentiation is influenced by mammary epithelial 
cells.   The effect of conditioned media from mammary epithelial cells on adipose cells 
depends on the source of conditioned medium.  In order to definitively determine the 
relationship between mammary epithelial cells and adipose cells, it will be necessary to 
conduct further analysis.  There may be factors expressed by mammary epithelial cells, 
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which may not have been produced in significant amounts in the conditioned media 
samples, thereby altering the outcome of these results.  Direct co-culture studies, placing 
both adipose and mammary epithelial cells in the same environment, may need to be 
conducted to further prove our conclusions.   
The effect that each type of conditioned medium has on adipose cell 
differentiation will depend on the specific medium used to culture cells.  Adipokines 
VEGF, TGF-β, and PAI-1 were expressed in the conditioned media in these studies an  
were noted as key to adipogenesis.  More definitive studies and further correlation with 
the results from conditioned media studies may be used to conclusively identify the effect 
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EVALUATION OF EPITHELIAL CELL CO-CULTURE ON ADIPOSE CELL 
DIFFERENTIATION IN THREE-DIMENSIONAL (3-D) CULTURE 
 
3.1 Background 
The studies detailed in Chapter 2 described the influence of mammary epithelial 
cell conditioned media on primary adipose cell differentiation in two-dimensional (2-D) 
culture.  It has been widely shown that growing cells in 3-D culture has an influence on 
cellular behavior.  For successful implementation of our injectable composite system, the 
three-dimensional beads must support adipose cell attachment in vi ro in order for 
proliferation and differentiation to occur.  Previous work showed that culturing adipose 
cells on injectable sized beads led to increased triglyceride production when compared to 
production by cells cultured in 2-D [1, 2].  Additionally, differences in adipogenic genes 
expressed by adipose cells were observed when cells were grown in 2-D versus 3-D 
culture [3].   
Various materials have been used in previous studies to determine how adipose 
cells will respond to beads made of those materials.  Evaluation of adipose cells cultured 
on gelatin, alginate, and polylactide beads showed that adipose cells do not readily attach 
to alginate and polylactide beads, resulting in fewer cells covering the beads and 
ultimately fewer cells that differentiated to mature cells [1].  Adipose cells readily 
attached to the gelatin beads and proliferated to completely cover the surfaces of the 
gelatin beads.  Finding a bead that would support cellular attachment was important; 
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however, in the case of these gelatin beads, the cells became so abundant that they 
detached from the surface of the beads with even the slightest disturbance [1].  It is 
therefore crucial to evaluate beads made of alternate materials for use in the injectable 
composite system. 
Chitosan is a natural biomaterial derived from the de-acetylation of chitin (a 
copolymer of N-acetyl-glucosamine and N-glucosamine units linked by β(14) 
glycosidic bonds [4-6].  Other than cellulose, chitin is the second most abundant 
polysaccharide on earth and is typically found in the exoskeleton of crusta eans such as 
crabs and shrimp [7-9].  As a natural material, the source of chitin and derivation process 
used to obtain chitosan will result in products of varied molecular weight and degree of 
deacetylation (DD).  Chitosan may range in molecular weight from 300 to more than 
1000kDa and have DD values from 30 to 95% [4, 6].  The degradation of chitosan, 
therefore, is characterized based on the molecular weight and degree of deacetylation, 
where chitosan degradation of chitosan will decrease as the DD increases [7].  Chitosan is 
typically insoluble in water or basic pH environments, but is soluble in acidic 
environments.  Degradation of chitosan in vivo occurs via lysozyme enzymatic activity 
and hydrolysis.  
Chitosan has been widely investigated for biomedical applications such as wound 
healing, anti-microbial treatment of bacteria, and drug delivery [6, 10, 11].  The use of 
chitosan for biomedical applications is so extensive because it is readily available, cost-
effective, biocompatible, biodegradable, and easily processed to form structures of varied 
shape and porosity [5, 11, 12].  As a result of these desirable attributes, chitosan has been 
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investigated for engineering skin, bone, cartilage, liver, nerve, and v scular tissues [13-
16].   
The use of chitosan for adipose tissue engineering has not been widely 
investigated by many researchers; however, great potential for chitosan in adipose tissue 
engineering applications exists.  Chitosan is easily processed into scaffolds of various 
shapes and sizes.  Fabrication of injectable chitosan microspheres tat would be well-
suited for minimally-invasive applications, such as those where adipose tis ue 
engineering would be useful, has been reported [16, 17].  Additionally, the ease of 
combining growth factors and therapeutics within chitosan, due to its cationic nature, 
may potentially produce scaffolds that will facilitate adipose cell attachment and 
differentiation to mature fat cells to form new tissue in vivo.  To produce a bead that will 
more optimally support adipose cell growth, while allowing successful delivery by 
injection, we opted to use beads made of a chitosan-gelatin blend. 
Adipose cells grown on microcarrier beads for inclusion in an injectable 
composite system will encounter mammary epithelial cells upon implantation in vivo.  It 
is therefore necessary to understand how the adipose cell behavior will be influenced by 
growth on 3-D microcarriers in the presence of mammary epithelial cells. This study was 
performed to evaluate primary adipose cell behavior when cultured with mammary 






3.2 Materials & Methods 
Solution Preparation 
 A 1% v/v glacial acetic acid was prepared by mixing 1mL glacia  acetic acid 
(Fisher Chemicals, Fair Lawn, NJ) in 100mL distilled water.  The glacial acetic acid was 
filter sterilized using a 0.22µm polyethylsulfone (PES) bottle-top filter (Corning, 
Corning, NY).  Chitosan (Deacetylation Degree: ≥90%, Acros Organics, Morris Plains, 
NJ) and gelatin (Type A from porcine skin; Bloom Number: ~300, Sigma, St. Louis, 
MO) powders were autoclaved at 124°C for 25 minutes to sterilize.  All other steps in the 
bead fabrication process were carried out in a SterilGARD III Advance laminar flow 
Class II Biological Safety Cabinet (The Baker Company, Sanford, ME) to maintain 
sterility.  A 3% w/v chitosan-gelatin solution was prepared by dissolving 3g of chitosan 
and 3g of gelatin in 100mL of 1% v/v glacial acetic acid and stirring at low heat until 
completely dissolved.  A 0.5N solution of sodium hydroxide (NaOH) was prepared by 
dissolving 20g NaOH salt (Fisher Chemicals, Fair Lawn, NJ) in 1L of distilled water and 
stirring at room temperature.  The solution was filter steriliz d using the 0.22µm PES 
filters. 
 
Bead Preparation & Characterization 
The chitosan-gelatin beads were formed using an electrostatic bead generator 
(Nisco, Zürich, Switzerland) shown in Figure 3.1.  The chitosan-gelatin solution was 
drawn into a 20cc syringe (Becton Dickinson, Franklin Lakes, NJ) using a 16 gauge 
 
needle (Becton Dickinson).  The syringe was secured in place on top of a syringe pump 
(kdScientific, New Hope, PA) 
Figure 3.1: Electrostatic Bead Generator
 
The chitosan-gelatin solution ejected from the syringe was guided through plastic 
tubing attached at the end of the syringe, into a metal needle of th
generator.  The syringe was secured in place on top of a syringe pump (kdScientific, New 
Hope, PA) that was set to eject the solution at a rte of 15 mL/hour.  The chitosan
solution was ejected from the syringe 
end of the syringe, into a metal needle of the electrostatic bead generator.  
was placed so that the point of ejection was approximately 4cm above the surface of the 
NaOH solution below.  The NaOH was pipette in
Corning, Corning, NY) until just overflowing(>180mL)  into a 100 x 20mm glass 
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e electrostatic bead 
a
and guided through plastic tubing attached 







collection dish (Pyrex) beneath.  The NaOH was continuously stirred at an agitation rate 
of 25%.  The applied voltage potential was set at 6.5kV to obtain beads.   The fabricated 
beads were collected in the 80 x40 cm dish and stirred for an additional 30 minutes post 
formation in the NaOH solution at the same agitation rate.  The NaOH was drained from 
the beads and the resulting beads were washed three times with sterile phosphate buffered 
saline (PBS).  The beads were placed in sterile Dulbecco’s Modified Eagle Medium 
(DMEM) (Gibco, Invitrogen, Carlsbad, CA) until cell seeding in well plates. 
To evaluate the morphology of the prepared scaffolds, images of each type were 
captured using an EMZ-TR stereomicroscope (Meiji Techno, Tokyo, Japan) with a 
Lumina light source (Chiu Technical Corporation, Kings Park, NY) and a SPOT 
INSIGHT Color digital camera (Diagnostic Instruments, Sterling Heights, MI). 
 
Gel Permeation Chromatography (GPC) 
 Samples of chitosan and gelatin were characterized using GPC to determine an 
approximate range of the weight average molecular weight (Mw) for the materials.  In 
order to determine the effects of autoclave sterilization of the powders, samples of the as-
received powders and post-sterilization powders were evaluated.  The GPC system 
consisted of a Waters 1525 Binary HPLC Pump, a Waters Ultrahydrogel™ 250 HPLC 
column, a Waters 2707 Autosampler, a Waters 2414 refractive index detector, and the 
Waters Breeze 2 software package (Waters, Milford, MA).   
 Deionized water (Millipore, Billerica, MA) was degassed by stirring under house 
vacuum overnight.  The degassed water was used to prepare the mobil phase solution 
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consisting of 0.20M sodium acetate (Sigma) in 0.33M glacial acetic acid (Fisher). The 
mobile phase was then filtered before use with the 0.22µm PES filters (Corning).   Fluka 
ReadyCal poly(ethylene glycol) and poly(ethylene oxide) standards of Mw 232-932,000 
Sigma) were used to calibrate the system and to form a standard curve for subsequent 
calculations.  Standards were prepared by dissolving the powder in mobile phase for a 
concentration of 1.5g/L.  The chitosan and gelatin samples were dissolved in mobile 
phase for a concentration of 2mg/mL.  The dissolved samples were filt d through 
Acrodisc® 0.2µm nylon filters (Pall Life Sciences, Port Washingto , NY) directly into 
sample vials.  A volume of 50µL was injected for each sample and st ard.  The flow 
rate was maintained at 0.7mL/minute and the run temperature was 25°C.  Samples and 
standards were both injected twice. 
 
Atomic Force Microscopy (AFM) 
 Since the beads for the injectable composite system will be enclos d within a 
surrounding hydrogel matrix, the properties of the matrix-bead system were characterized 
using atomic force microscopy (AFM).  Samples were constructed for evaluation, as 
shown in Figure 3.2A, and the stiffness of plain collagen-agarose gel was determined.  
Additionally, the gel stiffness was evaluated to determine how the inclusion of beads 




Figure 3.2: Collagen-Agarose Samples (A) and Silicone Molds for Casting Collagen-
Agarose Gels (B) 
 
 A volume of 1mL of collagen-agarose solution was prepared by mixing 450µL of 
3mg/mL PureCol® Purified Bovine Collagen (Advanced Biomatrix, San Diego, CA) with 
450µL of 1% agarose solution (Type VII-A, Sigma, St. Louis, MO) and 100µL of 
collagen reconstitution buffer.  The collagen reconstitution buffer consisted of 0.22g 
sodium bicarbonate (Fisher, Fair Lawn, NJ) and 0.48g HEPES (Fisher) in 10mL 
deionized water (Millipore, Billerica, MA).  The collagen-agarose gels were formed by 
placing two high-density silicone sheets (thickness per sheet = 1mm) with circular molds, 
as shown in Figure 3.2B, on top of each other.  The silicone sheets wer placed on top of 
a polystyrene slide and the collagen-agarose gel solution was distributed evenly to each 
circular mold.  The gel-bead sample had an individual chitosan-gelatin bead placed into 





slide was then incubated for 10 minutes at 4○C to gel the solution to.  The elastic modulus 
was tested immediately using AFM.   
 An MFD-3D-BIO™ atomic force microscope (Asylum Research, Santa Barbara, 
CA) and borosilicate AFM tips of radius 2.5µm and spring constant 0.093N/m were used.  
During testing, the AFM tip approached the gel surface at a speed of 5µm/second and the 
contact force was measured until an indentation depth of 10µm.  Each gel was tested at 
three random points in the central area of the gel, and measured thre  times.  The gel 
sample containing the chitosan-gelatin bead was tested at the interface of the gel and 
bead.  The gel elastic modulus was estimated by fitting a Hertz model to indentation 
depths from 800 to 1000nm as shown in Equation 3.1 [18, 19]. 
   	
 
//   Equation 3.1 
Where:  F = Measured Force 
  υ = Poisson’s Ratio (0.5 for hydrogel) 
  δ = Indentation Depth 
  R = AFM Tip Radius 
 
Cell Isolation and Culture 
Human tissue samples were obtained from Greenville Hospital System and 
digested according to the protocol detailed in Appendix A.  The isolated primary cells 
were seeded in T-25 culture flasks (Corning, Corning, NY) with DMEM supplemented 
with 1% antibiotic/antimycotic (AA) (Gibco) 0.2% fungizone (Gibco), 0.4% Insulin-
Transferrin-Sodium Selenite (ITS) media supplement (Sigma), and 10% fetal bovine 
serum (FBS) (Mediatech, Herndon, VA). Culture flasks were incubated at 37°C with 5% 
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CO2.  Cells were grown to confluence and then passaged to larger flasks until a sufficient 
number was obtained to seed on beads.  
MCF10A cells (ATCC, Manassas, VA) were cultured in T-150 flasks with 15mL 
of Mammary Epithelial Cell Growth Medium (MEGM) (Lonza, Walkersville, MD) until 
confluence.  The MCF10A culture medium consisted of 500mL MEGM supplement d 
with the contents of one MEGM bullet kit including 2mL bovine pituitary extract, 0.5mL 
human epidermal growth factor, 0.5ml hydrocortisone, 0.5mL insulin, and 0.5mL 
gentamicin.  MCF10A conditioned medium (MCF10A-CM) was collected every 2-3 days 
from confluent MCF10A cells; the medium was stored at 4˚C if used within the week or 
at -20°C if intended for later use.  Immediately before medium changes, the MCF10A-
CM was warmed to 37°C and centrifuged at 1000 rpm for 5 minutes to collect residual 
cellular debris. 
Cell Seeding 
Cells for this co-culture study were seeded according to the conditions shown in 
Table 3.1.    To determine the effect of culturing the adipose cells on beads in 3-D, 
control samples were also cultured in well plates with either MCF10A cells seeded on 
transwell inserts, as shown in Figure 3.3 or with MCF10A conditioned m ia. Cell 
seeding for this study was completed in two stages for the initiat on of the co-culturing 





Table 3.1: Co-Culturing Conditions for Cell Seeding
Condition 
AC 
AC + MCF10A-Cell 
AC + MCF10A-CM 
 
Figure 3.3: Transwell Inserts for Co
 
Figure 3.4 Study Timeline 
A volume of 0.6mL of chitosan




Cells cultured either in 2-D or 3-D with the 
adipogenic cocktail only 
Cells cultured either in 2-D or 3-D with MCF10A 
cells seeded on transwell inserts 
Cells cultured either in 2-D or 3-D with MCF10A 
conditioned medium 
-Culturing Study 





of passage 3 were seeded into each well containing beads, with 2.5x105 cells added to 
each well.  Additionally, the same number of cells was seeded in 24-well tissue culture 
plates (Corning) to prepare the 2-D samples.  Cells were maintained in DMEM at 
standard culturing conditions of 37°C and 5% CO2 on an orbital shaker at 50rpm (IKA
® 
Works, Wilimington, NC).  After two days of culture, upon medium change, cells were 
cultured with an adipogenic differentiation cocktail.  The adipogenic cocktail onsisted of 
100µl insulin (Sigma, St. Louis, MO), 2µl dexamethasone (Sigma, St. Louis, MO), and 
1mL IBMX (Sigma, St. Louis, MO) per 10mL of DMEM medium.  Also at Day 2, 
2.0x104 MCF10A cells, of passage 7, were seeded onto the surfaces of the transwell 
insert membranes (0.4µm) (Corning) that were maintained in a separat  set of well plates.  
MCF10A cells were maintained in MEGM at standard culturing conditions.   At Day 5, 
the inserts containing MCF10A cells were transferred to the well plates containing the 
adipose cells on beads and the adipose cells in 2-D.  Additionally, at Day 5, MCF10A-
CM was added to the specified wells.  Cells were then evaluated at Day 12 to determine 
the influence of culturing the adipose cells with mammary epithelial cells in vitro. 
 
Live/Dead Cell Viability Staining 
A LIVE/DEAD® Viability/Cytotoxicity Kit (Molecular Probes, Eugene, OR) was 
used to qualitatively assess cellular attachment to the beads and to assess cellular viability 
after culturing on the beads in vitro.  The LIVE/DEAD® working solution, consisting of 
10mL PBS, 20µL Ethidium-homodimer-1 (EthD-1), and 5µL calcein AM, was prepared 
in a sterile 15mL centrifuge tube according to the manufacturer’s instructions.  Culture 
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medium was aspirated and beads were rinsed with 1mL of sterile PBS.  The PBS was 
aspirated from the scaffolds and 1mL of the working LIVE/DEAD® solution was added 
to each well of the plate containing beads.  The plate was allowed to incubate for 45 
minutes at room temperature and protected from light.  Following the incubation period, 
images of the contents of each well were captured using the Axiovert 135 fluorescence 
inverted microscope (Zeiss, Thornwood, NY), with color digital camera and imaging 
software.  The wells were evaluated for green and red fluorescence caused by the activity 
of the calcein AM and EthD-1, respectively, present in the working solutions.  Esterase 
present in live cells cleaves the calcein AM, resulting in a green fluorescence, while the 
red fluorescence occurs when EthD-1 enters a dead cell. 
 
Metabolic Activity 
Cellular metabolic activity was quantitatively assessed using alamarBlue® Cell 
Viability Reagent (Invitrogen, Biosource International, Camarillo, CA).  The 
alamarBlue® reagent was added to each well at 10% of the amount of cul ure medium in 
each well.  Well plates were incubated for three hours at 37°C on a shaker plate (IKA® 
Works, Wilmington, NC).  Following incubation, 150µl of the reaction solution was 
transferred from the cell culture plates to wells of a black-walled, clear-bottom 96-well 
microplate to assay the fluorescence of samples resulting from the reduction of the dye by 
metabolically active cells to produce a color change from blue to pink.  The absorbance 
was read using a Biotek Synergy MX Multi-Mode Microplate Reader (Biotek 
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Instruments, Winooski, VT) at wavelengths of 570nm and 600nm.  The percent reduc ion 
of alamarBlue® was calculated using Equation 3.2 shown below.   
 
%    	  !!"	 !"  100%   Equation 3.2 
 
Where:  A1 = absorbance of experimental well at 570nm 
  A2 = absorbance of experimental well at 600nm 
  N1 = absorbance of negative control (medium plus alamarBlue® reagent  
without cells) at 570nm  
N2 = absorbance of negative control (medium plus alamarBlue® reagent  
without cells) at 600nm 
 
 
PicoGreen® DNA Assay 
 The deoxyribonucleic acid (DNA) concentration of cells cultured on the beads 
and in 2-D was determined using the Quant-iT™ PicoGreen® dsDNA assay kit (P7589, 
Invitrogen, Molecular Probes, Carlsbad, CA).  At Day 12, culture medium was aspirated 
from the well plates and cells were rinsed with sterile PBS.  A 1X TE Buffer (10mM 
Tris-HCl, 1mM EDTA, pH 7.5) was prepared from the 20X stock solution provided n 
the kit.  A volume of 1mL of the 1X TE buffer was added to each well of the plate.  The 
plates were frozen and thawed three times to lyse the cells.  A pipet tip was used to 
scrape the cells in each well.  An aqueous working solution of the Quant-iT™ 
PicoGreen® reagent was prepared by making a 1:200 dilution of the concentrated 
solution with 1X TE buffer.  A 2µg/mL stock solution of dsDNA in 1X TEbuffer was 
prepared and further diluted to prepare DNA standards, ranging from 0 to 1 00ng/mL, 
that were used to generate a standard curve.  A volume of 100µL of each sample and 
134 
 
standard was pipetted to wells of a black-walled 96-well plate.  Working solution in the 
amount of 100µL was pipetted to each well and the plate was incubated for 5 minutes in 
the dark at room temperature.  The fluorescence was read using a Flouroskan Ascent® 
FL flourometric plate reader (Labsystems, Franklin, MA) at 480nm excitation and 520nm 
emission wavelengths.   
 
Oil Red O Staining (ORO) 
Cell culture medium was aspirated from well plates and the cells and beads were 
rinsed twice with sterile PBS The cells were fixed with 2mL 10% Neutral Buffered 
Formalin (Fisher Chemicals, Fair Lawn, NJ) overnight.  An ORO stock solution was 
prepared by dissolving 0.5g ORO powder (Sigma, St. Louis, MO) to 100mL isopropanol 
(Fisher Chemicals, Fair Lawn, NJ)).  An ORO working solution was prepared by mixing 
60mL of ORO stock solution with 40mL deionized water and stirring for 30 minutes.  A 
volume of 500µL of the working solution was added to each well and incubated for 15
minutes at room temperature.  Following incubation, the wells were rins d three times 
with fresh deionized water.  After decanting excess water, th  red-stained lipid was 
imaged using an inverted microscope and imaging software.  After imaging, 500µL of 
isopropanol was added to each sample well and incubated for 20 minutes to extract the 
stain.  The extraction solution was collected into microcentrifuge t b s (Fisher Scientific, 
Fair Lawn, NJ) and 100µL of each sample was pipetted to the wells of a 96-well plate 




Total Triglyceride Measurement 
Cell culture medium was aspirated from well plates and the cells and beads were 
rinsed twice with sterile PBS. After subjecting the cells to three freeze-thaw cycles, 1mL 
of 1% Triton X-100 (Sigma, St. Louis, MO) was added to each well and the cells were 
incubated for 30 minutes at room temperature.  Standard glycerol solutions of 
concentrations ranging from 0 to 200µM glycerol were prepared by dissolv ng glycerol 
(Sigma, St. Louis, MO) in deionized water.  Following incubation, the cells from each 
well were collected with the Triton X-100 solution into microcentrifuge tubes and 
centrifuged for 10 minutes at 3000rpm.  A volume of 100µL of each sample and standard 
were pipette into the wells of a 96-well plate in triplicate.  A volume of 100µL of 
Infinity™ Triglyceride Reagent (Thermo Fisher Scientific, Waltham, MA) was added to 
each well and incubated for 15 minutes at room temperature.  The absorb nce was read at 




Samples of ribonucleic acid (RNA) were isolated from the adipose cells cultured 
at each condition.  The culture medium was aspirated from the wells of the culture plates 
and the cells and beads were rinsed with 1mL of sterile PBS.  The RNA was isolated 
from the samples using the reagents and instructions supplied in an RNeasy Mini Kit 
(QIAGEN, Valencia, CA) (Appendix D).  The concentration and purity of the isolated 
RNA samples was measured using the Agilent 2100 Bioanalyzer (Agilent Technologies, 
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Inc., San Jose, CA), RNA 6000 Nano Assay Kit (Agilent Technologies, Inc.), RNA 6000 
Ladder (Ambion, Inc., Austin, TX), RNA 6000 Nano LabChip® (Caliper Technologies 
Corp., Mountain View, CA), and 2100 Expert Software (Agilent Technologies, Inc.) 
(Appendix E).  PPAR-γ and aP2 were selected to identify cells in the early and late st g s 
of adipocyte differentiation; β-actin was selected as the housekeeping gene.  Primers 
specific for the human genes and accession numbers for the mRNA sequenc s for each 
specified gene were listed in Table 2.2.  Real-time, one step RT-PCR was performed 
using the Quantifast™ SYBR® Green RT-PCR kit (Qiagen) with conditions as shown in 
Appendix F.  The comparative Ct or delta-delta Ct (∆∆Ct) method was used to determine 
the relative expression level for each gene of interest using β-actin as the reference gene.   
 
Statistical Analysis 
Statistical analyses were performed using SAS 9.2 software (Cary, NC) to 
compare the effect of each culture medium on cell behavior.  The Least Squares Means 
(LSMEANS) was used with a significance level of p < 0.05 (n=3). Graphical error bars 
represent the standard error of the mean. 
 
3.3 Results 
Gel Permeation Chromatography 
 An estimated molecular weight range was determined for the as-r ceived chitosan 
and gelatin powders, using the standard curve generated from the retention times for each 
molecular weight standard.  The estimated range for the as-received chitosan was 
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253,000 to 341,393Da, while the sterilized chitosan was 256,946 to 310,672Da.  The as-
received gelatin was estimated to be 262,269 to 343,859Da and the sterilized gelatin was 
262,571 to 343,499Da.  There was no significant difference measured between mol cular 
weights of the as-received and sterilized samples.   
 
Table 3.2: Estimated Mw Range of Chitosan and Gelatin Samples 
Sample Estimated Mw Range (Da)  
As-Received Chitosan 253,060 - 341,393 
Sterilized Chitosan 256,946 - 310,672 
As-Received Gelatin 262,269 – 343,859 
Sterilized Gelatin 262,571 – 343,499 
 
Atomic Force Microscopy 
 After applying the Hertz model equation to the resulting AFM data, the estimated 
elastic modulus, as shown in Table 3.3, for the plain collagen-agarose gel was determined 
to be 22.71±1.76 kPa.  The addition of the chitosan-gelatin bead to the gel resulted in a 
significant increase in the gel stiffness to 33.93±3.7 kPa (p<0.05).  
 
Table 3.3: Estimated Elastic Modulus 
Sample 
Estimated Elastic Modulus 
(kPA) 
Gel 22.71 ± 1.76 
Gel Containing Chitosan-
Gelatin Bead 
33.93 ± 3.7 * 
* Indicates statistically different value (p<0.05) 
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Live/Dead Cell Viability Staining 
 Qualitative assessment of cell viability showed a similarly minimal number of 
live cells attached to beads for each cell condition, as shown in Figure 3.5.  Dead cells 
were not apparent.  
 
Figure 3.5: Live/Dead staining at Day 12 showed minimal number of live cells attached 






 The results of the alamarBlue® assay for metabolic activity are shown in Figure 
3.6.  Results of the alamarBlue® assay indicate that the most metabolically active cells 
were the samples cultured with the adipogenic cocktail in 2-D.  The cells cultured with 
the adipogenic cocktail and with MCF10A-CM were significantly more m tabolically 
active than the adipose cells cultured on beads with the adipogenic cocktail and 
MCF10A-CM (p<0.05).  The addition of conditioned medium to the cells in 2-D and the 
adipose cells on beads resulted in significantly lower metabolic activity than cells 
cultured with the adipogenic control and the cells co-cultured with the MCF10A cells in 
transwell inserts (p<0.05).  
  
PicoGreen® DNA Assay 
 The DNA concentration within each sample of adipose cells was qu ntified using 
PicoGreen® DNA assay, as shown in Figure 3.7.  The amount of DNA measured in each 
2-D sample was significantly higher than the respective condition cultured on beads 
(p<0.05).  Additionally, the MCF10A-CM sample in 2-D had a significantly higher DNA 
concentration than the adipogenic control and the cells cultured with MCF10A-Cell in 2-





Figure 3.6: Results of alamarBlue® assay indicate that cells cultured in 2-D were more 
metabolically active than the adipose cells cultured on beads (p<0.05).  Asterisk  (*) 
denote significantly different values.  Pound (#) and percent symbol indicate samples 
with metabolic activity statistically different from the other conditions in 2-D and on 





Figure 3.7: Results of the PicoGreen® assay showed that the cells cultured in 2-D had a 
significantly higher DNA concentration than samples cultured on beads for any condition 
(p<0.05).  Asterisks (*) indicate statistically different values.  Percent symbol (%) 
indicates value statistically higher than the AC and MCF10A-Cell samples in 2-D.  
Graphical error bars represent the standard error of the mean.  
 
Oil Red O Staining 
Oil Red O staining of human adipose cells cultured for each condition in 2-D 
revealed intracellular lipid within the cells.  As shown in Figure 3.8A, clearly rounded 
lipid droplets of increased size were present within the cells tr ated with the adipogenic 
control in 2-D.   Lipid droplets in the 2-D cells co-cultured with MCF10A cells were 
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smaller in size and more undefined than those in the 2-D AC samples (Figure 3.8C).  
Additionally, the cells in 2-D cultured with MCF10A conditioned medium  
 
Figure 3.8: Oil Red O staining of human adipose cells cultured in 2-D and on chitosan-




Figure 3.9: Measurement of the absorbance of the Oil Red O extraction solution showed 
significantly higher amounts of lipid in the human adipose cells cultured in 2-D than the 
cells cultured on beads for each condition, indicated by asterisks (*) (p<0.05).  Percent 
(%) symbol indicates a significantly lower value than the other conditions at 2-D.  
Graphical error bars represent the standard error of the mean. 
 
had lipid droplets dispersed throughout the sample; however, the droplets wer  mall and 
immature (Figure 3.8E).  Human adipose cells seeded on chitosan-gelati  b ads at each 
condition were stained with Oil Red O; however, there were littl  to no visible lipid 
droplets present on the beads at any condition (Figure 3.8B, 3.8D, and 3.8F).   
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Absorbance measurements of the Oil Red O extraction solution, as shown in 
Figure 3.9, indicated significantly higher amounts of lipid for all samples in 2-D culture 
than for their respective samples cultured on beads (p<0.05).  The extraction solution 
values for the 2-D adipogenic cocktail sample were, however, significantly lower than 
those for the cells cultured with MCF10A-Cells and MCF10A-CM in 2-D (p<0.05). 
 
Total Triglyceride Measurement 
 As shown in Figure 3.10, the total triglyceride within the human adipose cells for 
each condition in 2-D culture was significantly higher than their rspective samples 
cultured on chitosan-gelatin beads (p<0.05).  There was no difference measured between 






Figure 3.10: Measurement of total triglyceride content showed that the cells cultured in 
2-D produced significantly higher amounts of triglyceride than their respective samples 
cultured on beads (p<0.05).  Asterisks (*) indicate statistically different values.  
Graphical error bars represent the standard error of the mean. 
 
Quantitative Real Time RT-PCR 
 As shown in Figure 3.11A, culturing of the human adipose cells in 2-D with 
MCF10A-Cells, resulted in significantly lower PPAR-γ expression than the 2-D 
adipogenic control sample (p<0.05).  The cells cultured with MCF10A-CM, however, 





Figure 3.11: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by human adipose 
cells.  Results are reported as relative expression to β-actin using the ∆∆Ct method.  
Asterisk (*) indicates a statistical difference between specified conditions (p<0.05).  
Pound symbol (#), dollar sign ($), and percent symbol (%) denote values statistically 
different from each other for PPAR-γ expression.  At symbol (@) for PPAR-γ and percent 
(%) for aP2 indicate values statistically higher than other respectiv samples on in 2-D.  





cultured on beads with MCF10A-Cells expressed significantly higher amounts of PPAR-
γ than all other samples (p<0.05).   
 When evaluating human adipose cell samples of each condition for aP2 
expression, it was shown that the cells cultured in 2-D with the adipogenic cocktail 
expressed a significantly higher amount of aP2 than all other samples in 2-D (p<0.05).  
There was no difference observed between any of the samples cultured on beads. 
 
3.4 Discussion 
 Researchers have investigated the relationship between epithelial c ls and 
stromal cells within the breast to determine how these cells interact during normal 
mammary development.  We hypothesized that mammary epithelial cells wou d influence 
the differentiation of adipose cells since the two cell types are closely related in the 
mammary gland.  To further develop our injectable composite system for breast 
reconstruction, it was essential to understand the relationship between mammary 
epithelial cells of the microenvironment and adipose cells.    
When selecting a material for use as scaffolding in adipose tissue engineering, 
several aspects must be considered. Scaffold selection depends on the physical, 
mechanical, and chemical properties of the material [20].  Becaus the tissue that is being 
reconstructed is a “soft” tissue, a scaffold material that imparts a natural feel is ideal, 
particularly for restoration of breast tissue in women [21-23]. Additionally, the cell type 
of interest will affect the material selected for use as a caffold.  Preadipocytes are 
anchorage-dependent cells, meaning that they require a surface, i.e. substrate, of defined 
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stiffness in order for attachment, proliferation, and differentiation to occur [24-26].  The 
porosity of a scaffold surface can be selectively modified to both encourage cellular 
attachment and to allow the diffusion of nutrients and vascular ingrowth within a scaffold 
[21, 27].   More specifically, it has been shown that dispersed, cultured fat is difficult to 
maintain on two-dimensional (2-D) surfaces in static flow [28], perhaps attributable to 
the fact that mature adipocytes are capable of a phenomenon known as dedifferentiation, 
where the cells lose accumulated lipid and revert to a previous fusiform state observed in 
preadipocytes [29, 30].  Moreover, culturing anchorage dependent cells on appropriate 
substrata can result in increased proliferation and ultimately th  presence of a greater 
number of cells with the potential to differentiate in culture [31].   
 The chitosan used for manufacturing the chitosan-gelatin beads for this work is 
characterized between 100,000-300,000 Da with degree of deacetylation ≥90% according 
to the manufacturer’s technical specifications.  The gelatin blended with chitosan for our 
beads is characterized by its bloom of approximately 300.  The bloom is an indicator of 
the strength of a gel, where a higher bloom means a stronger gel.  Th  bloom is also 
proportional to the average molecular weight of the gelatin.  A high bloom, ranging from 
225 to 325, corresponds to a molecular weight range of 50,000 to 100,000 [32-34]. 
It has been noted that certain sterilization methods, including gas, autoclave, and 
gamma irradiation may result in alterations of the chitosan molecular structure that can 
affect its properties [7].  To sterilize our chitosan and gelatin powders in preparation for 
cell culturing, we autoclaved the chitosan and gelatin powders.  From GPC we were able 
to estimate the molecular weight of the as-received and sterilized chitosan and gelatin 
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powders.  Since no statistical significance was determined between the as-received and 
sterilized molecular weights for either the chitosan or gelatin, it was determined that our 
sterilization methods did not significantly alter the molecular prope ties of these 
materials.   
Characterization of mammary tissue has included identifying ad quantifying 
specific mechanical properties of the key tissue components that make up the breast 
composition.  Numerous studies to determine the elastic modulus and the strength of 
selected tissues of the breast have been performed, as knowledge of the elastic properties 
of breast tissue may be used for modeling of tissue dynamics and for imaging of the 
tissue to detect malignancies [35-38].  Three of the most predominant types of tissue that 
make up the mammary gland are skin, glandular tissue, and adipose tissue.  Reports 
indicate that the elastic modulus of skin is between 200-3000 kPa and its ultimate tensile 
strength is approximately 20 MPa [39].  The elastic modulus for normal glandular tissue 
has been reported as between 2-66 kPa [35, 40]; while the elastic modulus for mammary 
adipose tissue, characterized as white adipose tissue, has been reported as 0.5-25 kPa [36, 
40-44].  Some reports have indicated that normal glandular tissue is 5-50 times stiffer 
than adipose tissue, which is attributed to the higher lipid and water eight of the adipose 
tissue that influences the modulus according to the applied strain rate [39, 45].   
For breast reconstruction, scaffolds have typically been designed for rest ration of 
tissue volume, as opposed to the restoration of tissue function.  As a result, the scaffolds 
should ideally restore the aesthetic function of the tissue by imparting a soft, smooth feel 
closely resembling that of natural tissue.  The rigidity and stiffness of scaffolds used for 
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adipose tissue engineering is therefore one property that must be considered.  When 
compared to the elastic modulus of the tissue components of the breast, th  modulus of 
our proposed injectable composite system would not be as stiff as skin, but would have a 
modulus within the estimated range for normal glandular tissue and adipose tissue, 
indicating that the properties of the injectable composite system could closely resemble 
that of natural breast tissue. 
At the conclusion of the study, it was found that the most metabolically active 
samples were the cells cultured in 2-D, likely because there wsignificantly more cells 
measured in the 2-D samples than were measured in the bead samples, according to the 
PicoGreen® assay of DNA concentration.  One possible explanation for the significant 
difference in cell number among the 2-D and bead samples is that the addition of beads to 
the culture system resulted in an increase in surface area that the cells had to cover over 
the culture period.  Placing beads in the well plates introduced grooves and spaces such 
that the cells may not have been as readily in contact with each other as they were in the 
well plates.  Cell-cell interactions that encourage cellular growth and proliferation may 
have been limited by the beads, indicating that a larger number of c lls may need to be 
seeded in the 3-D system, or that the time for culturing the cells on beads should be 
lengthened.   
Because the number of cells found on the beads was significantly lower than the 
number of cells in the 2-D samples, it was anticipated that this result would influence the 
outcome of the other assays to assess adipogenesis.  Indeed the measured ORO 
absorbance from the cellular bead samples is likely attributed to Oil Red O stain solution 
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absorbed by the beads that was released with extraction in isopropanol and is not an 
indicator of lipid from stained cells.  The results of the triglyceride assay al o suggest that 
the significant difference in triglyceride concentration observed between the 2-D samples 
and the samples on beads was attributed to the significantly lower number of cells on the 
beads at the end of the study.  
Previous studies, in Chapter 1, evaluating the influence of conditioned media on 
primary human adipose cells in 2-D showed that MCF10A conditioned media negatively 
influenced adipogenesis.  Here, however, evaluation of the 2-D samples showed 
comparable absorbance of the Oil Red O extraction solution and comparable triglyceride 
concentration for the 2-D AC samples and also the 2-D samples cultured with MCF10A 
cells and MCF10A conditioned medium.  The different outcome here is possibly a result 
of different culturing and seeding conditions used in this study.  For the previous 
conditioned media studies, human adipose cells were cultured for two days and then 
MCF10A conditioned medium and the adipogenic cocktail were added simultaneously to 
the cells.  Here, the cells were cultured with the adipogenic cocktail for two days and then 
supplemented with MCF10A conditioned media two days later.  As a result, the cells in 
the conditioned media studies of Chapter 1 were exposed to the conditioned media for a 
longer period of time and the conditioned media was better able to influence adipogenesis 
of the cells.  The cells here likely had an opportunity to have diffrentiation initiated by 
the adipogenic cocktail and the conditioned media did not have a similar neg tive effect 
on adipogenesis because the cells were already undergoing differentiation.  This indicates 
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that attention must be paid to the specific time points for introducing onditioned media 
to cells, depending on the desired outcome.   
The gene expression data for the samples in 2-D and on the beads showed t e 
presence of PPAR-γ within each of the samples, indicating that adipose cells were present 
for each condition.  The significantly higher amount of PPAR-γ expression measured in 
the MCF10A-Cell sample on the beads has no clear explanation. Since a comparable 
number of cells were measured on all the samples cultured on beads, one would expect 
comparable gene expression.  This indicates that there likely may have been some dnase 
contamination in the MCF10A-Cell samples grown on beads.  Analysis of aP2 gene 
expression showed that the highest expression of aP2 was observed in the 2-D adipogenic 
control samples and indicated that there were mature cells present within those samples.  
Little to no expression of aP2 in the other samples indicates that those cells are not 
mature.  In regard to the other samples in 2-D, MCF10A-Cell and MCF10A-CM, 
comparable levels of triglyceride and lipid were observed in the 2-D AC sample and the 
2-D MCF10A-Cell and MCF10A-CM samples which suggested that the conditioned 
media and mammary epithelial cells did not have an effect on the adipose cell 
differentiation.  The significantly lower aP2 expression observed in the 2-D MCF10A-
Cell and MCF10A-CM samples when compared to the 2-D AC samples suggests that the 
cells cultured with MCF10A cells and conditioned media were in fact not as mature as 






 The autoclave conditions that were used for preparing sterile powders to 
manufacture sterile chitosan-gelatin beads for cell culturing d d not significantly alter the 
material properties of the chitosan and gelatin.  Measure of the elastic modulus of the 
components of the injectable composite system showed that the inclusion of chitosan-
gelatin beads within a collagen-agarose gel matrix significa tly increases the stiffness of 
the gel matrix.  The estimated stiffness of the collagen-agarose gel matrix and the 
collagen-agarose gel containing the chitosan-gelatin bead was comparable to the modulus 
of the normal tissue components of the mammary gland, suggesting that the injectable 
composite system of these materials could be successful for restoring the aesthetic 
function of the breast because of the similar material properties. 
 From this study, the significant difference in cell number observed between the 2-
D and samples and samples grown on beads indicates that for the injectable composite 
system, either a higher number of cells should be seeded initially on the beads, or the 
cells should be allowed to culture on the beads for a longer period of time before 
differentiation is induced.  Additionally, the time point during cell culture at which 
conditioned media should be added to cells, should be determined taking into account the 
desired potential outcome of the conditioned media treatment. Finally, while it is known 
that culturing of adipose cells on beads will influence their differentiation, to determine 
the true effects of co-culturing the adipose cells on beads with mammary epithelial cells, 
this study may need to be repeated with increased adipose cell numbers seeded on the 
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IN VITRO EVALUATION OF FATTY ACID INFLUENCE ON ADIPOSE CELL 
DIFFERENTIATION IN TWO-DIMENSIONAL (2-D) CULTURE 
 
4.1 Background 
It has already been noted that adipose tissue is the storage site for fat.  The formation 
of adipose tissue, or lipogenesis, is influenced by many factors such as insulin, glucose, and 
fatty acids [1].  Within fat tissue, adipocyte cells store lipids primarily in the form of 
triglyceride, which is made up of three fatty acids attached to a glycerol molecule.  Fatty 
acids are therefore often considered to be the building blocks of triglyceride, the stored fat 
within adipose tissue [2].   
 Common fatty acids were listed in Table 1.3 of Chapter 1.  Fatty acids are composed 
of carbon and hydrogen, and may be classified as either saturated or unsaturated, depending 
on the lack of presence of double bonds between the carbon and hydrogen units of the 
molecule.  Saturated fatty acids do not have any double bonds present in their structure; their 
structure is a straight, tightly-packed chain.  Unsaturated fatty acids have a double bond 
present between the hydrogen and carbon units which cause bends or kinks within the fatty 
acid chain.  The structure of fatty acids influences their physical properties; tightly bound 
saturated fatty acids have a higher melting temperature and are solid at room temperature, 
while unsaturated fatty acids are liquid at room temperature due to their low melting 
temperature.  Fatty acids are either synthesized within the body, or consumed by dietary 
intake of food.  The body, however, is not capable of synthesizing all fatty acids; those not 
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synthesized in the body must be consumed, and are known as essential fatty cids.  The 
essential fatty acids include linoleic acid, arachidonic acid, and linolenic acid, and they are 
required for synthesis of other key factors in the body, such as prostaglandins [2, 3].   
 Research has shown that many mammalian cells grown in vitro often require 
exogenous lipid or fatty acids in the culture medium to facilitate healthy cultures.  Cultures 
of rat preadipocyte cells that were given medium supplemented with oleic acid, 
demonstrated large accumulation of cytoplasmic lipid fairly rapidly [4].  Additionally, in the 
human diet, it has been suggested that fatty acids may influence adipogenesis at the 
transcriptional level.  The addition of a specific fatty acid, linoleic acid, to culture medium 
of adipose stromal-vascular (preadipocyte) cells, resulted in significant lipid accumulation 
observed within the cells [5].  In these cases, there was no other significant indicator of 
adipose cell differentiation besides the large accumulation of lipid; however, this outcome 
could prove advantageous for optimizing adipose tissue engineering st ategies.  Adipose 
tissue mass may increase either by an increase in the number of adipocytes present within 
adipose tissue (hyperplasia), or by an increase in the size of th adipocytes (hypertrophy) [3, 
6, 7].  Since mature adipocytes do not actively proliferate, the likelihood of the number of 
cells in adipose tissue increasing is minimal.  Therefore, the most promising means of 
increasing adipose tissue mass for adipose tissue engineering would be to stimulate an 
increase in the size of cells available.  We hypothesize that the inclusion of fatty acid 
supplements to our injectable composite system will enhance the succs  of the system for 
breast tissue reconstruction by stimulating lipid filling of the adipose cells to facilitate an 
increase in adipose tissue mass.  Initial studies were therefor  performed to first determine 
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what effect exogenous fatty acid would have on adipose cell differentiation in 2-D culture. 
After identifying the optimal concentration of linoleic acid, subsequent studies 
were performed to determine whether or not there was a difference in cell behavior when 
the fatty acid was added at different stages of cell culturing.  For instance, would 
differentiation be influenced by adding fatty acid at the initial seeding of cells, or post-
induction of differentiation?  Additional studies were therefore performed to determine 
the influence of linoleic acid, when added at specified culture periods, n D1 cell 
differentiation to adipocytes. 
 
4.2 Materials & Methods 
Determination of Optimal Fatty Acid Concentrations for Cell Cultures 
Cell Culturing 
Murine bone marrow stromal cells, D1 cells (CRL-1242, ATCC, Manassas, VA), 
of passage 11 were seeded in 24-well culture plates (Corning, Corning, NY) at 20% 
seeding density (2.6x104 cells per well).  Cells were maintained in Dulbecco’s Modifie  
Eagle Medium (DMEM) (ATCC, Manassas, VA) supplemented with 10% FBS 
(Mediatech, Herndon, VA), 0.2% fungizone (Gibco, Invitrogen, Carlsbad, CA) and 1% 
Antibiotic-Antimycotic (Gibco, Invitrogen, Carlsbad, CA) at standard culturing 
conditions of 37°C and 5% CO2.  After two days of culture, upon medium change, cells 
were then cultured with either an adipogenic differentiation cocktail, or with increasing 
concentrations of linoleic acid-albumin (LA) (L9530, Sigma, St. Louis, MO), ranging 
from 0.25-12% linoleic acid in the culture medium (Table 4.1).  The adipogenic cocktail 
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(AC) consisted of 100µl insulin (Sigma, St. Louis, MO), 2µl dexamethasone (Sigma, St. 
Louis, MO), and 1mL IBMX (Sigma, St. Louis, MO) per 10mLs of DME  medium.  
Culture medium was changed every 2 days during the study.  Cells were then evaluated at 
Day 7 and Day 14 to determine the influence of increasing amounts LA on cell behavior.  
 
Table 4.1: Linoleic Acid Cell Culturing Conditions: Optimization 
Medium Description 
No Additives DMEM only throughout 
Normal 
Cocktail 
Adipogenic cocktail (AC) 
Both 
Additives 
Adipogenic Cocktail + 1% LA (AC + LA) 
0.25% DMEM + with 0.25% LA 
0.50% DMEM + with 0.50% LA 
1% DMEM + with 1% LA 
2% DMEM + with 2% LA 
4% DMEM + with 4% LA 
6% DMEM + with 6% LA 
8% DMEM + with 8% LA 
10% DMEM + with 10% LA 
12% DMEM +with 12% LA 
Note: Percentage of linoleic acid added to cells was based on the 
volume of linoleic acid added per well, i.e. 4% LA = 80µL LA per 






Preliminary evaluation of fatty acid-supplemented cultures with LA resulted in 
bright yellow media, indicative of changes in the pH of the medium over the course of 
the study.  With increasing concentrations of fatty acid added to the culture medium, the 
pH of the medium was evaluated over time to determine if any significant changes 
occurred.  Samples of the culture medium were preserved at medium changes and 
evaluated using a Model 8805 pH meter (VWR, West Chester, PA) to determine the 
average pH value for each sample over time. 
 
PicoGreen® DNA Assay 
 The deoxyribonucleic acid (DNA) concentration within each sample was 
determined using the Quant-iT™ PicoGreen® dsDNA assay kit (P7589, Invitrogen, 
Molecular Probes, Carlsbad, CA).  At Day 7 and Day 14, culture medium was aspirated 
from the well plates and cells were rinsed with sterile PBS.  A 1X TE Buffer (10mM 
Tris-HCl, 1mM EDTA, pH 7.5) was prepared from the 20X stock solution provided n 
the kit.  A volume of 1mL of the 1X TE buffer was added to each well of the plate.  The 
plates were frozen and thawed three times to lyse the cells.  A pipet tip was used to 
scrape the cells in each well.  An aqueous working solution of the Quant-iT™ 
PicoGreen® reagent was prepared by making a 1:200 dilution of the concentrated 
solution with 1X TE buffer.  A 2µg/mL stock solution of dsDNA in 1X TEbuffer was 
prepared and further diluted to prepare DNA standards, ranging from 0 to 1 00ng/mL, 
that were used to generate a standard curve.  A volume of 100µL of each sample and 
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standard was pipetted to wells of a black-walled 96-well plate.  Working solution in the 
amount of 100µL was pipetted to each well and the plate was incubated for 5 minutes in 
the dark at room temperature.  The fluorescence was read using a Flouroskan Ascent® 
FL flourometric plate reader (Labsystems, Franklin, MA) at 480nm excitation and 520nm 
emission wavelengths.   
 
Oil Red O Staining (ORO) 
Cell culture medium was aspirated from well plates and the cells were rinsed 
twice with sterile PBS (Sigma, St. Louis, MO).  The cells were fixed with 2mL 10% 
Neutral Buffered Formalin (Fisher Chemicals, Fair Lawn, NJ) overnight.  An ORO stock 
solution was prepared by dissolving 0.5g ORO powder (Sigma, St. Louis, MO) to 100mL 
isopropanol (Fisher Scientific, Fair Lawn, NJ)).  An ORO working solution was prepared 
by mixing 60mL of ORO stock solution with 40mL deionized water and stirring for 30 
minutes.  A volume of 500µL of the working solution was added to each well and 
incubated for 15 minutes at room temperature.  Following incubation, the wells ere 
rinsed three times with fresh deionized water.  After decanting excess water, the red-
stained lipid was imaged using an inverted microscope and imaging software. 
 
Total Triglyceride Measurement 
Cell culture medium was aspirated from well plates and the cells rinsed twice 
with sterile PBS.  After subjecting the cells to three freeze-thaw cycles, 1mL of 1% 
Triton X-100 (Sigma, St. Louis, MO) was added to each well and the cells were 
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incubated for 30 minutes at room temperature.  Standard glycerol solutions of 
concentrations ranging from 0 to 200µM glycerol were prepared by dissolv ng glycerol 
(#G7793, Sigma, St. Louis, MO) in deionized water.  Following incubation, the cells 
from each well were collected with the Triton X-100 solution into microcentrifuge tubes 
and centrifuged for 10 minutes at 3000rpm.  A volume of 100µL of each sample and 
standard was pipetted into the wells of a 96-well plate in triplicate.  A volume of 100µL 
of Infinity™ Triglyceride Reagent (Thermo Fisher Scientific, Waltham, MA) was added 
to each well and incubated for 15 minutes at room temperature.  The absorbance was read 
at 490nm on a microplate reader (BioTek Instruments, Inc., Winooski, VT). 
 
Determination of the Effect of Exogenous Fatty Acids at Specified Cell Culturing 
Intervals 
Cell Culturing 
Murine bone marrow stromal cells, D1 cells, of passage 11 were seded in 12-
well culture plates at 20% seeding density (7.6x104 cells per well).  Cells were seeded 
according to the conditions specified in Table 4.2.  Cells were maintained in Dulbecco’s 
Modified Eagle Medium supplemented with 10% FBS, 0.2% fungizone, and 1% 
Antibiotic-Antimycotic at standard culturing conditions of 37°C and 5% CO2.  The 
culture condition, denoted as LA Begin, included 4% v/v linoleic acid-albumin (LA) 
(Sigma, St. Louis, MO); the linoleic acid-albumin was added to the DMEM medium at 
the initial cell seeding.  At confluence, upon medium change, cells w re cultured with 
either an adipogenic differentiation cocktail or maintained in DMEM with or without 4% 
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LA. The adipogenic cocktail consisted of 100µl insulin, 2µl dexamethasone, and 1mL 
IBMX per 10mL of DMEM.  Culture medium was changed every two days during the 
study.  Cells were evaluated at Day 12 to determine the influence of LA on cellular 
behavior.  
 
Table 4.2 Linoleic Acid Cell Culturing Conditions: Differentiation 
Medium Description 
DMEM DMEM only throughout 
AC Adipogenic cocktail added at confluence 
LA Begin 4% LA added at initial cell seeding 
LA Begin 
+AC 
4% LA added at initial cell seeding + adipogenic cocktail 
at confluence 
LA Confl 4% LA added at confluence 
LA Confl + 
AC 
4% LA + adipogenic cocktail added at confluence 
LA Diff 
4% LA added after cells differentiated with adipogenic 
cocktail for 6 days 
Note: Percentage of linoleic acid added to cells was based on the volume 





 Culture medium was aspirated from cells in well plates and the cells were rinsed 
with sterile PBS.  A volume of 1mL of PBS was then added to each well and the cells 
were scraped with a pipet tip and transferred to microcentrifuge tubes.  Tubes were stored 
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at -20°C until evaluated for lipid content.  Detailed methods used for sample preparation 
are found in Appendix D of this document.  For gas chromatography (GC) analysis, 
samples were first thawed at room temperature and then transferred to glass round bottom 
tubes (Pyrex, Corning, Corning, NY).  Total lipids were extracted from the cells using 
organic solvents according to the procedures of Folch and coworkers [8]. The resulting 
lipid extracts were transmethylated according to the procedures of Park and coworkers 
[9].  A volume of 100µL of methylene chloride (Fisher, Fair Lawn, NJ) and 1mL of 
sodium methoxide in methanol (Sigma, St. Louis, MO) was added to each sample tube.  
The tubes were flushed with nitrogen gas and heated at 90°C for 10 minutes, then cooled 
to room temperature.  A volume of 1mL of 14% boron trifluoride in methanol (Sigma, St. 
Louis, MO) was added to each sample tube.  The tubes were flushed with nitrogen, 
heated again to 90°C for 10 minutes, and cooled to room temperature.  A volume of 
500µL of GC grade hexane (VWR, West Chester, PA) and 500µL of GC grade hexane 
containing the internal standard (1ug/µL C23:0 methyl ester, Sigma, St. Louis, MO) was 
added to each sample.  Deionized water in the amount of 2mL was added to each sample 
and the tubes were vortexed for two minutes, then centrifuged at 1500rpm fo  five 
minutes.  The upper layer of the separated phases in each tube was transferred to a 
disposable glass test tube (Fisher, Fair Lawn, NJ) containing a sm ll amount of 
anhydrous sodium sulfate (Fisher, Fair Lawn, NJ).  The liquid in the disposable tubes was 
then transferred to a GC vial and fatty acid methyl esters we analyzed using an HP6850 
Series II Gas Chromatograph fitted with an autosampler (Agilent Technologies, Santa 
Clara, CA).  Chemstation software was used to analyze the resulting data (Agilent 
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Technologies).  Specific fatty acids were identified by comparing the internal standard 
and retention times.  The weight percentage of fatty acids was calculated according to the 
values from the resulting plots applied to Equation 4.1 and 4.2 shown below. 
 
%& '( )*   +,-./ 01.	01.234501.2345  .!78⁄      Equation 4.1 
 
'( ) :;'&   <01.=>??@ ABCD 01.2345/ .!78⁄78 E.--F GHIJ K L 100%  Equation 4.2 
 
Where: Total Area = area of entire sample plot 
 AreaISTD = area of the internal standard located on the resulting plot 




Statistical analyses were performed using SAS 9.2 software (Cary, NC) to 
compare the effect of each culture medium on cell behavior.  The Least Squares Means 
(LSMEANS) was used with a significance level of p < 0.05 (n=4 for PicoGreen and 
Triglyceride assays performed for LA optimization studies; n=3 for all other assays). 
Graphical error bars represent the standard error of the mean. 
 
4.3 Results 
Determination of Optimal Fatty Acid Concentrations for Cell Cultures 
 
pH Measurements 
 Measurement of the pH of samples of the culture medium from each condition 
showed that the addition of linoleic acid in concentrations 2% or greater influenced the 
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pH values of the culture medium (Figure 4.1).  The culture environment became slightly 
more acidic, as compared to the DMEM and AC control samples, as the amount of 
linoleic acid was increased to concentrations greater than 2%.  When compared to the 
DMEM and AC control samples, cells treated with 8%, 10%, and 12% fatty acid all had a 
significantly lower pH, indicating that the medium was more acidic with the addition of 
the linoleic acid.  There was no statistical difference between th  pH of samples treated 
with 4% and 6% fatty acid. 
 
 PicoGreen® DNA Assay 
The DNA concentration within each sample was quantified using a PicoGreen® 
DNA assay, as shown in Figure 4.2.  For each condition, the amount of DNA within 
samples was significantly higher on Day 14 than on Day 7.  Among the Day 7 samples, 
DNA concentration of the samples treated with 6% and 8% linoleic acid had significantly 
lower DNA concentrations. At Day 14, samples treated with 4% linole c acid had 
significantly higher DNA concentrations, while the samples treated with 0.25% linoleic 
acid had significantly lower concentrations than the AC samples.  The DNA 
concentration for cells treated with 4% linoleic acid was significantly higher (p < 0.05) 
than the concentration measured in cells treated with 6% and 2% linoleic acid at Day 14.  
There was no statistically significant difference between the DNA concentrations 





Figure 4.1: Measurement of the pH values for each sample condition showed that 
increasing the amount of fatty acid added to the culture medium does influence the 
acidity of the culture environment.  Asterisks (*) indicate statistically different value 
compared to the DMEM and AC controls (p<0.05). Graphical error bars represent th  







Figure 4.2: Results of the PicoGreen® assay showed that cells evaluated at Day 14 had a 
significantly higher DNA concentration than samples evaluated at Day 7 for all 
conditions (p<0.05).  Asterisks (*) indicate values statistically lower than the AC value at 
Day 7.  Percent symbols (%) indicate value statistically lower than AC at Day 14.  Pound 
symbol (#) indicates value statistically higher than the AC, 2%, and 6% values at Day 14. 
Graphical error bars represent the standard error of the mean. 
 
Oil Red O Staining 
 Oil Red O staining of cells treated with linoleic acid showed little to no lipid in 
D1 cells cultured in DMEM at Day 7 or Day 14 (Figure 4.3 A & G).  Staining of the 
samples treated with the adipogenic cocktail showed clearly rounded, large lipid droplets 





at both Day 7 and Day 14, indicating that the D1 cells were actively differentiating (4.3 B 
& H).  When linoleic acid was added to the D1 cells treated with the adipogenic cocktail 
(AC+LA sample), a similar pattern of lipid staining was observed as was seen in the AC 
control (4.3 C & I).  Of the samples treated with linoleic acid, only representative images 
of samples receiving low, mid, and high concentrations of linoleic acid re shown.  The 
addition of 1% linoleic acid resulted in small red lipid droplets within the cells; however, 
the lipid droplets were not uniform or well-defined, even over the course of the study 
from Day 7 to Day 14 (4.3 D & J).  As increased concentrations of lin leic acid were 
added to the D1 cells, more lipid was present in the samples, as seen in the 4% and 12% 
samples shown in Figure 4.3 E-F & K-L.   
 
Total Triglyceride Measurement 
 As shown in Figure 4.4, the total triglyceride within the D1 cell samples 
significantly increased from Day 7 to Day 14 for all conditions except for the DMEM, 
0.25%, 0.5%, and 1% conditions.  When compared to the AC controls at Day 7, the 0.5%, 
and 1% linoleic acid samples had significantly less triglyceride.  The 12% linoleic acid 
samples had significantly higher amounts of triglyceride.  Additionally, there was no 
difference between the 2%, 4%, and 6% linoleic acid samples.  At Day 14, the DMEM, 
0.25%, 0.5%, 1%, and 2% samples produced significantly lower concentrations of 
triglyceride than the AC control.  There was no difference between th  4% and 6% 





Figure 4.3: Oil Red O staining of samples treated with linoleic acid. Total magnification 
for all images is 320x. 
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produced in the 4% samples when compared to the 2% samples.  There was no difference 
between the AC and AC+LA samples at either Day 7 or Day 14. 
 
 
Figure 4.4: Measurement of total triglyceride content showed that the addition of linoleic 
acid to D1 culture medium does influence triglyceride production.  Asterisks (*) indicate 
statistically significant differences.  Pound symbols (#) indicate significantly lower 
concentrations than the AC samples at Day 7.  Percent signs (%) indicate s gnificantly 
higher concentrations than the AC samples at Day 7. Dollar signs ($) indicate 
significantly lower concentrations than the AC samples at Day 14.  Ampersand symbols 
(&) indicate significantly different triglyceride values (p<0.05). Graphical error bars 







Determination of the Effect of Exogenous Fatty Acids at Specified Cell Culturing 
Intervals 
Gas Chromatography 
 The fatty acid profile for samples of each condition is shown in Figure 4.5.  The 
percentage of each individual fatty acid within cell samples was calculated and the sum 
of identifiable fatty acids was determined.  More than 85% of total fa ty acids were 
identified from the evaluated samples.  Of the identified fatty cids within the D1 cells, 
four specific fatty acids were most abundant within cells of each sample condition.  
Palmitic, stearic, oleic, and linoleic fatty acids were all found in the highest percentages 
for each condition.   
Comparison of the percentages of the four most prevalent fatty acids is shown in 
Figure 4.6.  For samples treated with DMEM, the percentage of lin leic acid was 
significantly lower (p<0.05) than the percentages of stearic, palmitic, or oleic acid; the 
percentage of oleic acid, however was significantly higher than stearic, palmitic, and 
linoleic acid.  For samples treated with AC, the percentage of lin leic acid was 
significantly lower than palmitic and oleic acid.  The percentage of oleic acid was 
significantly higher than linoleic and stearic acid, but there was no difference between the 
percentage of oleic acid and palmitic acid for samples treated with AC.  For all samples 
that were supplemented with linoleic acid, the percentage of linoleic acid was 
significantly higher than stearic, palmitic, or oleic acid percentages.  For samples treated 
with linoleic acid at the initial seeding, denoted as LA Begin, there was no significant 
difference in the percentage of oleic, stearic, or palmitic acids.  For samples treated with 
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linoleic acid at initial seeding and then cultured with the adipogenic cocktail, denoted LA 
Begin + AC, the percentage of palmitic acid was significantly higher than that of stearic 
and oleic acid.  When linoleic acid was added to cells once they reached confluence (LA 
Confl) the percentage of palmitic acid was significantly higher t an the percentage of 
stearic and oleic acid.  Similarly, when linoleic acid and the adipogenic cocktail were 
both added at confluence (LA Confl+AC) the percentage of palmitic acd was 
significantly higher than stearic and oleic acid.  Finally, when linoleic acid was added to 
the cells after they were stimulated to differentiate for six days, there was no difference in 
the percentage of stearic, oleic, or palmitic acids.   
Comparison of the amount of palmitic acid present within cells of each condition 
showed no difference in the percentage of palmitic acid present in samples treated with 
DMEM or AC.  When compared to the DMEM control, there was no difference in the 
percentages of palmitic acid and any samples cultured with linoleic acid.  Additionally, 
when compared to the AC control, there was no difference in the perc ntage of palmitic 
acid and any samples cultured with linoleic acid.  Comparison of samples treated with 
linoleic acid showed no difference in the percentage of palmitic acid, regardless of when 
the linoleic acid was added to the culture medium of the cells. 
Comparison of the amount of stearic acid present within cells of each condition 
showed no difference in the percentage of stearic acid present in samples treated with 
DMEM or AC.  The percentage of stearic acid in the DMEM samples was significantly 
higher than all conditions, with the exception of the LA Diff samples.  When compared to 





Average Percent (%) of Total Fatty Acid Composition 
Note: Values reported as Percent of Fatty Acid ± Standard Deviation (n=3 samples per condition) 
Carbon # Common Name DMEM AC LA Begin LA Begin + AC LA Confl LA Confl + AC  LA Diff 
12 Lauric 0.69 ± 0.19 0.83 ± 0.09 0.38 ± 0.09 0.66 ± 0.12 0.43 ± 0.09 0.41 ± 0.07 0.73 ± 0.08 
14 Myristic 4.06 ± 3.58 2.79 ± 0.43 1.78 ± 0.23 2.41 ± 0.71 1.89 ± 0.43 2.23 ± 0.37 1.97 ± 0.16 
14:1 c9 Myristoleic 0.36 ± 0.06 0.47 ± 0.18 0.24 ± 0.05 0.41 ± 0.16 0.43 ± 0.25 0.53 ± 0.33 0.35 ± 0.05 
15 Pentadecanoic 2.03 ± 0.30 1.58 ± 0.15 0.74 ± 0.25 0.56 ± 0.10 0.57 ± 0.10 0.65 ± 0.05 0.73 ± 0.27 
16 Palmitic 16.47 ± 1.02 20.89 ± 2.52* 13.02 ± 2.24* 15.35 ± 2.94* 15.07 ± 3.78* 18.19 ± 1.82* 15.27 ± 2.50 
16:1 c9 Palmitoleic 2.15 ± 0.20 3.65 ± 1.57 0.70 ± .63 0.72 ± 0.16 0.86 ± 0.46 1.12 ± 0.17 1.51 ± 0.34 
17 Heptadecanoic 0.47 ± 0.12 0.45 ± 0.10 0.94 ± 0.70 0.32 ± 0.02 0.79 ± 0.36 0.99 ± 1.09 0.33 ± 0.06 
18 Stearic 15.92 ± 1.49 13.08  0.47 8.56 ± 1.09 8.82 ± 0.61 8.45 ± 0.97 7.31 ± 1.05 10.37 ± 0.18 
18:1 t9 Trans-9 octadecenoic 0 0 0.65 ± 0.36 0.44 ± 0.04 0.49 ± 0.17 0.29 ± 0.09 0 
18:1 t10 Trans-10 octadecenoic 0 0 0.38 ± 0.65 0 0.17 ± 0.29 0.12 ± 0.20 0 
18:1 c9 Oleic 26.00 ± 1.09* 25.47 ± 2.51* 6.85 ± 6.71 4.03 ± 1.94 7.80 ± 5.33 6.50 ± 2.55 14.75 ± 1.02 
18:1 c11 Cis-11 octadecenoic 0 0 1.75 ± 1.57 1.12 ± 0.41 1.34 ± 0.44 1.43 ± 0.10 3.93 ± 0.28 
18:2 Omega-6 Linoleic 6.32 ± 0.20 7.17 ± 0.14 44.61 ± 14.13* 45.02 ± 2.19* 44.08 ± 6.18* 44.70±  3.93* 31.14 ± 0.92* 
18:3 Omega-3 Linolenic 2.67 ± 0.91 2.47 ± 0.24 0.15 ± 0.27 0.15 ± 0.13 0.12 ± 0.11 0.15 ± 0.17 0.53 ± 0.08 
18:2 c9t11 CLA cis9 trans11 1.47 ± 1.22 0.72 ± 0.14 0.19 ± 0.33 0 0.04 ± 0.06 0.00 0.06 ± 0.11 
18:2 c11t13 CLA cis11 trans13 1.25 ± 0.46 1.19 ± 0.14 3.45 ± 1.65 3.72 ± 0.58 3.33 ± 0.53 2.79 ± 0.28 1.83 ± 0.16 
18:2 t10c12 CLA trans10 cis12 0 0 0.16 ± 0.27 0.05 ± 0.09 0.00 0.17 ± 0.04 0.66 ± 0.28 
18:2 c9c11 CLA cis9cis11 0.54 ± 0.15 0.44 ± 0.06 0.24 ± 0.02 0.31 ± 0.10 0.28 ± 0.14 0.55 ± 0.33 0.51 ± 0.34 
18:2 t11t13/t8t10 CLA trans11 trans13/trans8 trans10 0.92 ± 0.11 0.75 ± 0.03 1.06 ± 0.20 1.03 ± 0.31 0.90 ± 0.19 0.31 ± 0.53 0.41 ± 0.17 
18:2 t9t11/t10t12 CLA trans9 trans11/trans10 trans12 0.45 ± 0.04 0.38 ± 0.03 0.15 ± 0.13 0.11 ± 0.10 0.18 ± 0.05 0.15 ± 0.02 0.53 ± 0.40 
20:4 Omega-6 Arachidonic acid 3.34 ± 0.50 2.40 ± 0.20 2.07 ± 0.90 2.26 ± 0.64 1.68 ± 0.09 1.76 ± 0.39 1.28 ± 0.17 
20:5 Omega-3 EPA 0.61 ± 0.06 0.43 ± 0.08 0.54 ± 0.08 0.48 ± 0.08 0.57 ± 0.27 0.43 ± 0.07 0.42 ± 0.09 
22:5 Omega-3 DPA 1.26 ± 0.22 0.96 ± 0.11 0.41 ± 0.05 0.44 ± 0.11 0.50 ± 0.28 0.53 ± 0.06 0.45 ± 0.03 
22:6 Omega-3 DHA 1.72 ± 0.38 1.34 ± 0.05 0.49 ± 0.24 0.41 ± 0.17 0.41 ± 0.12 0.42 ± 0.12 0.45 ± 0.03 
  Total Fatty Acid Percentage (SUM) 88.75 87.46 89.51 88.83 90.40 91.73 88.21 
  Unidentified Fatty Acids (100%-SUM) 11.25 12.54 10.49 11.17 9.60 8.27 11.79 
Figure 4.5: The fatty acid composition of each sample condition was determined by gas chromatography analysis.  The most 
abundant fatty acids present within each sample were palmitic, stearic, oleic, and linoleic.  The percentage of linoleic acid was 
consistently higher for samples that were cultured with linoleic acid in vitro. Asterisks (*) indicate values significantly higher 




cultured with linoleic acid.  Comparison of samples treated with linole c acid showed no 
difference in the percentage of stearic acid, regardless of when the linoleic acid was 
added to the culture medium of the cells.   
Comparison of the amount of oleic acid present within cells of each condition 
showed no difference in the percentage of oleic acid present in samples treated with 
DMEM or AC.  When compared to the DMEM control, the percentage of oleic acid was 
significantly higher than that of any samples treated with linoleic acid.  Similarly, when 
compared to the AC control, the percentage of oleic acid was significantly higher than the 
percentage of oleic acid in any samples treated with linoleic ac d during culture.  
Comparison of samples treated with linoleic acid during culture showed that the 
percentage of oleic acid in the LA Diff samples (linoleic acid added 6 days post-
differentiation) was significantly higher than any other samples that were cultured with 
linoleic acid. 
Comparison of the amount of linoleic acid present within cells of each condition 
showed no difference in the percentage of linoleic acid present in samples treated with 
DMEM or AC.  When compared to the DMEM and AC controls, the percentag of 
linoleic acid was significantly higher in all other samples that were cultured with linoleic 
acid, regardless of when the linoleic acid was added to the culture medium.  Comparison 
of all samples treated with linoleic acid during culture showed that the percentage of 
linoleic acid in the LA Diff samples was significantly lower than any other samples 






Figure 4.6: The fatty acids found in the highest percentage for each medium were 
palmitic, stearic, oleic, and linoleic.  Samples noted as a, c and b, d have significantly 
higher and lower percentages of palmitic and stearic acids than samples treated with 
DMEM and AC, respectively.  Samples noted as e, g, i, k, and l have significantly higher 
palmitic, stearic, and oleic acid percentages than samples treated with a specific 
medium.  Samples noted as f, h, and j have significantly higher stearic and oleic acid 
percentages than samples treated with a specific medium.  Asterisks (*) note samples 
with significantly higher percentages of linoleic acid than DMEM and AC samples.  
Pound signs (#) note samples that have significantly higher percentages of oleic acid 




percentage of stearic acid than all other samples. Graphical error bars represent the 
standard error of the mean. 
 
Oil Red O Staining 
 Representative images of the DMEM and AC control samples at Day 8 are shown 
in Figure 4.7A and C, respectively.  The image of the DMEM sample shows the normal 
morphology of a confluent layer of D1 cells (4.7A).  Oil Red O staining for intracellular 
lipid resulted in minimal red-stained lipid in samples cultured with DMEM alone at Day 
12 (Figure 4.7B).  The addition of the adipogenic cocktail to the D1 cells resulted in the 
formation of lipid droplets as seen in Figure 4.7C; Oil Red O staining of the cells, shown 
in Figure 4.7D, confirmed the presence of large, red-stained lipid droplets characteristic 
of differentiating cells.   
Representative images of D1 cells treated with linoleic acid t various stages of 
cell culture are shown in Figure 4.8 A, C, E, G, I.  The addition of lin leic acid to D1 
cells at initial seeding, LA Begin (4.8A), at confluence, LA Confl (4.8E), and 
differentiation for six days, LA Diff (4.8I), resulted in what appear to be minimal changes 
in cell morphology when compared to the AC control (4.7C).  When linoleic acid was 
added at the initial seeding and then supplemented with the adipogenic cocktail (LA 
Begin+AC), obvious changes in cell morphology occurred.  As shown in Figure 4.8C, 
rounded lipid droplets that appear as bright, opaque circles, are visible throughout the 




both added at confluence (LA Conf AC), the D1 cell morphology appeared to be similar 
to that of the AC control sample.  Oil Red O staining of cell samples at Day 12  
 
 
Figure 4.7: At Day 8, representative microscopic images of D1 cells cultured in DMEM 
(A) and AC (C) show a confluent layer of stromal cells, and the cells accumulating lipid 
droplets upon differentiation, respectively.  Oil Red O staining at Day 12 of the D1 cells 
cultured in DMEM (B) and AC (D) highlighted minimal lipid within the undifferentiated 
cells, but clearly rounded red-stained lipid when the AC was added.  Totalmagnification 





highlighted red-stained lipid droplets within cells of each condition (Figure 4.8 B, D, F, 
H, and J).  There were apparent differences in the amount of stained lipid and the pattern 
of staining within each sample condition.  When linoleic acid was added at initial 
seeding, LA Begin, accumulated lipid appeared largely disorganized and non-uniform 
throughout the cells (4.8B).  When D1 cells were initially seeded with linoleic acid and 
then supplemented with the adipogenic cocktail, LA Begin+AC, stained lipid appeared to 
become more uniformly rounded within the cells (4.8D), similar to cells treated with AC 
alone.  Addition of linoleic acid once the D1 cells reached confluence, LA Confl, resulted 
in red-stained lipid that appeared to be lighter in color and more randomly distributed 
throughout the cell sample (4.8F).  When both linoleic acid and the adipogenic cocktail 
were added to the D1 cells at confluence, LA Confl+AC, brightly stained rounded lipid 
droplets were apparent throughout the culture (4.8H).  Finally, addition of li oleic acid 
following differentiation of the D1 cells for six days with the adipogenic cocktail, LA 
Diff, resulted in large, darker red stained lipid droplets that were clearly rounded and 
similar in shape to those seen in the AC samples; the staining of the LA Diff samples, 






Figure 4.8: Representative images of each sample were captured at Day 8 (A, C, E, G, 
and I).  Oil Red O staining of each sample at Day 12 showed varied patterns of staining, 
depending on when linoleic acid was added to D1 culture medium (B, D, F, H, and J).  




Total Triglyceride Measurement 
As shown in Figure 4.9, measurement of total triglyceride concentration within 
D1 cells showed that when compared to the DMEM control, the amount of triglyceride 
was significantly higher in all other sample conditions.  When compared to the AC 
control sample, the amount of triglyceride was significantly higher in all other sample 
conditions containing linoleic acid, with the exception of the LA Diff samples.  The
 
Figure 4.9: Measurement of total triglyceride concentration confirmed there was no 
difference between AC and LA Diff, denoted by asterisks (*), and there was no difference 
between LA Begin and LA Confl + AC, denoted by percent signs (%) (p<0.05).  All other 
measured concentrations were significantly different from each other. Graphical error 





amount of triglyceride in the LA Begin + AC samples was significantly higher than all 
other sample conditions. Additionally, there was no significant difference in the amount 
of triglyceride measured in cells treated with linoleic acid at initial seeding (LA Begin) 
and cells treated with both the linoleic acid and the adipogenic cocktail once the D1 cells 
reached confluence (LA Confl + AC).   
 
4.4 Discussion 
Determination of Optimal Fatty Acid Concentrations for Cell Cultures 
 Measurement of the pH of the culture medium from each sample was performed 
to determine if the addition of fatty acids had any influence on the acidity of the culture 
environmentand to help determine an optimal concentration of fatty acid to use for future 
studies—i.e. to define a concentration that would provide the desired outcome without 
compromising the culture environment.  The addition of linoleic acid did not begin to 
influence the medium pH until concentrations of 2% or greater were add d to the cells.  
A significant difference in pH was not observed until concentrations greater than 8% 
were added to the cells.  There was no significant difference between the pH of samples 
treated with 4% and 6% linoleic acid, so our concentrations of interest w re limited to 
either 2% or 4%.  Additional analyses were then considered to determine which was 
more optimal for future studies, 2% or 4%.  
For each condition, there was a significant increase in DNA concentratio  from 
Day 7 to Day 14, indicating that the cells were still proliferating after Day 7 of culture, 




linoleic acid had a significantly lower amount of DNA, suggesting hat the cell number 
was lower due to the addition of a higher amount of fatty acid.  At Day 14, it was 
observed that the samples treated with 4% linoleic acid had a significantly higher amount 
of DNA than the AC samples, indicating that there was a higher number of cells present 
within the 4% samples.  Additionally, when compared to the 6% and 2% samples, the 4% 
sample had a higher DNA concentration at Day 14, suggesting that optimal cell number 
may be obtained by treating cells with 4% linoleic acid.  It isalso important to note that 
the cells cultured with the AC+LA (adipogenic cocktail + 1%LA) resulted in no 
significant difference in DNA concentration when compared to the AC.  s it is shown 
that addition of linoleic acid to the culture medium does influence DNA concentration, it 
is likely that the concentration of linoleic acid combined with the adipogenic cocktail 
should be increased from 1%.   
Adipogenesis is characterized by biochemical and morphological changes, where 
preadipocytes begin to accumulate intracellular lipid droplets, and cell shape changes 
from a fibroblast-like spindle shape to a rounded shape, characteristi  of mature 
adipocytes [10-14].  The addition of linoleic acid to the 1%, 4%, and 12% samples 
appeared to induce lipid-filling within the cells, similar to the outcome observed by 
Shillabeer and coworkers, where addition of fatty acid to preadipocytes resulted in 
increased lipid accumulation within cells [4].  Increased amounts of fatty acid added to 
the D1 cultures also correlated with increased staining of lipid within the cells.   The 
exact mechanism of cellular fatty acid uptake is not clearly defined, however, it has been 




cytosolic fatty acid binding proteins, thus explaining the rapid uptake of fatty acids from 
culture medium [15].    
The increase in amount of triglyceride within samples from Day 7 to Day 14 
indicated that the cells were actively differentiating over time with the addition of higher 
concentrations of linoleic acid added to the culture medium.  In order to maximize 
triglyceride production, it seems that the addition of linoleic acid, at a concentration 
higher than 1%, with the adipogenic cocktail will stimulate more triglyceride production.  
In order to determine the optimal concentration to be used for future studies, the results of 
each assay were considered.  From the pH measurements it was determined that 
concentrations of 2%, 4%, and 6% did not significantly influence the pH of the culture 
medium.  Concentrations higher than 6% created a more acidic environment.  There was 
no difference observed between the 4% and 6% pH values, so 2% and 4% were selected 
as possible optimal concentrations that would allow treatment with the minimal amount 
and stimulation of the desired outcome.  Comparison of the DNA concentratio s of the 
2% and 4% samples showed that the 4% samples had significantly more DNA than the 
2% samples.  Likewise, measurement of the triglyceride content at the end of the study 
showed that the 4% samples had significantly more triglyceride than the 2% samples.  A 
concentration of 4% linoleic acid was therefore identified as the optimal concentration to 






Determination of the Effect of Exogenous Fatty Acids at Specified Cell Culturing 
Intervals 
 Unsaturated fatty acids, that contain one or more carbon-carbon double bonds 
within their carbon chain, may be characterized as n-3, n-6, or n-9 fatty acids, and are 
more commonly referred to as omega (ω)-3, ω-6, or ω-9 fatty acids.  This designation of 
the fatty acids refers to the location of the double bond in proximity to the carboxyl gr up 
of the fatty acid molecule [16].  With the exception of n-3 and n-6 fatty acids, fatty acids 
may be synthesized by animal cells.  The n-3 and n-6 fatty acids re therefore known as 
essential fatty acids (EFAs) because they must be provided by dietary sources since they 
cannot be produced within the body.  The EFAs include the ω-3 fatty acid, linolenic acid, 
and the ω-6 fatty acids linoleic acid and arachidonic acid.  EFAs are important to cellular 
processes because they are required for synthesis of other fatty acids, prostaglandins, 
prostacyclins, and thromboxanes [2, 17].  
 The culture medium for mammalian cell culture is composed of inorga ic salts, 
vitamins, and amino acids.  Cellular growth, however, requires additional nutrients in the 
form of other proteins and lipids, which are most often supplied via serum that is added 
to the culture medium.  Serum derived from cattle, horses, and goats, f r example, are 
often used to supplement cell culture medium.  Since lipids and fatty acids are insoluble 
in water they are often bound to proteins, such as albumin, that faciliate their transport.  
EFAs are often provided to cells as albumin-bound fatty acids within serum.  Fatty acids 
are also provided to cells in serum-free cultures via lipid blends con isting of non-




and linolenic acid [16].  Early evaluation of bovine serum fatty acid components showed 
that palmitic, oleic, and stearic acids account for 74% of the total fatty acids, while 
linoleic acid accounts for 12% of total fatty acids [18].  In human serum, palmitic, oleic, 
and stearic acids account for 59.5% of total fatty acids, while linoleic acid is 20% of total 
fatty acids [19].  Fatty acids are therefore vital to cell cu turing systems.  Additionally, 
since linoleic acid is the only EFA constituting a large part of he serum used for cell 
culture, it is likely that the inclusion of linoleic acid is imperative for cell culture systems 
[2, 17].   
 There are two proposed mechanisms by which cells uptake fatty acids.  It has 
been suggested that fatty acids can move unassisted across cell membranes via passive 
diffusion.  Alternatively, it has been suggested that proteins bound to the fat y acids (fatty 
acid binding proteins) facilitate their transport into cells [20-24].   Early research 
conducted by Abumrad and coworkers evaluated cultures of BFC-1 preadipocytes, 
derived from brown mouse fat, to determine the uptake of fatty acids by preadipocytes 
during differentiation in vitro [25].  Confluent cultures of the BFC-1 cells were 
stimulated to differentiate with the addition of insulin and triiodothyronine.  Preadipocyte 
cells and differentiated mature cells were incubated with medium containing 80nmol of 
oleate (oleic acid) and analyzed using a transport assay to observe fatty acid uptake.  
Analysis of the preadipocytes and mature adipocytes showed that the most rapid uptake 
of fatty acids occurred in the preadipocytes.  Mature fat cells contain intracellular lipid 
which serves as a source of fatty acids for the cells.  The preadi ocytes, meanwhile, only 




coworkers to speculate that early stage differentiation cellswill rapidly uptake available 
lipids and ultimately produce increased levels of intracellular lipid because more fatty 
acids are available for synthesis of triglycerides [25].   
For the D1 cells cultured in this study, the uptake of linoleic acid is apparent from 
comparisons of the fatty acid profile for each cell condition determined by gas 
chromatography.  Cells cultured for each specified condition commonly expressed four 
fatty acids in the highest percentages: palmitic, stearic, oleic, and linoleic acid.  When 
linoleic acid was added to the cells at any point during culturing, whether at initial 
seeding, at confluence, or post-differentiation, there was significantly more linoleic acid 
within the cells than the cells cultured in normal DMEM media or when the cells were 
differentiated with only the specified adipogenic cocktail.  The lack of exogenous linoleic 
acid in the culture medium of the DMEM and AC samples resulted in a much lower 
percentage of linoleic acid within the cells.  The point during cell culture at which the 
linoleic acid was added to the D1 cells did appear to have some influ nce on the amount 
of linoleic acid measured within the cells—the percentage of linoleic acid in the LA Diff 
samples that were differentiated for 6 days and then supplemented with linoleic acid, had 
a significantly lower percentage of linoleic acid than the cells that had linoleic added at 
initial seeding or confluence.  As was observed in the study conducted by Abumrad and 
coworkers, however, it is possible that the differentiated cells did not take up as much of 
the linoleic acid because there was already a source of intracellul r fatty acids within the 




The fatty acid profile for the D1 cells in the study also interestingly showed that 
for samples cultured without linoleic acid, i.e. the DMEM and AC samples, oleic acid 
was present in the highest percentage and linoleic acid was found in the lowest 
percentage (of the four common fatty acids).  The addition of linoleic acid to the D1 clls, 
however, resulted in decreased percentages of oleic acid and significantly higher 
percentages of linoleic acid.  There appears to be an exchange of some sort occurring 
between linoleic and oleic acid within the cells, whereby the influx of linoleic acid 
replaces the oleic acid within the cells.  This is likely due to similarities n the structure of 
oleic and linoleic acids; they are both unsaturated fatty acids that are 18 carbon atoms 
long, with linoleic having only one more double bond than oleic acid.  Stearic acid levels 
were significantly lower in all samples treated with linoleic acid, with the exception of 
the LA Diff samples.  Stearic acid is also 18 carbon atoms in length so there may be some 
influence on its percentage by the increase in linoleic acid.  The amount of palmitic acid, 
within cells of each condition, was not significantly changed by the addition of linoleic 
acid—palmitic acid is 16 carbon atoms in length and therefore likely not influenced by 
increased linoleic acid, assuming this theory is correct.  
Fatty acids have also been suggested to influence adipogenesis of fat cells.  The 
differentiation of fat cells from preadipocytes to mature adipocytes is characterized by 
morphological and biochemical changes, where triglycerides accumulate within maturing 
cells to form intracellular lipid droplets.  The relationship betwen fatty acids and 
triglycerides is well established as it is known that triglycerides are composed of fatty 




coenzyme A molecules that are either oxidized for energy expenditure, or used to 
synthesize triglycerides [2, 14].  Studies by Amri [26, 27] and coworkers and Grimaldi 
and coworkers [28] evaluated the effect of derivatives of linolenic acid and palmitic acid, 
respectively, on preadipocyte cell differentiation.  Both groups determin d that the 
addition of fatty acids, particularly long-chain fatty acids result d in the expression of 
aP2, a known marker of adipogenesis.  Additionally, Hutley and coworkers evaluated the 
effect of culturing human primary preadipocytes with 100µM of linoleic acid over 21 
days [5] and found that linoleic acid facilitated triglyceride storage within the cells.  
 The results of the total triglyceride assay and Oil Red O staining here indicate that 
linoleic acid does have an influence on D1 cell adipogenesis.  Each sample cultured with 
linoleic acid contained higher levels of triglyceride than the DMEM and AC samples, 
which did not have added linoleic acid.  Addition of linoleic acid also appeared to lead to 
increased staining of intracellular lipid within the D1 cells; however the lipid within cells 
that did not receive the adipogenic cocktail was not uniformly rounded in shape, as is 
typically characteristic for maturing cells.  This suggests that the linoleic acid alone may 
stimulate accumulation of lipid within the cells, caused by the excess fatty acids which 
are available for synthesis of triglycerides.  The lowest triglyceride concentration was 
measured in the LA Diff samples, likely because these samples were exposed to linoleic 
acid for the shortest period of time and thus did not accumulate as much linoleic acid that 
could be used for synthesis of triglyceride.   
Early introduction of fatty acids to the D1 cell cultures resulted in increased 




means that the cells were provided with a fatty acid source earlier in culture that was used 
for synthesis of triglycerides within the cells.  Additionally, the addition of the 
adipogenic cocktail to cells cultured with linoleic acid may have ided in the resulting 
increased triglyceride accumulation.  The adipogenic cocktail contains IBMX, 
dexamethasone, and insulin which all influence differentiation.  Insulin is a hormone that 
regulates cell growth and metabolism.  In fat cells, insulin suppresses the lipolysis, or 
breakdown, of stored triglycerides, facilitates the influx of glucose into the cells, and 
facilitates triglyceride synthesis by stimulating the esterification of fatty acids [2, 29-35].   
It is therefore likely that the combination of increased fatty acid and insulin could 
together facilitate increased triglyceride production as was observed in these studies. 
Evaluation of the triglyceride measurement and Oil Red O staining of the LA Begin and 
LA Confl samples with and without the adipogenic cocktail suggest that combination of 
the linoleic acid with the adipogenic cocktail results in higher amounts of triglyceride and 
larger, more uniform lipid droplets.   
 
4.5 Conclusions 
The addition of linoleic acid to cultures of D1 stem cells was shown t  influence 
adipogenesis.  Increased amounts of triglyceride were produced within cells cultured with 
linoleic concentrations higher than 2%.  The optimal concentration for treating cells to 
garner increased triglyceride production without compromising the intgrity of the 




 It can be concluded that cells grown in culture medium supplemented with 
exogenous fatty acids will uptake the fatty acid that they are provided, such that increased 
levels of that specific fatty acid will be found within intracellular lipid.  Inclusion of 
exogenous linoleic acid in D1 cell culture medium resulted in increased triglyceride 
production and lipid accumulation when compared to D1 cells without any linoleic acid.   
The combination of linoleic acid and an adipogenic inducing cocktail resulted in 
increased triglyceride levels of triglyceride and lipid as compared with levels in cells 
grown with only linoleic acid in the culture medium.  This suggests that the components 
of the adipogenic cocktail, most likely the insulin, and linoleic acid work together to 
facilitate lipid production.  The period of time at which linoleic acid is added to cell 
cultures also influences the accumulation of intracellular lipid, suggesting that long-term 
exposure of cells to fatty acids will result in increased intracellular lipid.  This idea, 
therefore, could prove useful for further development of adipose tissue engine ring 
strategies; supplying adipose cells with available fatty acids will likely stimulate 
triglyceride production and lipid accumulation which should result in increase adipose 
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EVALUATION OF FATTY ACID-SUPPLEMENTED SUBSTRATES ON 




The injectable composite system for breast reconstruction is comprised of cells 
seeded on biodegradable beads of an injectable size; these cellular constructs are then 
mixed with a hydrogel delivery medium, resulting in a composite that may be injected 
into a patient through a syringe at the defect site.  For succe sful implementation of our 
injectable composite system, the three-dimensional (3-D) beads must support adipose cell 
attachment in vitro in order for proliferation and differentiation to occur.  Preadipocytes 
are anchorage-dependent cells, thus, if the cells are not attached to a scaffold or support 
structure, they will not proliferate.  Additionally, the cells may potentially stop 
proliferation should they become detached from the scaffold surface.  Sugihara and 
coworkers demonstrated that with primary adipose cells, adhesion directly influences 
proliferation of cells, which in turn influences the differentiation of fat cells [1].  Previous 
work has shown that for our proposed injectable composite system, culturing adipose 
cells on injectable sized beads led to increased triglyceride production when compared to 
cells cultured in two-dimensional (2-D) culture [2, 3].  Additionally, differences in 
adipogenic genes expressed by adipose cells were observed when cells were grown in 2-




Chitosan is a natural biomaterial derived from the de-acetylation of chitin (a 
copolymer of N-acetyl-glucosamine and N-glucosamine units linked by β(14) 
glycosidic bonds [5-7].  Other than cellulose, chitin is the second most abundant 
polysaccharide on earth and is typically found in the exoskeleton of crusta eans such as 
crabs and shrimp [8-10].  Chitosan has been widely investigated for biomed cal 
applications such as wound healing, anti-microbial treatment of bacteria, and drug 
delivery [7, 11, 12].  The use of chitosan for biomedical applications is so extensive 
because it is readily available, cost-effective, biocompatible, biodegra able, and easily 
processed to form structures of varied shape and porosity [6, 12, 13].  As a result of these 
desirable attributes, chitosan has been investigated for engineering skin, bone, cartilage, 
liver, nerve, and vascular tissues [14-17].   
The use of chitosan for adipose tissue engineering has not been widely 
investigated by many researchers; however, great potential for chitosan in adipose tissue 
engineering applications exists.  Chitosan is easily processed into scaffolds of various 
shapes and sizes.  Fabrication of injectable microspheres that would be well-suited for 
minimally invasive applications, such as those where adipose tissue engineeri  would be 
useful, has been reported [17, 18].  Additionally, the ease of combining growth factors 
and therapeutics within chitosan, due to its cationic nature, may potentially provide 
scaffolds that will facilitate adipose cell attachment and differentiation to mature fat cells 
to form new tissue in vivo.  To produce a bead that would more optimally support adipose 
cell growth, while allowing successful delivery by injection, we opted to use beads made 




The studies in Chapter 4 were performed to determine what influence exogenous 
fatty acids in cell culture medium would have on adipogenic differentiation in 2-D 
culture.  It was determined that the addition of linoleic acid to the culture medium of D1 
cells positively influenced adipogenic differentiation by facilitating increased triglyceride 
production and intracellular lipid accumulation.  In order to improve the existing 
injectable composite system, it was therefore suggested to incorporate fatty acids into the 
microcarrier beads such that release of the fatty acids over tim  would ideally stimulate 
increased lipid production over time.  This study was performed to determine the efficacy 
of producing fatty acid-loaded chitosan-gelatin beads and to determine the r sponse of 
cells to the manufactured beads in vitro. 
 
5.2 Materials & Methods 
Solution Preparation 
 A 1% v/v glacial acetic acid was prepared by mixing 1mL glacia  acetic acid 
(Fisher Chemicals, Fair Lawn, NJ) in 100mL distilled water.  The glacial acetic acid was 
filter sterilized with a 0.22µm polyethylsulfone (PES) bottle-top filter (Corning, Corning, 
NY).  Chitosan (MW: 100,000-300,000, Acros Organics, Morris Plains, NJ) and gelatin 
(Sigma, St. Louis, MO) powders were autoclaved at 124°C for 25 minutes to sterilize.  
All other steps in the bead fabrication process were carried out in a SterilGARD III 
Advance laminar flow Class II Biological Safety Cabinet (The Baker Company, Sanford, 
ME) to maintain sterility.  A 3% w/v chitosan-gelatin solution was prepared by dissolving 




heat until completely dissolved.  A 0.5N solution of sodium hydroxide (NaOH) was 
prepared by dissolving 20g NaOH salt (Fisher Chemicals, Fair Lawn, NJ) in 1L of 
distilled water and stirring at room temperature.  The solution was filter sterilized before 
use using the 0.22µm PES filters. 
 
Bead Preparation & Characterization 
The chitosan-gelatin beads were formed using an electrostatic bead generator 
(Nisco, Zürich, Switzerland).  The chitosan-gelatin solution was drawn into a 20cc 
syringe (Becton Dickinson, Franklin Lakes, NJ) using a 16 gauge needle (Becton 
Dickinson).  The syringe was secured in place on top of a syringe pump (kdScientific, 
New Hope, PA) that was set to eject the solution at a rate of 15 mL/hour.  The chitosan-
gelatin solution was ejected from the syringe and guided through plastic tubing attached 
to the end of the syringe, into a metal needle of the electrostatic bead generator.  The 
needle was placed so that the point of ejection was approximately 4cm above the surface 
of the NaOH solution below.  The NaOH was pipette into a glass 80 x 4 mm dish 
(Pyrex®, Corning, Corning, NY) until just overflowing(>180mL)  into a 100 x 20mm 
glass collection dish (Pyrex) beneath.  The NaOH was continuously stirred at an agitation 
rate of 25%.  The applied voltage potential was set at 6.5kV to obtain e ds.   The 
fabricated beads were collected in the 80 x40 cm dish and stirred for an additional 30 
minutes post formation in the NaOH solution at the same agitation rate. The NaOH was 




phosphate buffered saline (PBS) (Sigma, St. Louis, MO).  The beads were then placed in 
sterile DMEM until seeded into well plates.    
To prepare the beads loaded with fatty acid, immediately before preparation, 
10mL of the chitosan-gelatin solution was mixed with 5mL of sterile linoleic acid-
albumin solution (Sigma, St. Louis, MO) in a sterile 50-mL centrifuge tube (Fisher 
Scientific, Fair Lawn, NJ).  The solution was pipetted up and down several times to 
ensure complete mixing and then drawn into a 20cc syringe  (BD, Franklin Lakes, NJ) 
using a 16 gauge needle (BD, Franklin Lakes, NJ).  The beads were then prepared using 
the previously described settings.   
 To evaluate the morphology of the prepared scaffolds, images of each type were 
captured using an EMZ-TR stereomicroscope (Meiji Techno, Tokyo, Japan) with a 
Lumina light source (Chiu Technical Corporation, Kings Park, NY) and a SPOT 
INSIGHT Color digital camera (Diagnostic Instruments, Sterling Heights, MI).  The 
average diameter of the scaffolds was measured using Image-Pro Plus version 4.1 
software (Media Cybernetics, Inc., Silver Spring, MD). 
 
Cell Culture 
A volume of 0.6mL of plain and fatty acid loaded chitosan-gelatin beads were
placed into individual wells of 24-well ultra-low binding plates (Corning, Corning, NY).  
Murine bone marrow stromal cells, D1 cells (ATCC, Manassas, VA)of passage 9 were 
seeded into each well containing beads, with 4.5x105 cells added to each well.  Cells were 




supplemented with 10% FBS (Mediatech, Herndon, VA), 0.2% fungizone (Gibco, 
Invitrogen, Carlsbad, CA) and 1% Antibiotic-Antimycotic (Gibco, Invitrogen, Carlsbad, 
CA) at standard culture conditions of 37°C and 5% CO2.  After 2 days of culture, upon 
medium change, cells were cultured with either an adipogenic differentiation cocktail, or 
with DMEM.  The adipogenic cocktail consisted of 100µl insulin (Sigma, St. Louis, 
MO), 2µl dexamethasone (Sigma, St. Louis, MO), and 1mL IBMX (Sigma, St. Louis, 
MO) per 10mL of DMEM medium.  Culture medium was changed every 2 days uring 
the study.  Cells were then evaluated at Day 10 and Day 17 to determine the influence of 
culturing cells on plain or fatty acid loaded chitosan-gelatin beads. 
 
Fatty Acid Release Characterization 
 To evaluate the amount of fatty acid released from the loaded fatty-acid beads 
over time, the same volume of beads used for cell culture studies, 0.6mL, was placed into 
wells of a 24-well culture plate  (Corning, Corning, NY) with 1mL PBS per well.  The 
plate containing the beads was also incubated at 37°C and 5% CO2.  Aliquots of the PBS 
were taken over time and evaluated using the working solution contained in the BCA 
Protein Assay Kit (Pierce, Rockford, IL).  Incubation of the samples with the BCA 
working solution resulted in a colorimetric change that could be read using a Biotek 
Synergy MX Multi-Mode Microplate Reader (BioTEK Instruments, Winooski, VT) at 
562nm wavelength to determine the concentration fatty acid released from the beads.  
Diluted samples of the linoleic-albumin stock solution (Stock Concentration = 




measurements of the diluted samples were used to prepare a standard curve that was used 
for determination of the concentration of fatty acid released from beads over time. 
 
Live/Dead Cell Viability Staining 
A LIVE/DEAD® Viability/Cytotoxicity Kit (Molecular Probes, Eugene, OR) was 
used to qualitatively assess cellular attachment to the beads and to assess cellular viability 
after 10 days and 17 days of cell culture.  The LIVE/DEAD® working solution, 
consisting of 10mL PBS, 20µL Ethidium-homodimer-1 (EthD-1), and 5µL calcein AM, 
was prepared in a sterile 15mL centrifuge tube according to the manufacturer’s 
instructions.  Culture medium was aspirated and beads were rinsed with 1mL of sterile 
PBS (Sigma).  The PBS was aspirated from the scaffolds and 1mL of the working 
LIVE/DEAD® solution was added to each well of the plate containing scaffolds.  The 
plate was allowed to incubate for 45 minutes at room temperature nd protected from 
light.  Following the incubation period, images of each well were captured using the 
Axiovert 135 fluorescence inverted microscope (Zeiss, Thornwood, NY), with color 
digital camera and imaging software.  The wells were evaluated for green and red 
fluorescence apparent by the activity of the calcein AM and EthD-1, respectively, present 
in the working solutions.  Esterase present in live cells cleaves the calcein AM, resulting 








Cellular metabolic activity was quantitatively assessed using alamarBlue® Cell 
Viability Reagent (Invitrogen, Biosource International, Camarillo, CA).  The 
alamarBlue® reagent was added to each well at 10% of the amount of cul ure medium in 
each well.  Well plates were incubated for three hours at 37°C on a shaker plate (IKA® 
Works, Wilmington, NC).  Following incubation, 150µl of the reaction solution was 
removed from the cell culture plates to wells of a black-walled, clear-bottom 96-well 
microplate to assay the fluorescence of samples resulting from the reduction of the dye by 
metabolically active cells to produce a color change from blue to pink.  The absorbance 
was read using a Biotek Synergy MX Multi-Mode Microplate Reader (Biotek 
Instruments, Winooski, VT) at wavelengths of 570nm and 600nm.  The percent reduc ion 
of alamarBlue® was calculated using Equation 5.1 shown below.   
 
%    	  !!"	 !"  100%   Equation 5.1 
 
Where:  A1 = absorbance of experimental well at 570nm 
  A2 = absorbance of experimental well at 600nm 
  N1 = absorbance of negative control (media plus alamarBlue® reagent  
without cells) at 570nm  
  N2 = absorbance of negative control (media plus alamarBlue® reagent  
without cells) at 600nm 
 
 
Oil Red O Staining (ORO) 
Cell culture medium was aspirated from well plates and the cells were rinsed 




(Fisher Chemicals, Fair Lawn, NJ) overnight.  An ORO stock solution was prepared by 
dissolving 0.5g ORO powder (Sigma, St. Louis, MO) in 100mL isopropanol (Fisher 
Chemicals, Fair Lawn, NJ)).  An ORO working solution was prepared by mixing 60mL 
of ORO stock solution with 40mL deionized water and stirring for 30 minutes.  A volume 
of 500µL of the working solution was added to each well and incubated for 15 minutes at 
room temperature.  Following incubation, the wells were rinsed three imes with fresh 
deionized water.  After decanting of excess water, the red-stained lipid was imaged using 
an inverted microscope and imaging software. 
 
Total Triglyceride Measurement 
Cell culture medium was aspirated from well plates and the cells rinsed twice 
with sterile PBS. After subjecting the cells to three freeze-thaw cycles, 1mL of 1% Triton 
X-100 (Sigma, St. Louis, MO) was added to each well and the cells w re incubated for 
30 minutes at room temperature.  Standard glycerol solutions of concentrations ranging 
from 0 to 200µM glycerol were prepared by dissolving glycerol (Sigma, St. Louis, MO) 
in deionized water.  Following incubation, the cells from each well wre collected with 
the Triton X-100 solution into microcentrifuge tubes and centrifuged for 10 minutes at 
3000rpm.  100µL of each sample and standard were pipetted into the wells of a 96-well 
plate (Corning, Corning, NY) in triplicate.  A volume of 100µL of Infinity™ Triglyceride 
Reagent (Thermo Fisher Scientific, Waltham, MA) was added to each well and incubated 
for 15 minutes at room temperature.  The absorbance was read at 490nm on a Biotek 





Statistical analyses were performed using SAS 9.2 software (Cary, NC) to 
compare the effect of each culture medium on cell behavior.  The Least Squares Means 
(LSMEANS) was used with a significance level of p < 0.05 (n=3). Graphical error bars 





 Measurement of the beads revealed that each type was approximately 0.24cm in 
diameter, as indicated in Table 5.1.  As observed in the images of Figure 5.1, there was 
no difference observed in bead color or shape due to addition of linoleic acid. 
 









Chitosan-Gelatin 0.221 0.275 0.246 ± 0.013 
Fatty Acid- Loaded 
Chitosan-Gelatin 







Figure 5.1: Both the chitosan
gelatin beads (B) were similar in color, shape, and size. The distance between divisions 
on the ruler in each image is 1 mm.
 
Fatty Acid Release 
 The cumulative amount of fatty acid released from the chitosan
loaded with linoleic acid was determined by comparison with a set of diluted standards 
prepared from the stock linoleic acid solution.  Asshown in Figure 5.2, at Time 0, 
immediately after seeding into the well plates, there was a sm ll quantity of linoleic acid 
(3.87±0.10 µg/mL) detected in the medium.  After the first hour of incubation the fatty 
acid concentration increased to approximately six times more than the initial 
concentration.  The amount of fatty acid released from the beads steadily increased 
during the incubation period until around Day 10, when minimal change in the released 
concentration was observed.  The cumulative quantity of fatty acid released from the 
















Figure 5.2: Evaluation of the cumulative release of linoleic acid from the chitosan-
gelatin beads showed a steady release of fatty acid during incubation.  After Day 10, 
minimal change in the amount of fatty acid released was detected. 
 
LIVE/DEAD® Cell Viability Staining 
 Qualitative assessment of cell viability showed live cells attached to each type of 
bead, as shown in Figure 5.3.  Cells were visible on the periphery of ach bead type, and 
covered the surface of the beads.  The cells in the Beads+AC sample (5.3C) appear to be 
detaching from the surface of the cells, as evidenced by the apparent tear in the cells on 
the surface of the beads.  The FA-Beads+DMEM (5.3E) and FA-Beads+AC (5.3G) cells 





Figure 5.3: Live/Dead staining at Day 17 showed live cells attached to the surface of 
each bead type.  Minimal dead cells were observed for each sample; however, more dead 
cells were observed in the Beads+DMEM and FABeads+DMEM samples.  Total 




with the inverted microscope.  Minimal dead cells are seen for each condition.  There do, 
however, appear to be more dead cells in the Beads+DMEM (5.3B) and 
FABeads+DMEM (5.3F) samples. 
 
Metabolic Activity 
 The results of the alamarBlue® assay for metabolic activity are shown in Figure 
5.4.  Results of the alamarBlue® assay indicate that at Day 10, cells cultured on plain 
chitosan-gelatin beads and on fatty acid loaded chitosan-gelatin beads in the presence of 
the adipogenic cocktail, Beads+AC and FA-Beads+AC, respectively, wre significantly 
more metabolically active than cells cultured on fatty acid loaded and plain beads in 
DMEM.  The metabolic activity for each condition was significantly lower at Day 17 
than at Day 10.  At Day 17, the metabolic activity of cells in the Beads+AC was 
significantly higher than cells in the Beads+DMEM and FA-Beads+AC.  Additionally, at 
Day 17, the metabolic activity of cells in the FA-Beads+DMEM was significantly higher 
than cells in the Beads+DMEM and FA-Beads+AC. 
 
Oil Red O Staining 
Oil Red O staining of D1 cells cultured on each type of bead shows stained 
intracellular lipid present within cells on each type of bead.  At Day 10, there were small 
lipid droplets in the Beads+DMEM samples (Figure 5.5A).  The lipid ape red to cover 
the surface of the beads; however, the droplets are not large and rounded as one would 





Figure 5.4: Results of alamarBlue® assay indicate that the samples were significantly 
(p<0.05) more metabolically active at Day 10 than at Day 17, denoted by asterisks (*).  
Letters a and b indicate samples with statistically higher metabolic activity than other 
samples at Day 10.  Letters c and d indicate samples with statistically higher metabolic 
activity than other samples at Day 17. Graphical error bars represent the standard error 
of the mean. 
 
the Beads+DMEM samples, although the stained droplets did appear to be larger than at 
Day 10 (5.5E).  The addition of the adipogenic cocktail to the plain chitosan-gel tin 




of lipid were stained at Day 10 (5.5B).  At Day 17 an increased amount of lipid droplets 
were stained and appeared larger in size for the Beads+AC samples (5.5F).  Culture of 
the D1 cells on the beads loaded with linoleic acid, FA-Beads+DMEM, showed red-
stained clusters of lipid on the surface of the beads at Day 10 (5.5C).  The lipid droplets 
were not large or uniform in shape; however, there appeared to be more lipid present on 
the FA-Beads+DMEM than on the plain Beads+DMEM.  By Day 17, red stained lipid 
was still visible on the periphery of the FA-Beads+DMEM; however, there was not as 
much lipid present on the surface of the beads (5.5G).  The addition of the adipogenic 
cocktail to D1 cells cultured on the fatty acid-loaded beads caused active differentiation 
of the cells by Day 10, as indicated by the uniformly round, red-stained lipid droplets 
seen on the surface of the beads (5.5D).  The amount of lipid stained on the FA-
Beads+AC was greater than that observed on any other beads at Day 10.  By Day 17, 
however, the amount of red stained lipid was decreased on the FA-Beads+AC, as smaller 
and fewer lipid droplets were observed on the surface of the beads (5.5H). 
 
Total Triglyceride Measurement 
 As shown in Figure 5.6, measurement of the total triglyceride content within the 
D1 cells cultured on each bead type showed a significant decrease in th amount of 
triglyceride measured at Day 17 than was measured at Day 10.  At Day 10, the amount of 
triglyceride measured in the FA-Beads+AC samples was significa tly greater than all 
other sample conditions.  Additionally, the amount of triglyceride produced by the 





Figure 5.5: Oil Red O staining of cells on the chitosan-gelatin beads showed that 
culturing of the D1 cells on fatty acid loaded beads resulted in a greater amount of 
stained lipid (C) than was observed in the Beads+DMEM or Beads+AC samples.  Total 




in cells cultured on Beads+DMEM alone.  At Day 17, the amount of triglyceride 
measured in the FA-Beads+DMEM and FA-Beads+AC was significatly higher than that 
measured in the Beads+DMEM or Beads+AC.   
 
 
Figure 5.6: Measurement of total triglyceride content showed that, over tim , he amount 
of triglyceride measured within the cells significantly decreased over time, as noted by 
asterisks (*) (p<0.05).  Letter a indicates condition for which triglyceride quantity is 
significantly greater than that for all other conditions at Day 10.  Letter b indicates 
conditions for which triglyceride quantities significantly greater than that for the 
Beads+DMEM sample at Day 10. Letter c indicates conditions for which quantities are 
significantly greater than that of the Beads+DMEM and Beads+AC samples at Day 17. 





The idea of delivering fatty acids and lipids to cells and tissues is not new.  Early 
methods to deliver lipids involved preparation of lipid microemulsions that could be used 
to provide lipids to mammalian cell cultures in vitro [19, 20].   In agricultural research, 
preparations of fatty acid salts encapsulated in a polymer coating have been manufactured 
to deliver feed supplements to cattle [21].  Delivering fatty acids to supplement adipose 
cell cultures for tissue engineering purposes, however, is novel.  H re, we successfully 
prepared fatty-acid loaded chitosan-gelatin beads useful for adipose tissue engineeri .   
Chitosan has been used in many biomedical applications, often as a mode of 
delivery for other molecules.  Chitosan microcapsules containing omega-3 fatty acids 
eicosapentaenoic acid, EPA, and docosahexaenoic acid, DHA, were produced by 
Klaypradit and Huang for potential use in food supplementation [22].  Additionally, Han 
and coworkers produced alginate beads coated with chitosan to encapsulate vitamins and 
other water-soluble food additives [23].   
The two types of beads produced in our study were approximately 0.24cm in 
diameter, which is larger than the ideal size for our injectable composite system; 
however, bead size may be reduced by varying bead fabrication parameters of the 
electrostatic generator.  Within an hour of incubation, measurable quantities of fatty acid 
were detected in the samples of PBS solution, indicating that the fat y acid was likely not 
solely encapsulated in the bead, but that some fatty acid was distributed on the surface of 




until around Day 10, providing a steady influx of fatty acids to the D1 cells that they wer  
able to uptake. 
The significant increase in metabolic activity observed when the adipogenic 
cocktail was added to the D1 culture could indicate that initiation of adipogenesis and the 
subsequent stimulation of triglyceride synthesis yields more metabolic lly active cells 
than proliferating cultures of the D1 cells in DMEM only.  The lower metabolic activity 
by Day 17 could indicate that there were no longer as many cells proliferating, and that 
the cells may have been actively differentiating at the end of the study.  From the results 
of LIVE/DEAD® staining and alamarBlue® assay, it can be determined that chitosan-
gelatin beads may be useful as cell carriers in the injectabl composite system because 
they support both cellular growth and proliferation.  The fatty acid loaded beads, even 
when releasing fatty acid into the cell culture environment, still support cell growth and 
proliferation.   
Evaluation of Oil Red O staining and the total triglyceride assay showed that the 
chitosan-gelatin beads not only supported cellular growth and proliferation, but they also 
provided a surface that permitted cellular differentiation to occur.  The larger and more 
uniformly rounded lipid in the FA-Beads+AC condition at Day 10 suggests that the 
addition of the fatty acid and the adipogenic cocktail facilitated more triglyceride 
synthesis within the D1 cells.  The presence of cells with less triglyceride and lipids at 
Day 17 suggests that the cells on the beads may have either lost intracellular lipid to the 
culture medium, or that they were synthesizing fewer triglycerides.  The amount of fatty 




were not receiving as much fatty acid by the end of the study as they were at earlier time 
points in the study.  The addition of fatty acid to the beads was therefore shown to 
influence the triglyceride accumulation and differentiation of the D1 cells.  Lower 
amounts of fatty acid available for the cells to use for triglyceride synthesis resulted in 
decreased amounts of triglyceride, suggesting that the fatty acid concentration may need 
to be increased for longer-lasting effects. 
Recent studies by Rubin and coworkers were conducted to evaluate the effect of 
culturing human adipose-derived stem cells with poly (lactic-co-glycolide) (PLG) 
microspheres with encapsulated insulin and dexamethasone.  From their studies Rubin 
and coworkers were able to determine that the cells cultured with m crospheres 
containing only insulin produced a higher number of cells with lipid inclusions than the 
cells cultured with the dexamethasone containing microspheres, or cells cultured with a 
combination of insulin and dexamethasone microspheres [24].  This suggests that insulin 
is an important factor in the process of adipogenesis.  For our injectable composite 
system, it is likely that a combination of factors may need to be included in the cellular 
carriers to maximize the lipid-filling of adipose cells and sustain tissue volume over time. 
 
5.5 Conclusions 
Using the fabrication methods described here, dual purpose beads useful for tissue 
engineering were created.  Chitosan-gelatin beads were shown to support cellular growth 
and differentiation.  Meanwhile, inclusion of linoleic acid into the polymer solution to 




D1 cells in culture over time.  Addition of fatty acids to cells undergoing adipogenesis 
facilitated increased triglyceride production and lipid-filling of the cells.  This suggests 
that inclusion of fatty acids into microcarrier beads for the injectable composite system 
could be useful for stimulating fatty acid uptake and lipid production, which could lead to 
increased adipose tissue mass and ideally sustain the tissue volume over time if the fatty 
acid is provided to cells at a sufficient quantity.   
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EVALUATION OF FATTY ACID INFLUENCE ON ADIPOSE CELL-BREAST  
CANCER CELL INTERACTIONS IN VITRO 
 
6.1 Background 
Fatty acids within the adipose tissue of the breast have been shown to play a key 
role in the mammary microenvironment.  Dietary fatty acids have been identified within 
deposits of mammary tissue in the body, the measurement of which has been determined 
to be useful as a biomarker of dietary fatty acid intake by individuals [1-6].  There are 
conflicting reports in the literature regarding the influence of dietary fatty acids on the 
behavior of breast cancer cells; for example, specific fatty acids have been shown to act 
as anti-cancer agents (eicosapentaenoic acid, EPA, and docosahexaenoic acid, DHA), 
while others have been considered cancer promoting agents (linoleic acid and arachi onic 
acid) in certain instances [2, 3, 7-16].  Numerous epidemiological, experimental, and 
ecological studies have been conducted to evaluate the relationship between dietary fatty 
acids and breast cancer risks [6, 9, 15-22].  Analysis of normal brest tissue samples, i.e. 
those that are identified as free of tumorigenic cells, has sown that the fatty acids found 
most commonly in the highest concentrations are oleic, palmitic, linoleic, and stearic 
acids [13, 23]. In the case of cancerous mammary tissue samples, inv tigation of fatty 
acids contributing to cancer growth or inhibition has led to overall thinking that increased 
levels of linoleic acid and arachidonic acid are associated with increased risk of breast 




conjugated linoleic acid have been associated with decreased risk of breast cancer 
occurrence [7, 8, 11, 13, 25]. 
Breast cancers may be categorized based on hormone receptor status and 
molecular subtype.  Hormone receptors are proteins located on the outside surface of 
cells, which bind specific circulating hormones, most often estrogen and progesterone, 
ER and PR, respectively.  Receptors for these hormones are often found on surfaces of 
normal breast cells as well as cancerous breast cells.  Breast cancer cells may contain 
one, both, or neither of these receptor types.  Those that have estrogen or progesterone 
receptors present are known as ER+ or PR+; likewise, if the estrogen or progesterone 
receptors are not present, the breast cancers are known as ER- or P -.  It has been 
reported that approximately 75% of all breast cancers are ER+, and of those cases, 65% 
are also PR+ [26].   The hormone receptor status is often used in assigning a course of 
treatment for patients because the presence of the receptors means the cancers can be 
treated with hormonal therapies, while those without receptors may not be treated with 
hormones; thus giving patients with either ER+ or PR+ cancers a more positive prognosis 
[27, 28].   
Hormonal therapies to treat ER+ breast cancers typically function to inhibit the 
effects of estrogen or to lower the levels of estrogen present in the body.  Tamoxifen is 
the most widely-known anti-estrogen drug that blocks the estrogen receptor of tumors 
[27, 29].  It is typically taken orally daily, and has been used to treat metastatic cancers 
and to help reduce the risk of tumor recurrence [30-32].  In vivo evaluation of the effects 




mice was performed by Haran and coworkers.  Treatment of the tumors with pellets 
loaded with 5mg of tamoxifen over 60 days resulted in tumor cell death, which was 
attributed to an inhibition of new tumor vascularization as a result of the treatment [33].  
Researchers have also investigated methods for delivering tamoxifen to tumor cells via 
nanoparticles, and showed that treatment of MCF-7 cells with tamoxifen-loaded 
nanoparticles resulted in uptake of the nanoparticles by the cells, which ultimately led to 
apoptosis of the cells [34, 35]. 
From the previously described work in Chapter 5, methods to produce fatty acid 
loaded chitosan-gelatin beads were developed.  The beads could potentially serve two 
purposes in the injectable composite system; they could function as cell carriers to 
support cell growth and differentiation, and they could function as delivery devices that 
could provide fatty acids to the surrounding cells.  As noted in Chapter 1, fatty acids 
present in the body have been shown to influence the behavior of both normal and 
cancerous cells.  The addition of fatty acids to the bead component of our injectable 
composite systems leads one to wonder, if by chance there were residual cancer cells 
within a post-surgical patient, how the implantation of this device would influence the 
behavior of those cells.  Additionally, fatty acids have been shown to ifluence the 
effectiveness of cancer-treating drugs.  In a study conducted by eGraffenried and 
coworkers, MCF-7 cells were transfected with Akt, a downstream mediator of PI3-
kinase, to induce tamoxifen resistance.  The researchers were abl  to show that treatment 
of the transfected cells with the n-3 fatty acid, EPA, not only inhibited activation of Akt, 




with the EPA and tamoxifen [36].  Additionally, studies by Chen and coworkers showed 
that the growth of tumors created by injection of MCF-7 cells into athymic mice, was 
inhibited in mice fed a diet high in flaxseed, which is rich in α-linolenic acid.  Tumor 
growth was also significantly inhibited when animals fed flaxseed were also administered 
tamoxifen to treat the cancer, suggesting that the two work together to prom te tumor cell 
death [37].  If a patient receiving therapeutic agents underwent immediate breast 
reconstruction using our injectable composite system, incorporation of fatty acids into the 
implant could potentially increase the efficacy of the treatment.   
The objective of this final study was to evaluate fatty acid influence on adipose 
cell and breast cancer cell interactions i  vitro by evaluating the influence of fatty acid 
supplemented beads on breast cancer cell behavior.  Chitosan-gelati b ds with and 
without incorporated fatty acids were produced and cultured with human adipose cells.  
These cellular microcarriers were co-cultured with breast cncer cells and then treated 
with a commonly used anti-cancer drug, tamoxifen.   
 
6.2 Materials & Methods 
Solution Preparation 
 A 1% v/v glacial acetic acid was prepared by mixing 1mL glacia  acetic acid 
(Fisher Chemicals, Fair Lawn, NJ) in 100mL distilled water.  The glacial acetic acid was 
filter sterilized using a 0.22µm polyethylsulfone (PES) bottle-top filter (Corning, 
Corning, NY).  Chitosan (Deacetylation Degree: ≥90%, Acros Organics, Morris Plains, 




minutes to sterilize.  All other steps in the bead fabrication process were carried out in a 
SterilGARD III Advance laminar flow Class II Biological Safety Cabinet (The Baker 
Company, Sanford, ME) to maintain sterility.  A 3% w/v chitosan-gelatin solution was 
prepared by dissolving 3g of chitosan and 3g of gelatin in 100mL of 1% v/v glacial acetic 
acid and stirring at low heat until completely dissolved.  A 0.5N solution of sodium 
hydroxide (NaOH) was prepared by dissolving 20g NaOH salt (Fisher C emicals, Fair 
Lawn, NJ) in 1L of distilled water and stirring at room temperature.  The solution was 
filter sterilized before use with the 0.22µm PES filters. 
 
Bead Preparation & Characterization 
The chitosan-gelatin beads were formed using an electrostatic bead generator 
(Nisco, Zürich, Switzerland).  The chitosan-gelatin solution was drawn into a 20cc 
syringe (Becton Dickinson, Franklin Lakes, NJ) using a 16 gauge needle (Becton 
Dickinson).  The syringe was secured in place on top of a syringe pump (kdScientific, 
New Hope, PA) that was set to eject the solution at a rate of 15 mL/hour.  The chitosan-
gelatin solution was ejected from the syringe and guided through plastic tubing attached 
to the end of the syringe, into a metal needle of the electrostatic bead generator.  The 
needle was placed so that the point of ejection was approximately 4cm above the surface 
of the NaOH solution below.  The NaOH was pipette into a glass 80 x 4 mm dish 
(Pyrex®, Corning, Corning, NY) until just overflowing(>180mL)  into a 100 x 20mm 
glass collection dish (Pyrex) beneath.  The NaOH was continuously stirred at an agitation 




fabricated beads were collected in the 80 x40 cm dish and stirred for an additional 30 
minutes post formation in the NaOH solution at the same agitation rate. The NaOH was 
drained from the beads and the resulting beads were washed three times w th sterile 
phosphate buffered saline (PBS) (Sigma, St. Louis, MO).  The beads were then placed in 
sterile Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Invitrogen, Carlsbad, CA) 
until cell seeding in well plates.    
To prepare the beads loaded with fatty acid, immediately before preparation, 
10mL of the chitosan-gelatin solution was mixed with 5mL of sterile linoleic acid-
albumin solution (Sigma, St. Louis, MO) in a sterile 50-mL centrifuge tube (Fisher 
Scientific, Fair Lawn, NJ).  The solution was gently triturated to ensure complete mixing 
and was then drawn into a 20cc syringe  (BD, Franklin Lakes, NJ) usinga 16 gauge 
needle (BD, Franklin Lakes, NJ).  The beads were prepared using the previously 
described settings.   
  
Cell Isolation and Culture 
Human tissue samples were obtained from Greenville Hospital System and 
digested according to the protocol detailed in Appendix A.  The isolated primary cells 
were seeded in T-25 culture flasks (Corning, Corning, NY) with Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Gibco, Invitrogen, Carlsbad, CA) supplemented with 1% 
antibiotic/antimycotic  (AA) (Gibco) 0.2% fungizone (Gibco), 0.4% Insulin-Transferrin-
Sodium Selenite (ITS) media supplement (Sigma), and 10% fetal bovine serum (FBS) 




were grown to confluence and then passaged to larger flasks until a sufficient number for 
seeding on beads was obtained. 
 MCF-7 cells (ATCC, Manassas, VA) were cultured in T-150 flasks with 15mL of 
DMEM (Gibco) until confluence.  The MCF-7 culture medium consisted of 500mL 
DMEM supplemented with 10% FBS, 2% AA, 0.2% fungizone, and 0.l% insulin 
(Sigma).   
 
Cell Seeding 
Cells for this co-culture study were seeded according to the conditions specified 
in Table 6.1.    Control samples were seeded in well plates with conditions also as 
specified.  Additionally, co-culture samples to evaluate the influe ce of culturing MCF7 
cells with adipose cells grown on beads were seeded as shown in Figure 6.1.  The 
timeline for cell seeding is shown below in Figure 6.2.   
 










• MCF-7 + TAM 






• MCF-7 + TAM 
 
Figure 6.2: Study Timeline 
 
A volume of 0.6mL of plain and fatty acid loaded chitosan
placed into individual wells of 24
Primary human adipose cells, of passage 3, were seeded into each well containing beads, 
with 2.5x105 cells added to each well.  Cells were maintained in DMEM at 
culture conditions of 37°C and 5% CO






• Cells cultured in 2-D alone 
• Cells cultured in 2-D with tamoxifen
• Cells cultured in 2-D with tamoxifen and 
4% linoleic acid 
 
• Cells cultured in 2-D with adipose cells 
seeded on plain (Bead) or fatty acid loaded 
(FA-Bead) chitosan-gelatin beads in 
transwell inserts 
• Cells cultured in 2-D with adipose cells 
seeded on plain (Bead) or fatty acid loaded 
(FA-Bead) chitosan-gelatin beads in 
transwell inserts and with tamoxifen
-gelatin beads 
-well Ultra-low Binding plates (Corning, Corning, NY)











with an adipogenic differentiation cocktail.  The adipogenic cocktail consisted of 100µl 
insulin (Sigma, St. Louis, MO), 2µl dexamethasone (Sigma, St. Louis, MO) and 1mL 
IBMX (Sigma, St. Louis, MO) per 10mL of DMEM medium.  Also at Day 2, 7.5x104 
MCF-7 cells, of passage 10, were seeded into the wells of tissue cult re treated 24-well 
culture plates (Corning, Corning NY) and maintained in DMEM supplemented with 10% 
FBS, 2% AA, 0.2% fungizone, and 0.l% insulin, at standard culturing conditions.  At Day 
5, the plain or fatty acid loaded chitosan-gelatin beads, seeded with cells, were transf rred 
to transwell inserts (Corning, Corning, NY), and the inserts containi g cellular beads 
were transferred to the well plates containing the MCF-7 cells in 2D.  Additionally, at 
Day 5, 4% linoleic acid-albumin (Sigma) (80µL per well) was added to the specified 
MCF-7 cells in 2D.  At Day 10, 10µM tamoxifen (Sigma) was added to the specified 
conditions and the plates were incubated for an additional two days.  At the conclusion of 
the culture period at Day 12, specific assays were performed to characterize the behavior 
of both the adipose cells grown on beads in the transwell inserts and he MCF-7 cells in 
the co-culture system.    
 
Atomic Force Microscopy (AFM) 
 Since the beads for the injectable composite system will be enclos d within a 
surrounding hydrogel matrix, the properties of the matrix-bead system were characterized 
using AFM.  The stiffness of the following samples were evaluated: plain collagen-
agarose gel, collagen-agarose gel containing chitosan-gelatin bead, and collagen-agarose 




 A volume of 1mL of collagen-agarose solution was prepared by mixing 450µL of 
3mg/mL PureCol® Purified Bovine Collagen (Advanced Biomatrix, San Diego, CA) with 
450µL of 1% agarose solution (Type VII-A, Sigma, St. Louis, MO) and 100µL of 
collagen reconstitution buffer.  The collagen reconstitution buffer consisted of 0.22g 
sodium bicarbonate (Fisher, Fair Lawn, NJ) and 0.48g HEPES (Fisher) in 10mL 
deionized water (Millipore, Billerica, MA).  The collagen-agarose gels were cast in 
silicone molds. Specifically, two high-density silicone sheets (ach sheet 6.5cm L x 
2.5cm W, thickness per sheet = 1mm) were punched to create three 1.4-cm circular 
“wells” in each sheet.  The silicone sheets were placed on top of a polystyrene slide and 
the collagen-agarose gel solution was distributed evenly to each circular well.  An 
individual chitosan-gelatin bead or fatty acid loaded chitosan-gelatin bead was placed 
into the center of an individual circular well such that the gelscompletely surrounded the 
beads.  The solutions were gelled on the slides for 10 minutes at 4○C. The elastic 
modulus was tested immediately using AFM.   
 The MFD-3D-BIO™ AFM (Asylum Research, Santa Barbara, CA) and 
borosilicate AFM tips of radius 2.5µm and spring constant 0.093N/m were used.  For 
AFM testing, the AFM tip approached the gel surface at a speed of 5µm/second and the 
contact force was measured until an indentation depth of 10µm.  Each gel was tested at 
three random points in the central area of the gel, and measured thre  times.  The gel 
sample containing the chitosan-gelatin bead was tested at the interface of the gel and 
bead.  The gel elastic modulus was estimated by fitting a Hertz model to indentation 
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Where:  F = Measured Force 
  υ = Poisson’s Ratio (0.5 for hydrogel) 
  δ = Indentation Depth 
  R = AFM Tip Radius 
 
Live/Dead Cell Viability Staining 
A LIVE/DEAD® Viability/Cytotoxicity Kit (Molecular Probes, Eugene, OR) was 
used to qualitatively assess attachment of the human adipose cells to the beads and to 
assess cellular viability after in vitro culture.  The LIVE/DEAD® working solution, 
consisting of 10mL PBS, 20µL Ethidium-homodimer-1 (EthD-1), and 5µL calcein AM, 
was prepared in a sterile 15mL centrifuge tube according to the manufacturer’s 
instructions.  Transwell inserts containing beads were removed from the well plates, and 
the beads were placed into fresh wells of 24-well plates.  Culture medium was aspirated 
and beads were rinsed with 1mL of sterile PBS (Sigma).  The PBS was aspirated from the 
scaffolds and 1mL of the working LIVE/DEAD® solution was added to each well of the 
plate containing scaffolds.  The plate was incubated for 45 minutes at room temperature 
and protected from light.  Following the incubation period, images of each well were 
captured using the Axiovert 135 fluorescence inverted microscope (Zeiss), with color 
digital camera and imaging software.  The wells were evaluated for green and red 
fluorescence, as produced by the activity of the calcein AM and EthD-1, respectively, 
present in the working solutions.  Esterase present in live cells cl aves the calcein AM, 





Oil Red O Staining (ORO) 
Transwell inserts containing beads were removed from the well plates, nd the 
beads were placed into fresh wells of 24-well plates.  Culture mediu  was aspirated and 
beads were rinsed with 1mL of sterile PBS (Sigma).  The cells w re fixed with 2mL 10% 
Neutral Buffered Formalin (Fisher Chemicals, Fair Lawn, NJ) overnight.  An ORO stock 
solution was prepared by dissolving 0.5g ORO powder (Sigma, St. Louis, MO) in 100mL 
isopropanol (Fisher Chemicals, Fair Lawn, NJ)).  An ORO working solution was 
prepared by mixing 60mL of ORO stock solution with 40mL deionized water and stirring 
for 30 minutes.  A volume of 500µL of the working solution was added to each well and 
incubated for 15 minutes at room temperature.  Following incubation, the wells ere 
rinsed three times with fresh deionized water.  After decanting the excess water, the red-
stained lipid was imaged using an inverted microscope and imaging software.  After 
imaging, 500µL of isopropanol was added to each sample well and incubated for 20 
minutes to extract the stained lipid.  The extraction solution was collected into 
microcentrifuge tubes (Fisher Scientific, Fair Lawn, NJ) and 100µL of each sample was 
pipetted into the wells of a 96-well plate (Corning, Corning, NY).  The absorbance of the 
samples was read at 530nm. 
 
Total Triglyceride Measurement 
Transwell inserts containing beads were removed from the well plates, nd the 
beads were placed into fresh wells of 24-well plates (Corning, Corning, NY).  Culture 




subjecting the cells to three freeze-thaw cycles, 1mL of 1% Triton X-100 (Sigma, St. 
Louis, MO) was added to each well and the cells were incubated for 30 minutes at room 
temperature.  Standard glycerol solutions of concentrations ranging from 0 to 200µM 
were prepared by dissolving glycerol (Sigma, St. Louis, MO) in deionized water.  
Following incubation, the cells from each well were transferred with the Triton X-100 
solution into microcentrifuge tubes and centrifuged for 10 minutes at 3000rpm.  A 
volume of 100µL of each sample and standard was pipetted into the wells of a 96-well 
plate (Corning, Corning, NY) in triplicate.  A volume of 100µL of Infinity™ Triglyceride 
Reagent (Thermo Fisher Scientific, Waltham, MA) was added to each well and incubated 
for 15 minutes at room temperature.  The absorbance was read at 490nm on a Biotek 
Synergy MX Multi-Mode Microplate Reader (Biotek Instruments, Winooski, VT). 
 
Real-Time RT-PCR 
Samples of ribonucleic acid (RNA) were isolated from the adipose cells cultured 
at each condition.  Transwell inserts containing beads were removed fr m the well plates, 
and the beads were placed into fresh wells of 24-well plates.  Culture medium was 
aspirated and beads were rinsed with 1mL of sterile PBS (Sigma).  The RNA was isolated 
from the samples using the reagents and instructions supplied in an RNeasy Mini Kit 
(QIAGEN, Valencia, CA) (Appendix D).  The concentration and purity of the isolated 
RNA samples was measured using the Agilent 2100 Bioanalyzer (Agilent Technologies, 
Inc., San Jose, CA), RNA 6000 Nano Assay Kit (Agilent Technologies, Inc.), RNA 6000 




Corp., Mountain View, CA), and 2100 Expert Software (Agilent Technologies, Inc.) 
(Appendix E).  PPAR-γ and aP2 were selected to identify cells in the early and late st g s 
of adipocyte differentiation; and β-actin was chosen as the housekeeping gene.  Primers 
specific for the human genes and accession numbers for the mRNA sequenc s for each 
specified gene are listed in Table 2.2.  Real-time, one step RT-PCR was performed using 
the Quantifast™ SYBR® Green RT-PCR kit (Qiagen) with conditions as shown in 
Appendix F.  The comparative Ct or delta-delta Ct (∆∆Ct) method was used to determine 
the relative expression level for each gene of interest using β-actin as the reference gene.   
 
Gas Chromatography (GC) 
Culture medium was aspirated from MCF-7 cells in well plates nd the cells were 
rinsed with sterile PBS.  Transwell inserts containing beads seeded with fat cells were 
removed from the well plates, and the beads were placed into fresh wells of 24-well 
plates.  Culture medium was aspirated and beads were rinsed with 1mL of sterile PBS 
(Sigma).  The PBS was aspirated from the MCF-7 cells growing in 2D and the beads 
seeded with fat cells.  A volume of 1mL of PBS was added to each well and the cells 
were scraped with a pipet tip and transferred to microcentrifuge t bes.  Bead samples 
were also transferred to the tubes since cells were attached to the beads.  Tubes were 
stored at -20°C until evaluation for lipid content.  Detailed methods used for sample 
preparation are found in Appendix D of this document.  Total lipids wereextracted from 
the cells using organic solvents according to the procedures of Folch and coworkers [40]. 




coworkers [41].  Fatty acid methyl esters were analyzed using an HP6850 Series II Gas 
Chromatograph fitted with an autosampler (Agilent Technologies, Santa Clara, CA).  
Chemstation software was used to analyze the resulting data (Agilent Technologies).  
Specific fatty acids were identified by comparing the internal st ndard and retention 
times.  The weight percentage of fatty acids was calculated using the values from the 
resulting plots applied to Equation 6.2 and 6.3 shown below. 
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Where: Total Area = area of entire sample plot 
 AreaISTD = area of the internal standard located on the resulting plot 
 AreaFatty Acid = area of specific fatty acids located on the resulting plot 
 
Metabolic Activity 
Metabolic activity of MCF-7 cells in culture was quantitatively assessed using 
alamarBlue® Cell Viability Reagent (Invitrogen, Biosource International, Camarillo, CA).  
The alamarBlue® reagent was added to each well at 10% of the amount of culture 
medium in each well.  Well plates were incubated for three hours at 37°C on a shaker 
plate (IKA® Works, Wilmington, NC).  Following incubation, 150µl of the reaction 
solution was removed from the cell culture plates to wells of a black-walled, clear-bottom 
96-well microplate (Corning, Corning, NY) to assay the fluorescence of samples 




change from blue to pink.  The absorbance was read using a Biotek Synergy MX Multi-
Mode Microplate Reader (Biotek Instruments, Winooski, VT) at wavelengths of 570nm 
and 600nm.  The percent reduction of alamarBlue® was calculated using Equation 6.4 
shown below.   
%    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"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"  100%   Equation 6.4 
Where:  A1 = absorbance of experimental well at 570nm 
  A2 = absorbance of experimental well at 600nm 
  N1 = absorbance of negative control (medium plus alamarBlue® reagent  
without cells) at 570nm  
N2 = absorbance of negative control (medium plus alamarBlue® reagent  
without cells) at 600nm 
 
PicoGreen® DNA Assay 
 The deoxyribonucleic acid (DNA) concentration of MCF-7 cells grown in 2D and 
MCF-7 cells from the co-cultured samples was determined using the Quant-iT™ 
PicoGreen® dsDNA assay kit (P7589, Invitrogen, Molecular Probes, Carlsbad, CA).  At 
Day 12, culture medium was aspirated from the well plates and cells w re rinsed with 
sterile PBS.  A 1X TE Buffer (10mM Tris-HCl, 1mM EDTA, pH 7.5) was prepared from 
the 20X stock solution provided in the kit.  A volume of 1mL of the 1X TE buffer was 
added to each well of the plate.  The plates were frozen and thawed three times to lys  the 
cells.  A pipet tip was used to scrape the cells in each well.  An aqueous working solution 
of the Quant-iT™ PicoGreen® reagent was prepared by making a 1:200 dilution of the 
concentrated solution with 1X TE buffer.  A 2µg/mL stock solution of dsDNA in 1X TE 
buffer was prepared and further diluted to prepare DNA standards, ranging from 0 to 




sample and standard was pipetted to wells of a black-walled 96-well plate.  Working 
solution in the amount of 100µL was pipetted to each well and the plate was incubated 
for 5 minutes in the dark at room temperature.  The fluorescence was read using a 
Flouroskan Ascent® FL flourometric plate reader (Labsystems, Franklin, MA) at 480nm 
excitation and 520nm emission wavelengths.   
 
Cell Apoptosis Assay 
 Apoptotic MCF-7 cells from 2D culture and from the co-culture samples with 
adipose cells were stained using the Alexa Fluor® 488 Annexin V/Dead Cell Apoptosis 
Kit (V13241, Invitrogen, Molecular Probes, Carlsbad, CA).  At Day 12, the culture 
medium was aspirated from MCF-7 cells in the well plates and the cells were rinsed with 
PBS.  A 1X annexin-binding buffer was prepared from the 5X stock solution provided in 
the kit.  A 100µg/mL working solution of propidium iodide (PI) was prepad by diluting 
the stock PI solution with 1X annexin-binding buffer.  A volume of 10µL of the annexin 
V conjugate provided in the kit and 2µL of the PI working solution was added to ach 
well containing MCF-7 cells.  The well plates were incubated t room temperature for 15 
minutes in the dark.  Following incubation, images of each well were captured using the 









Statistical analyses were performed using SAS 9.2 software (Cary, NC) to 
compare the effect of each culture medium on cell behavior.  The Least Squares Means 
(LSMEANS) was used with a significance level of p < 0.05 (n=4 for PicoGreen and 
Triglyceride for linoleic acid optimization studies; n=3 for allother assays). Graphical 
error bars represent the standard error of the mean. 
 
6.3 Results 
Atomic Force Microscopy 
 After applying the Hertz model equation to the resulting AFM data, the estimated 
elastic modulus, as shown in Table 6.2, for the plain collagen-agarose gel was determined 
to be 22.71±1.76 kPa.  The addition of the chitosan-gelatin bead to the gel resulted in a 
significant increase in the gel stiffness to 33.93±3.7 kPa (p<0.05).   Inclusion of the fatty 
acid loaded chitosan-gelatin bead to the gel resulted in a significant increase in the gel 
stiffness to 28.86±3.84 kPa (p<0.05).  There was no difference in the elastic modulus of 
the gels containing either the plain or fatty acid loaded bead. 
Table 6.2: Estimated Elastic Modulus 
Sample 
Estimated Elastic Modulus 
(kPA) 
Gel 22.71 ± 1.76* 
Gel Containing Chitosan-Gelatin 
Bead 
33.93 ± 3.7  
Gel Containing Fatty Acid 
Loaded Chitosan-Gelatin Bead 
28.86 ± 3.84 




Live/Dead Cell Viability Staining 
As shown in Figure 6.3, qualitative assessment of cell viability using the 
Live/Dead stain showed a minimal number of live adipose cells attached to plain and 
fatty acid loaded chitosan-gelatin beads at Day 12.  Of the adipose cell  grown on the two 
different bead types, there appeared to be a comparable number of cells attached to the 
beads.  The appearance of dead cells was not apparent for the cells attached to the beads. 
 
Figure 6.3: Live/Dead staining at Day 12 showed minimal live adipose cells attached to 
the surface of the plain and fatty acid loaded chitosan-gelatin beads.  Total magnification 






Oil Red O Staining 
 Staining of the adipose cells seeded onto the plain and fatty acid lo ded chitosan-
gelatin beads for the co-culture system showed little to no visible lipid droplets present on 
the beads.  As shown in Figure 6.4, however, there did appear to be more red-stained 
lipid in cells on the surface of the plain beads than those cultured on the fatty acid loaded 
beads.  Measurement of the absorbance of the Oil Red O extraction solution, as shown in 
Figure 6.5, showed no statistically significant difference in the absorbance for adipose 
cells seeded at any condition.   
 
Figure 6.4:  Oil Red O staining of human adipose cells cultured on the plain and fatty 






Figure 6.5: Measurement of the absorbance of the Oil Red O extraction solution showed 
no significant difference in the amount of lipid in the human adipose cells cultured on the 
plain or fatty acid loaded chitosan-gelatin beads at any condition.  Graphical error bars 
represent the standard error of the mean. 
 
Total Triglyceride Measurement 
 As shown in Figure 6.6, there was no statistical difference i the amount of total 
triglyceride measured in the human adipose cells cultured on plain or fatty acid loaded 
chitosan-gelatin beads at any condition.  Comparable amounts of triglyce ide were 





Figure 6.6: Measurement of total triglyceride content showed no statistic l difference in 
any of the concentrations measured in the human adipose cells cultured on the plain or 
fatty acid loaded chitosan-gelatin beads. Graphical error bars represent the standard 
error of the mean. 
 
Real Time RT-PCR 
 Minimal levels of PPAR-γ and aP2 gene expression were detected in samples of 
human adipose cells cultured at each condition with MCF-7 cells. As shown in Figure 
6.7A, there was significantly greater PPAR-γ expression observed for adipose cells 
cultured on beads with MCF-7+TAM than was observed in cells cultured on FA-Beads 




γ expression.  Additionally, as shown in Figure 6.7B, there was no statistic l difference 
observed in the expression of aP2 for human adipose cells cultured at any condition.   
 
 
Figure 6.7: RT-PCR results for PPAR-γ (A) and aP2 (B) expressed by the human adipose 
cells seeded on the beads of the co-culture system.  Asterisk  (*) indicate statistically 
different values for PPAR-γ expression. No statistical difference was observed in the 
expression of aP2 for any culture condition.  Graphical error bars represent the standard 








 The fatty acid profile for both the adipose cells and the MCF-7 cells for each 
condition was determined, and is shown in Figure 6.8.  The percentage of each individual 
fatty acid within cell samples was calculated and the sum of identifiable fatty acids was 
determined.  More than 75% of total fatty acids were identified or samples of each 
condition.  Of the identified fatty acids within the human adipose cells ultured on the 
plain or fatty acid loaded chitosan-gelatin beads, four specific fatty acids were most 
abundant within the cells.  Myristic, palmitic, stearic, and oleic fatty acids were all found 
in the highest percentages for the adipose cells of each co-culture condition.   
 Comparison of the percentages of the four most prevalent fatty acids in the 
adipose cells is shown in Figure 6.9A.  The percentage of palmitic and stearic acids were 
significantly higher than myristic and oleic acids for all co-culture conditions in which 
the adipose cells were evaluated (p<0.05).  There was no difference observed betw en the 
four most prevalent fatty acids in the adipose cells for any co-culture condition. 
 Of the identified fatty acids within the MCF-7 cells co-cultured with the adipose 
cells on beads, myristic, palmitic, stearic, and oleic acids were most abundant.  As shown 
in Figure 6.9B, the percentage of myristic was significantly lower for each sample 
condition than the other most prevalent fatty acids for that condition.  For the MCF-7 
cells cultured on FA-Beads, the percentage of stearic acid was significantly lower than 





    Sample Condition 
    Average Percent (%) of Total Fatty Acid Composition (n=3 samples per condition) 
MCF-7 Cells from Co-Culture MCF-7 Cells in 2D Adipose Cells on Beads from Co-Culture 






M+FA Bead Bead+TAM FABead 
FABead+TA
M 
12 Lauric 1.21±0.21 1.19±0.29 1.50±0.15 1.71±0.21 1.43±0.19 1.16±0.09 1.20±0.46 3.43±0.87 3.40±1.81 2.92±0.81 3.76±0.69 
13:0 Tridecanoic 1.80 ±0.09 2.18 ±0.51 1.88± 0.06 2.39± 0.31 2.01± 0.51 1.52± 0.21 .49± 0.44 4.61± 0.84 4.09 ±1.84 3.79± 0.59 3.55 ±0.86 
14 Myristic 5.69±0.37 4.78±0.07 6.89±0.82 5.84±1.07 5.18±0.90 3.98±0.38 2.89 ±0.18 4.64±0.33 4.20±0.55 4.24±0.51 5.61±1.36 
14:1 c9 Myristoleic 0.68± 0.09 0.88± 0.34 0.55± 0.07 0.54 ±0.49 0.45± 0.40 0.39 ±4 0.63 ±0.13 1.44 ±1.39 1.09± 0.95 1.60± 0.44 0.00 
15 Pentadecanoic 0.19± 0.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
16 Palmitic 19.06± 0.93* 18.35±1.72* 17.12±1.32* 17.67±1.26* 16.24±1.46  15.25±2.57 14.85±1.363 22.26±1.79* 22.05±5.50* 23.22±1.40* 20.11±3.88* 
16:1 c9 Palmitoleic 4.48 ±0.24 3.42± 0.32 4.79± 0.28 3.86 ±0.69 6.08± 0.74 6.84± 0.67 1.67± 0.16 0.71± 0.64 1.07± 1.04 1.28 ±0.41 1.79± 0.10 
17 Heptadecanoic 0.45± 0.08 0.34± 0.30 0.24 0.21 0.17 0.29 0.13 0.23 0.39 0.10  0.13 0.22 0.00 0.32 0.56 0.51 0.89 0.00 
18 Stearic 12.94± 0.93 13.66±2.26 10.16±1.44 11.94±2.11 11.31±1.91 12.01±3.02 12.05±1.84 21.30±1.57* 22.08±5.55* 21.54±1.68* 18.78±3.36* 
18:1 t11 Trans-11 vaccenic 0.71± 0.79 0.83± 0.76 0.00 0.00 0.25 ±0.44 0.49 ±0.85 0.00 0.57± 0.99 3.00 ±3.75 0.00 0.00 
18:1 c9 Oleic 19.78± 0.33* 17.88±1.07* 19.82±0.30* 18.27±1.95* 24.43±1.36* 24.07±1.93* 7.83± 0.24 8.45±2.21 5.94±5.14 6.87±4.04 11.37±1.17 
18:2 Omega-6 Linoleic 1.88± 0.03 1.75 0.15 2.53 0.05 2.53 0.53 0.82 0.13 1.12 0.11 34.45 3.61* 1.72 0.49 1.82 0.62 4.23 3.32 3.46 0.48 
20:0 Arachidic 0.56± 0.53 1.02± 0.13 1.08± 0.07 1.21± 0.18 0.76± 0.26 1.02± 0.23 0.57 ±0.17 0.86±0.76 0.66± 0.63 1.99± 1.29 1.76± 2.49 
20:1 Eicosenoic 0.62± 0.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
21:0 Heneicosanoic 0.68± 0.04 0.63± 0.12 0.56± 0.48 0.45± 0.77 0.75± 0.66 0.00 0.09± 0.15 0.00 0.00 0.00 0.00 
18:3 Omega-3 Linolenic 0.40± 0.04 0.42± 0.07 0.57± 0.21 0.64± 0.28 0.77± 0.14 0.98± 0.22 1.57 ±2.23 0.40±0.69 1.48 ±0.32 1.86± 0.33 2.42 ±0.02 
20:2 Eicosadienoic 0.66± 0.17 0.83± 0.23 0.58± 0.10 0.84± 0.22 0.56± 0.12 0.58± 0.14 3.63 ±2.40 0.33±0.58 0.45± 0.78 0.00 0.00 
22:0 Behenic 0.52± 0.02 0.56± 0.06 0.49± 0.12 0.21 ±0.37 0.38± 0.36 0.52 ±0.06 0.32 ±0.27 0.00 0.00 0.00 0.00 
20:3 Eicosatrienoic 0.23± 0.20 0.00 0.23± 0.20 0.14± 0.24 0.26± 0.24 0.32± 0.05 0.10 ±0.18 0.00 0.00 0.00 0.00 
20:4 Omega-6 Arachidonic 2.62± 0.08 2.72± 0.20 2.92± 0.24 2.64± 0.55 1.88± 0.08 2.45± 0.37 1.01± 0.11 1.31±0.38 1.38 ±0.60 1.54± 0.77 3.08± 0.10 
20:5 Omega-3 EPA 0.94± 0.27 1.18 ±0.15 0.76± 0.2 0.80± 0.08 0.80± 0.24 0.62± 0.16 0.74± 0.34 1.28±0.16 1.60± 0.32 1.14± 0.15 1.78 ±0.25 
22:5 Omega-3 DPA 2.03± 0.64 2.51 ±0.33 1.13± 0.08 1.60± 0.83 1.39± 0.55 1.15 ±0.37 0.96 ±0.43 3.76±1.24 3.44 ±0.08 4.20± 1.90 2.40± 0.03 
22:6 Omega-3 DHA 1.54± 0.02 1.57± 0.14 1.72± 0.13 1.55± 0.36 1.20± 0.02 1.52± 0.20 1.65 ±1.57 0.31±0.53 0.00  0.00 0.00 
  
Total FA 
Percentage (SUM) 79.68 76.68 75.52 75.01 77.08 76.37 87.81 77.41 78.05 80.93 79.87 
  Other (100%-SUM) 20.32 23.32 24.48 24.99 22.92 23.63 12.19 22.59 21.95 19.07 20.13 
 
Figure 6.8: The fatty acid composition of each sample condition was determined by gas chromatography analysis. Asterisks 





Figure 6.9: The fatty acids found in the highest percentage for the adipose cell  and 
MCF-7 cells in the co-culture system were myristic, palmitic, stearic, and oleic acids (A 
and B).  For the MCF-7 cells in 2D culture, the most prevalent fatty acids were myristic, 
palmitic, stearic, and oleic acids for the MCF-7 and MCF-7+TAM samples, while 
linoleic acid was among the most prevalent found in the MCF-7+TAM+FA samples (C).  
Asterisks (*) and percent symbols (%) indicate values statistically different from all other 
fatty acids for that specified condition (p<0.05).  Graphical error bars represent the 
standard error of the mean.  
Most Prevalent Fatty Acids in Co-Cultured MCF-7 
Cells 
Most Prevalent Fatty Acids in Co-Cultured 
Adipose Cells 







(p<0.05).  There was no difference observed between the percentages of a specific fatty 
acid for any co-culture condition, or in the percentage of linoleic ac d measured for any 
of co-cultured MCF-7 cells. 
 For the MCF-7 cells cultured in 2D, the most prevalent fatty acids identified was 
not the same for all samples cultured in 2D.  For the MCF-7 cells alone and the MCF-7 
cells cultured with tamoxifen, the most prevalent fatty acids were myristic, palmitic, 
stearic, and oleic acids.  For the MCF-7 cells cultured with a combination of tamoxifen 
and linoleic acid, the most prevalent fatty acids were myristic, palmitic, stearic, and 
linoleic acids.  As shown in Figure 6.9C, there was a significantly higher percentage of 
linoleic acid in the 2D MCF-7+TAM+FA samples than was measured in the MCF-7 cells 
alone and the MCF-7+TAM samples.  The percentage of linoleic acid for the MCF-
7+TAM+FA sample in 2D was also significantly higher than the other most prevalent 
fatty acids for that sample (p<0.05).  For the MCF-7 and MCF-7+TAM samples in 2D, 
there was a significantly higher percentage of oleic acid measur d than any of the other 
most prevalent fatty acids for those conditions.   
 
Metabolic Activity 
 The metabolic activity of the MCF-7 cells in 2D and in the co-culture system was 
evaluated with the alamarBlue® assay.  As shown in Figure 6.10A, of the MCF-7 cells 
cultured in 2D, the samples cultured with a combination of tamoxifen and linoleic acid 
(MCF-7+TAM+FA) were significantly less metabolically active than the MCF-7 cells 




cells co-cultured with adipose cells seeded on plain or fatty acid loaded chitosan-gelatin 
beads, there was no difference observed in the metabolic activity of co-cultured MCF-7 
cells at any condition (Figure 6.10B). 
 
 
Figure 6.10: Results of the alamarBlue assay indicate that the MCF-7+TAM F  cells in 
2D (A) were less metabolically active than the MCF-7 cells cultured alone or with 
tamoxifen (p<0.05).  No difference was observed among the MCF-7 cells of any co-
culture condition.  Asterisk (*) denotes a value significantly different from the other 
conditions in 2D.  Graphical error bars represent the standard error of the mean. 






 To further characterize the MCF-7 cells in this study, a PicoGreen assay to 
measure the DNA concentration was performed.  The DNA concentratio  within each 
sample of MCF-7 cells is shown in Figure 6.11.  For the MCF-7 cells ultured in 2D, 
there was a significant difference observed among all values (Figure 6.11A).  The MCF-7 
cells alone had the highest concentration of DNA, while the DNA concentration of the 
MCF-7+TAM cells was significantly lower (p<0.05).  The DNA cone tration of the 
MCF-7+TAM+FA cells was significantly lower than both the MCF-7 and MCF-7+TAM 
cells (p<0.05). 
 Of the MCF-7 cells grown in the co-culture conditions (Figure 6.11B), there was 
no difference observed in the DNA concentration of the MCF-7 cells ultured with 
adipose cells grown on plain chitosan-gelatin beads with or without tamoxifen treatment.  
There was, however, a significantly lower DNA concentration measur d in the MCF-7 
cells cultured with adipose cells grown on fatty acid loaded beads and treated with 
tamoxifen (FA-Bead+MCF7+TAM) than was measured in MCF-7 cells cultured with 
cellular fatty acid loaded beads alone.  Additionally, the DNA concentration of the MCF-
7 cells treated with tamoxifen was significantly lower when co-cultured with adipose 






Figure 6.11: Results of the PicoGreen® assay showed that the DNA concentrations of all 
samples in 2D were statistically different from each other (A) (p<0.05).  For the co-
cultured samples, MCF-7 cells cultured with adipose cells on FA-Beads with tamoxifen 
had a significantly lower DNA concentration than those co-cultured with plain beds and 
without tamoxifen (B).  Asterisks (*), pound (#), and percent (%) symbols denote 








Cell Apoptosis Assay 
 Qualitative assessment of MCF-7 cell viability was performed to identify 
populations of apoptotic cells, stained green by the assay, for each condition.  As shown 
in Figure 6.12, the resulting images of the apoptosis assay showed visible differences in 
the number of apoptotic MCF-7 cells for the 2D samples.  For MCF-7 cells alone 
cultured in 2-D, little to no apoptotic cells were observed (Figure 6.12B).  The addition of 
tamoxifen to the MCF-7 cells in 2D resulted in an increased number of apoptotic cells 
than the MCF-7 cells alone, as shown in Figure 6.12D.  Additionally, culturing the MCF-
7 cells in 2-D with tamoxifen and fatty acid resulted in what appears to be even more 
apoptotic cells (Figure 6.12F). 
 For the MCF-7 cells co-cultured with adipose cells seeded on plaichitosan-
gelatin beads, there were very few apoptotic cells observed with the apoptosis assay 
(Figure 6.13B).  With the addition of tamoxifen to the co-culture system of MFC-7 cells 
adipose cells on plain beads, more apoptotic cells were observed (Figure 6.13D).  For 
MCF-7 cells cultured with adipose cells on fatty acid loaded beads a number of apoptotic 






Figure 6.12: Results of the apoptosis assay for MCF-7 cells cultured in 2Dshowed more 
apoptotic cells in samples treated with tamoxifen (D) and tamoxifen with fatty acid (F) 





Figure 6.13: Results of the apoptosis assay for MCF-7 cells co-cultured with adipose 
cells grown on plain beads showed very few apoptotic cells (B), while mor apoptotic 
MCF-7 cells were observed upon treatment with tamoxifen or culturing w th adipose 






 Cellular co-culture studies are often used to model in vivo cell interactions.  
Culture of multiple cell types may not be advantageous in all circumstances because 
many variables are introduced in the culturing system, which may result in a system that 
is more complex and therefore more difficult to manage and assess.  However, co-
cultures are necessary for better understanding cell-cell interactions.  The mammary 
gland largely consists of glandular tissue embedded within a stromal network consisting 
of adipose tissue and fibrous connective tissue [42-46]. The most prevalent ce l types 
present within the breast tissue, epithelial cells, adipocytes, and fibroblasts, interact not 
only through physical contacts but mainly through paracrine signaling. In particular, the 
interactions between the epithelial cells and the stromal (fibroblast, adipocytes mostly) 
cells within the normal mammary microenvironment modulate the effects of hormones 
during mammary gland developmental processes, such as cell differentiation, ductal 
elongation, and ductal branching morphogenesis [47].  
Since the relationship between mammary epithelial cells and stromal cells plays a 
key role during normal developmental processes, it is presumable that there will also be a 
key relationship between stromal and epithelial cells in the cas of a cancerous mammary 
gland.  Specifically, the interaction of breast cancer cells with adipose cells has been 
investigated by researchers through several in vitro studies.   Johnston and coworkers 
conducted a study where MCF-7 cells were cultured with conditioned mediu  collected 
from 3T3-L1 preadipocyte cells.  The influence of the preadipocyte conditi ed media on 




found that MCF-7 cell growth was inhibited by 55% when compared to control samples 
after 96 hours, suggesting that the 3T3-L1 preadipocyte cells secrete factors that inhibit 
the growth of mammary carcinoma cells [48].   
Manabe and coworkers investigated the effects of co-culturing MCF-7 cells with 
either preadipocytes or mature adipocytes to determine the influence of adipose cells on 
growth of the breast cancer cells.  The preadipocytes or mature adipocytes from rat tissue 
were seeded in a three-dimensional collagen gel system with MCF-7 cells.  Evaluation of 
tumor clusters that formed within the gels was performed, and it was determined that 
after 7 days, the MCF-7 cells grown with the mature adipocytes formed structures 
possessing characteristics of basement membranes, indicating cellular growth, while 
MCF-7 cells cultured with preadipocytes retained morphology characteristic of MCF-7 
cells without treatment [49].  Manabe and coworkers concluded that the mature 
adipocytes promoted breast cancer cell growth, while preadipocytes inhibited growth.  
Similar findings were reported by Kashani and coworkers who determin d that human 
preadipocytes inhibited MCF-7 cell growth, while mature human adipocytes promoted 
MCF-7 cell growth in collagen gels [50]. 
 These studies used simple co-cultures of MCF-7 cells and adipose cell  to 
determine how adipose cells influence breast cancer cell behavior.  There was no 
attention, however, paid to the adipose cells and their behavior in the syst m.  
Additionally, the mammary microenvironment contains other factors, such as fatty acids, 
that also play a role in development. In our studies, we implemented a multi-faceted co-




would behave in co-culture, but also determine the response of the cells to treatment with 
tamoxifen if fatty acids were included in the co-culture system.   
Previous studies in Chapter 5 showed that culturing of D1 mesenchymal stem 
cells, differentiated to fat cells, resulted in increased triglyceride production when cells 
were grown for 17 days on fatty acid loaded chitosan-gelatin beads as opposed to the 
plain beads.  Here, however, primary human adipose cells were used for these studies and 
no differences were observed in adipose cell behavior.  It is likely that no difference was 
observed from any of the assays for the adipose cells because the cells were not cultured 
on the beads for a similar length of time as the D1 cells in preliminary studies. From the 
fatty acid release profile used to characterize the fattyacid loaded beads in Chapter 5, it 
was determined that the release of fatty acids steadily increased until Day 10 when the 
fatty acid concentration began to level off.  Additionally, significantly higher 
concentrations of triglyceride were measured at Day 10 than at Day 17.  The culture 
conditions for cell seeding in this study were based on the outcome of the studies in 
Chapter 5, such that human adipose cells were cultured on the fatty acid loaded beads for 
a total of 10 days in an attempt to culture the cells with the highest concentrations of fatty 
acids.  It is likely, however, that although similar processing parameters were used for 
manufacturing the beads for both studies, batch-to-batch variations may have led to an 
altered release profile for the beads.  Optimization of the fatty acid loading methods will 
likely need to be conducted in order to better define the release properties of th  beads for 
future studies.  More importantly, the fatty acid uptake of primary human adipose cells 




for each specific cell type should be performed to determine that cell types’ specific rate 
of fatty acid uptake.  It should also be pointed out, that similar to the study in Chapter 3, 
the human adipose cells may require an extended culture period on the beads in order for 
proliferation and ultimately differentiation to occur.  Seeding more cells at the initiation 
of the cultures could reduce the amount of time required for culturing. 
The studies in Chapter 4, evaluating linoleic acid influence on D1 cell 
differentiation to fat cells, showed that the differentiating cells readily take up exogenous 
lipid from culture medium.  For the differentiating D1 cells in Chapter 4, stearic, 
palmitic, oleic, and linoleic acid were the most prevalent fatty cids found within the 
cells.  The fatty acid profile from gas chromatography showed significant increases in 
linoleic acid for D1 cells cultured with exogenous lipid when compared to control 
samples in normal medium.  Here, in contrast, the fatty acid profile  adipose cells 
cultured on both the plain and fatty acid loaded beads was evaluated.  For adip se cells 
cultured on plain or fatty acid loaded beads, the most prevalent fatty acids found within 
the cells were myristic, oleic, stearic, and palmitic acids.  There was no difference 
observed for any sample conditions when adipose cells were co-cultured with MCF-7 
cells treated with tamoxifen or not.  It is interesting to note, however, the difference in the 
most prevalent fatty acids observed in the differentiating D1 cells and the human adipose 
cells from these co-culture studies.  Both cell types contained high percentages of stearic, 
oleic, and palmitic acids; however, the human adipose cells contained a high percentage 
of myristic acid, while the D1 cells (even the D1 control samples not supplemented with 




mammary tissue samples has shown that the fatty acids found most commonly in the 
highest concentrations are oleic, palmitic, linoleic, and stearic ac ds [13, 23].  The 
difference observed with the most prevalent fatty acids within the human adipose cells 
from these co-culture studies, may likely be attributed to the fact th t the cells were co-
cultured with MCF-7 cells, which may have influenced the normal composition of the 
human adipose cells.   
In addition to evaluating the fatty acid profile of the adipose cells, the fatty acid 
profile of the MCF-7 cells from the co-culture system and MCF-7 cells in two-
dimensional culture was determined.  Kaur and coworkers demonstrated th  the MDA-
MB-231 breast cancer cells were capable of taking up fatty acids, including oleic acid, 
arachidonic acid, and EPA.  By evaluating the MDA-MB-231 cells incubated with radio-
labeled fatty acids, the rate of fatty acid uptake was measur d and it was found that 
arachidonic acid, in their study, was taken up faster than the EPA or oleic acid [51].  
Additional studies by Evans and coworkers showed that dietary stearic acid reduced the 
metastasis of MDA-MB-435 breast cancer cells in vivo.  Nude mice were fed a diet 
containing normal feed, safflower oil, or stearic acid in combination with safflower oil.  
The mice were then injected with MDA-MB-435 breast cancer cells into the mammary 
fat pad.  At the conclusion of the study, metastasis of the cells to the animals’ lungs was 
evaluated, and it was determined that growth and metastasis of the breast cancer cells in 
mice fed stearic acid was inhibited [52].  These studies by Kaur and coworkers, and 
Evans and coworkers showed that breast cancer cells are capable of taking up fatty acids, 




between linoleic percentages in MCF-7 cells co-cultured with adipose cells on plain 
beads and MCF-7 cells co-cultured with fatty acid loaded beads suggests that perhaps the 
fatty acid released from the beads may not have reached the MCF-7 cells beneath the 
transwell inserts.  Additionally, the release of the linoleic acid from the beads may have 
been at a different rate than that measured from preliminary studie  in Chapter 5—either 
the linoleic acid was released quickly from the beads and was then lost by the cells over 
time, or the linoleic acid was released slowly and not supplied to the cells for uptake.  It 
is not clear which is the case since the fatty acid releasd from the beads was not 
measured in this particular study. 
Similar to the observations of Kaur and coworkers, the MCF-7 cells cultured with 
exogenous fatty acid in 2D readily took up that fatty acid such that linoleic acid made up 
the largest percentage of the total fatty acids for those cells.   
Fatty acids have been shown to influence the effectiveness of tam xifen to treat 
breast cancer cells.  As previously described, deGraffenried and coworkers showed that 
treatment of transfected MCF-7 cells that were resistant to tamoxifen with the n-3 fatty 
acid, EPA, and tamoxifen led to enhanced growth inhibition of the tumor cells [36].  
Additionally, as described in the background section of this chapter, Ch n and coworkers 
showed that the growth of tumors created by injection of MCF-7 cells into athymic mice, 
was inhibited in mice fed a diet high in flaxseed, which is rich in α-linolenic acid [37].  
To determine if the uptake of linoleic acid influenced the effectiv ness of tamoxifen in 
this study, the metabolic activity, DNA concentration and presence of apoptotic cells was 




Based on measurement of metabolic activity, measurement of DNA 
concentration, and evaluation of apoptotic MCF-7 cells within each conditi , it can be 
determined that tamoxifen induced death of MCF-7 cells in the co-culture with adipose 
cells grown on fatty acid loaded beads.  Additionally, results of MCF-7 cells cultured in 
2-D at each condition, suggest that supplementation of MCF-7 culture mediu  with 
linoleic acid positively influences the effectiveness of tamoxifen to induce death of the 
MCF-7 cells.  Linoleic acid, in our studies, appears to enhance the effectiveness of 
tamoxifen to induce apoptosis of breast cancer cells, suggestin that the inclusion of 
linoleic acid in our injectable composite system could be advantageous for post-surgical 
treatment of breast cancer while also providing a stimulus for lipid formation in adipose 
cells in vivo.  Conflicting opinions regarding the influence of linoleic acid on breast 
cancer cells exist, however.  Rose and coworkers performed studies evaluating the effect 
of dietary linoleic acid on MDA-MB-435 breast cancer cell metastasi .  Tumors were 
formed by injecting MDA-MB-435 cells into nude mice fed varying concentrations of 
linoleic acid, and evaluation of the metastasis of cancer cells showed that the linoleic acid 
stimulated metastasis of the breast cancer cells to the liver [53, 54].  Schley and 
coworkers, meanwhile, performed a study evaluating the effect of EPA and DHA on 
MDA-MB-231 breast cancer cells with and without linoleic acid included.  As an 
essential fatty acid, linoleic acid was used to supplement the culture medium of MDA-
MB-231 cells that were treated also with EPA or DHA in vitro.  It was found that 
culturing the cells with EPA and DHA in the presence of linoleic acid resulted in growth 




fatty acids, or perhaps a combination of fatty acids be considered fo  inclusion in the 
injectable composite system.  It is also likely that the selection of fatty acid(s) could vary 
from patient-to-patient depending on that patient’s dietary fatty acid intake which has 
been shown to influence the fatty acid profile of adipose tissue deposits in the body.  
Additional investigation of the literature and further studies are therefore required to 
identify the optimal fatty acids for possible use in the injectable composite sytem. 
 
6.5 Conclusions 
 From this study, it can be concluded that there is likely some batch variation in 
the fatty acid loaded chitosan-gelatin bead production, indicating that further 
optimization of bead processing methods is necessary to produce beads cap ble of 
consistently releasing a desired fatty acid concentration.  Becaus  of possible limited 
release of linoleic acid to the cells from beads in the co-culture system, the influence of 
this co-culture system on adipose cell and breast cancer cell behavior cannot be 
determined definitively.  To more definitively determine the influence of fatty acids on 
adipose cell-breast cancer cell interactions, the culture conditi s would first need to be 
optimized and the study then repeated.   
The results of this study indicate that the addition of linoleic acid to MCF-7 cells 
does indeed increase the effectiveness of tamoxifen in inducing apoptosis of the MCF-7 
cells.  These results suggest that inclusion of linoleic acid in the injectable composite 
system could be used for post-surgical treatment of breast cancer whil  also stimulating 
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The overall goal of this work was to investigate two specific factors that influence 
adipose cell differentiation.  With a better understanding of how adipose cell-mammary 
epithelial cell interactions and fatty acids influence adipogenesis, we hope to identify 
improved culturing conditions to yield a more successful injectable composite system for 
breast tissue reconstruction.  Initial studies for this work allowed us to identify methods 
to successfully isolate populations of primary bovine, murine, and human adipose cells 
that are capable of differentiating to mature adipose cells given an appropriate stimulus.   
 Our studies of the relationship between mammary epithelial cells and adipose 
showed that adipose cell differentiation is influenced by mammary epithelial cells.   
Conditioned medium from mammary epithelial cells will either yield increased or 
decreased triglyceride and lipid accumulation and adipogenic gene expression, or have no 
immediate effect on adipose cell differentiation, depending on the source f conditioned 
medium.  Additionally, from characterization of the specific components of each type of 
conditioned medium, specific factors that influence adipogenesis were id ntified and it 
was determined that the specific concentrations of those factors, expressed in media 
conditioned from mammary epithelial cells, will vary depending on the cell type.  
 Processing methods for preparing sterile chitosan-gelatin beads and terile fatty 
acid loaded chitosan-gelatin beads were successfully developed.  It was determined that 




significantly alter the material properties of the chitosan or gelatin.  Characterization of 
the mechanical properties of the components of the injectable composite sy tem showed 
that the inclusion of chitosan-gelatin beads, with or without fatty acid, within a collagen-
agarose gel matrix increases the stiffness of the gel matrix, however, the estimated 
stiffness of the gel matrix and gel matrix containing beads wacomparable to the 
modulus of the normal tissue components of the mammary gland, suggesting that the 
injectable composite system of these materials would be successful for restoring the 
aesthetic function of the breast because of the similar material properties. 
Significant differences in cell number observed between primary human adipose 
cells grown in 2-D versus 3-D culture suggest that either a higher number of primary 
cells should be seeded initially on the beads, or the primary cells should be cultured on 
the beads for a longer period of time before differentiation is induced, particularly 
because primary cells do not proliferate as quickly in culture as cell lines. 
It can be concluded that the addition of linoleic acid to cultures of D1 stem cells 
will influence adipogenesis.  Additionally, cells grown in culture medium supplemented 
with exogenous fatty acids will take up the fatty acid that they ar  provided, such that 
increased levels of that specific fatty acid will be found within intracellular lipid, as 
observed by evaluation of D1 stem cells and MCF-7 breast cancer cells. It was also 
determined that long-term exposure of adipose cells to fatty acidswill result in increased 
intracellular lipid, which could prove useful for further development of adipose tissue 
engineering strategies. The inclusion of fatty acids into microcarrier beads for the 




lipid production, which would lead to increased adipose tissue mass and ideally sustain 
the tissue volume over time if the fatty acid is provided to cells at a sufficient qua tity.   
Finally, preliminary evaluation of fatty acid influence on the eff ctiveness of the 
anti-cancer drug tamoxifen lead to the conclusion that the addition of li oleic acid to 
cultures of MCF-7 cells does increase the effectiveness of tamoxifen in inducing 
apoptosis of the cancer cells.  This suggests that inclusion of linoleic acid in the injectable 
composite system could be used for post-surgical treatment of breast cancer while also 
stimulating lipid-filling of adipose cells. 
 
 





RECOMMENDATIONS FOR FUTURE WORK 
 
1. For future conditioned media studies, cells of interest should be cultured in vitro 
with non-conditioned medium first, possibly on chamber slides, to determine if 
the non-conditioned base medium may influence cell behavior.   
 
2. Freshly obtained conditioned media samples should be re-analyzed with the 
adipokine protein array.  Subsequent quantification of specific products of interest 
should be performed to determine at what concentration those factors may 
influence adipogenesis. 
 
3. Future in vitro studies should be performed using the specific identified factors 
from conditioned media characterization, e.g., TGF-β or PAI-1, to determine if 
that one factor could influence adipogenesis or if there is a synergistic effect of all 
conditioned media components.  
 
4. Studies evaluating the interaction of adipose cells and mammary epithelial cells in 
three-dimensional culture should be repeated, using increased primary cell 
number for seeding onto beads, and extended culture time to allow the primary 




5. Studies evaluating the influence of bead processing parameters on chitosan-
gelatin bead stiffness should be performed.  Follow-up studies to determine if 
varied hydrogel/bead stiffness will influence adipose cell differentiation should be 
performed.  Additionally, in vitro analysis of the injectable composite system 
(hygdrogel and multiple bead composition) with co-cultures of adipose cells and 
mammary epithelial cells should be performed to determine how cell behavior 
will be influenced. 
 
6. For future fatty acid studies, it should be determined if linoleic ac d is the most 
optimal fatty acid for inclusion in the injectable composite system.  It should be 
determined if one particular fatty acid should be use, or if a blend of multiple fatty 
acids would be ideal, particularly with consideration of the ω-3/ω-6 ratio of fatty 
acids in adipose tissue deposits, that has been shown to be an indicator of breast 
cancer risk.  Assessment of the effect of various fatty acids on normal mammary 
cells should be performed. 
 
7. Further characterization of the fatty acid loaded chitosan beads is necessary to 
determine if the fatty acid release profile will vary from batch-to-batch.  Bead 
fabrication methods may need to be altered if the fatty acids are to be delivered in 





8. Further investigation of multi-purpose beads within the injectable composite 
system should be performed.  Beads may potentially be used for site-specific 
delivery of post-surgical treatments for tumors or for cell carriers for tissue 
reconstruction.   
 
9. In vivo evaluation of fatty acid delivery from the microcarrier beads should be 
performed within a nude mouse model to identify the influence of the fatty acids 




















Digestion of Human Fat Tissue 
Reagents and Medium: 
• Collagenase Medium (DMEM-Incomplete) 
500ml Dulbecco’s Modified Eagle Medium (DMEM) + 5mL AA + 1mL 
fungizone 
 
• Fat Growth Medium (DMEM-Fat)  
500mL DMEM + 50mL FBS + 5mL AA + 1mL fungizone + 2mL Insulin-
Transferrin-Sodium Selenite Media Supplement (ITS)  
 
• Red Blood Cell (RBC) Lysis Buffer 
 Stock Solutions:  
 1M NH4Cl (FW=53.49) 26.75g to 500mL ddH2O 
 
 100mM KHCO3 (FW=100.1) 5.0g to 500mL ddH2O 
   
 10mM EDTA 
 
 Working Solution (500mL): 
 77mL 1M NH4Cl + 50mL 100mM KHCO3 + 5mL 10mM EDTA + 368mLddH2O 
 
Tissue Retrieval Preparation: 
1. Autoclave all needed instruments including scissors, forceps, funnel, nylon mesh 
for filtering, beakers 
2. Provide cooler to OR nurses station before scheduled procedure so that sample 
may be placed in cooler on ice. 
 
Collection and Isolation of Fat Cells: 
1. Obtain tissue sample from the hospital OR. Transport back to the laboratory for 
processing.  Complete the Clemson Data Sheet for sample log. 
2. Warm all media and PBS to 37°C in the water bath. 
3. Open the tissue sample in the sterile hood.  Cut off the desired amount of fat from 
the larger sample.  Place the fat tissue on a sterile disposable Petri dish and rinse 
with fresh PBS.  Rinse 1-2 more times to rinse away excess blood from the tissue. 
4. Mince the tissue finely using disposable scalpels and scissors, carefully removing 




5. Place ~5 grams of tissue into a sterile 50mL-centrifuge tube.  Add filter sterilized 
collagenase solution to each tube 4mL/gram tissue. 
a. Prepare as much collagenase solution as needed for a given day 
immediately before use. Filter sterilize before use.  To prepare the 
collagenase solution, add: 
DMEM-Incomplete + 2mg/mL Type I collagenase + 2mg/mL 
Type II collagenase (both from Worthington Biochemical) + 2% 
BSA (Sigma) 
6. Incubate the tubes containing the tissue at 37°C in rotating water b h for 45 
minutes at 100rpm.   
7. Pipet the lysate up and down several times to break up remaining large pieces. 
Filter the digested material using 1000µm nylon mesh into another sterile 50ml-
centrifuge tube to remove remaining tissue fragments. Dilute the filtrate with 
DMEM-Fat to minimize collagenase activity.   
8. Spin the tubes for 10 minutes at 1000rpm.  At the top will be an oily layer with a 
fatty layer beneath. The middle is aqueous layer and the sediment is preadipocytes 
and endothelial cells. Aspirate the fatty layer and liquid layer from the tube.   
9.  Resuspend the cell pellet in 20mL of RBC Lysis Buffer for 10 minutes.  Filterthe 
lysate with 100µm cell strainer into a new tube and spin for 5 minutes a  
1000rpm. 
10. Aspirate the top layer and aqueous layer in the tube.  Resuspend the final pellet in 
DMEM-Fat and seed in T-25 culture flasks with 5ml of DMEM-Fat medium.  If 
there appears to be a large number of cells, perform a cell count and seed cells in 
T-75 flask with 10ml fresh medium.  Check cells after 24 hours to ensur  no 
contamination.   
11. Change medium after 48hours to remove cellular debris and unattached cells.  








Digestion of Bovine Fat Tissue 
Reagents and Medium: 
• Sterile Transport Solution 
500mL Hank’s Balanced Salt Solution (HBSS) + 5mL antibiotic-antimycotic 
(AA) + 1mL fungizone  
 
• Collagenase Medium (DMEM-Incomplete) 
500ml Dulbecco’s Modified Eagle Medium (DMEM) + 5mL AA + 1mL 
fungizone 
 
• Fat Growth Medium (DMEM-Fat)  
500mL DMEM + 50mL FBS + 5mL AA + 1mL fungizone + 2mL Insulin-
Transferrin-Sodium Selenite Media Supplement (ITS) 
 
Tissue Retrieval Preparation: 
1. Autoclave all needed instruments including scissors, forceps, funnel, nylon mesh 
for filtering, beakers 
 
2. Prepare sterile HBSS solution and aliquot to several sterile 50ml-centrifuge tubes 
(30mL per tube) 
 
3. Before going to slaughterhouse, warm tubes with HBSS in water b th to 37°C.  
Also warm the Vector Travel warmer to 37°C.  Place the tubes of HBSS into the 
warmer and travel to the slaughterhouse. 
 
Collection and Isolation of Fat Cells: 
1. Obtain either subcutaneous or intraabdominal (from around internal organs) fatty 
tissue from cow at slaughterhouse.  Place tissue in tube containing sterile HBSS 
solution.  Place tubes back in travel warmer and transport back to the laboratory 
for processing. 
2. Warm all media and reagents to 37°C in the water bath. 
3. Place the fat tissue on a sterile disposable Petri dish and rinse with fresh HBSS 
solution.  Rinse again. (Can also rinse again with sterile PBS solution.) 
4. Mince the tissue finely using disposable scalpels and scissors.   
5. Place ~5 grams of tissue into a sterile 50mL-centrifuge tube.  Add filter sterilized 




a. Prepare as much collagenase solution as needed for a given day 
immediately before use.  Filter sterilize before use.  To prepare the 
collagenase solution, add: 
DMEM-Incomplete + 2mg/mL Type I collagenase + 2mg/mL 
Type II collagenase (both from Worthington Biochemical) + 2% 
BSA (Sigma) 
6. Incubate the tubes containing the tissue at 37°C in rotating water b h for 60 
minutes. 
7. Filter the digested material using 1000µm nylon mesh into another sterile 50ml-
centrifuge tube to remove remaining tissue fragments. Dilute the filtrate with 
DMEM-Fat to minimize collagenase activity.  Filter liquid through 100µm cell 
strainer to another 50ml-centrifuge tube. 
8. Spin the tubes for 10 minutes at 1000rpm.  The thin, white layer at the top is fat 
cells, middle is aqueous layer, sediment is preadipocytes and endothelial cells.   
9. Aspirate the top layer and aqueous layer in the tube.  Resuspend the final pellet in 
DMEM-Fat and seed in T-25 culture flasks with 5ml of DMEM-Fat medium.  If 
there appears to be a large amount of cellular debris in the tube, resuspend the 
pellet in fresh medium and spin again.  Aspirate the medium and seed cells in T-
25 flask.  
10. Check cells after 24 hours to ensure no contamination.   
11. Change medium 1-2 days following isolation to remove cellular debris and 
unattached cells.  Aspirate medium, rinse with sterile PBS, aspirate PBS, and 







Digestion of Murine Fat Tissue 
 
 
Reagents and Medium: 
• Collagenase Medium (DMEM-Incomplete) 
500ml Dulbecco’s Modified Eagle Medium (DMEM) + 5mL AA + 1mL 
fungizone 
 
• Fat Growth Medium (DMEM-Fat)  
500mL DMEM + 50mL FBS + 5mL AA + 1mL fungizone + 2mL Insulin-
Transferrin-Sodium Selenite Media Supplement (ITS) 
 
Tissue Retrieval Preparation: 
1. Autoclave all needed instruments including scissors, forceps, funnel, nylon mesh 
for filtering, beakers 
 
2. Prepare sterile HBSS solution and aliquot to several sterile 50ml-centrifuge tubes 
(30mL per tube) 
 
3. Before going to Godley-Snell, place the tubes into a Styrofoam cooler filled with 
ice. 
Collection and Isolation of Fat Cells: 
1. Obtain either subcutaneous or epididymal fatty tissue from several mice at the 
research facility. If mice have been used in research studies, be sure to use only 
the control animals that have not been subject to experimental treatments.  Place 
tissue in tube containing sterile HBSS solution.  Place tubes back into cooler and 
transport back to the laboratory for processing. 
2. Warm all media and reagents to 37°C in the water bath. 
3. Place the fat tissue on a sterile disposable Petri dish and rinse with fresh HBSS 
solution.  Rinse again. (Can also rinse again with sterile PBS solution.) 
4. Mince the tissue finely using disposable scalpels and scissors.   
5. Place tissue into a sterile 50mL-centrifuge tube.  Add filter s ilized collagenase 




a. Prepare as much collagenase solution as needed for a given day 
immediately before use.  Filter sterilize before use.  To prepare the 
collagenase solution, add: 
DMEM-Incomplete + 2mg/mL Type I collagenase + 2mg/mL 
Type II collagenase (both from Worthington Biochemical) + 2% 
BSA (Sigma) 
6. Incubate the tubes containing the tissue at 37°C in rotating water b h for 60 
minutes. 
7. Filter the digested material using a 100µm cell strainer into aother sterile 50ml-
centrifuge tube to remove remaining tissue fragments. Dilute the filtrate with 
DMEM-Fat to minimize collagenase activity.   
8. Spin the tubes for 10 minutes at 1000rpm.  The thin, white layer at the top is fat 
cells, middle is aqueous layer, sediment is preadipocytes and endothelial cells.   
9. Aspirate the top layer and aqueous layer in the tube.  Resuspend the final pellet in 
DMEM-Fat and seed in T-25 culture flasks with 5ml of DMEM-Fat medium.  If 
there appears to be a large amount of cellular debris in the tube, resuspend the 
pellet in fresh medium and spin again.  Aspirate the medium and seed cells in T-
25 flask.  
10. Check cells after 24 hours to ensure no contamination.   
11. Change medium 1-2 days following isolation to remove cellular debris and 
unattached cells.  Aspirate medium, rinse with sterile PBS, aspirate PBS, and 











Purification of Total RNA from Animal Cells  
Note:  This protocol is adapted from Qiagen RNeasy Mini Kit Handbook and intended 
for use with Qiagen RNeasy Mini Kit (Qiagen, Catalog #74106) and Qiagen 
QIAshredders (Qiagen, Catalog #79656) 
 
Reagents and Supplies 
• Qiagen RNeasy Mini Kit 
• Qiagen QIAshredders 
• β-mercaptoethanol (β-ME)solution 
• RNase/DNase-free aerosol tips 
• RNase/DNase-free centrifuge tubes 
• RNase/DNase-free microcentrifuge tubes 
• 70% and 100% ethanol 
• Micropipettors designated for RNA work 
• Microcentrifuge 
• Gloves and appropriate protective equipment 
• Designated RNA workspace (PCR Hood) 
 
RNA Isolation Procedure 
1. Add 4 volumes of 100% ethanol to the Buffer RPE stock solution supplied in the 
RNeasy Mini Kit to obtain a working solution.  This is done only before using the 
kit for the first time. 
 
2. Before starting, mix 10µL β-ME per 1mL Buffer RLT in RNase free centrifuge 
tube.  Be sure to perform this step in the chemical fume hood. 
 
3. For cells grown in well plates, aspirate the culture medium fromthe cells.  Rinse 
each well with 1-2mL PBS.  Aspirate the PBS from the wells. 
 
4. Lyse cells directly in the well plates by adding either 350µL or 600µL of Buffer 
RLT to each well to disrupt the cells.  The volume of Buffer RLT added to each 
well is dependent on the size of the culture vessel, as shown in Table 6 of the 
RNeasy Mini Kit Manual. 
 





6. Collect the cell lysate from each well and transfer to a RNase/DNase-free 
microcentrifuge tube (one tube per sample).  Vortex each sample briefly. 
 
7. Pipette the cell lysate directly into a QIAshredder spin column supplied with a 
2mL collection tube.  Centrifuge the samples for 2 minutes at full speed 
(13,000rpm) to homogenize the samples. 
 
8. Discard the spin column from the tube, saving the cell lysate.  Add 1 volume 
(either 350µL or 600µL depending on the volume of Buffer RLT added to the 
samples) of 70% ethanol to the homogenized lysate, and mix well by pipetting.  
Mix any precipitate that forms in the tube as well. 
 
9. Transfer up to 700µL of the sample to and RNeasy spin column supplied in a 
2mL collection tube.  Centrifuge for 15s at ≥10,000rpm.  Discard the sample 
flow-through.  If sample volume was greater than 700µl transfer up to 700µl of 
sample volume again to RNeasy spin column and repeat, discarding the flow-
through after each centrifugation step. 
 
10. Add 700µL of Buffer RW1 to the RNeasy spin column of each sample.  Close the 
lid and centrifuge for 15s at ≥10,000rpm to wash the spin column membrane.  
Discard the flow-through. 
 
11. Add 500µL of Buffer RPE to the RNeasy spin column of each sample.  Close the 
lid and centrifuge for 15s at ≥10,000rpm.  Discard the flow-through. 
 
12. Add 500µL of Buffer RPE to the RNeasy spin column of each sample.  Close the 
lid and centrifuge for 2 minutes at ≥10,000rpm to wash the membrane.   
 
13. Place the RNeasy spin column into a new 1.5mL collection tube supplied in the
kit.  Add 50µL of RNase-free water directly to the spin column membrane.  Close 
the lid and centrifuge for 1 minute at ≥10,000rpm to elute the RNA.  
 
14. If the expected RNA yield is >30µg, repeat the elution step by adding another 
50µL of RNase-free water to the RNeasy spin column.   
 





Agilent Bioanalyzer RNA 6000 Nano Protocol 
Note: This protocol was adapted from the Agilent RNA 6000 Nano Kit Gu de and is 
intended for use with the Agilent 2100 Bioanlyzer (Agilent Technologies) and 
Agilent RNA 6000 Nano Kit (Catalog #5067-1511). 
 
Reagents and Supplies 
• RNA 6000 Nano Kit including Chips 
• Agilent 2100 Bioanalyzer with chip priming station and IKA vortex mixer 
• RNaseZap (Ambion #9780) 
• RNase-free water 
• RNase/DNase-free pipette tips 
• Micropipettors 
• RNase-free microcentrifuge tubes (1.5mL) 
• Microcentrifuge 
• Water bath heated to 70°C for ladder denaturation 
 
Setup 
1. Before starting, remove the RNA 6000 Nano kit from the refrigerator and allow to 
equilibrate at room temperature for 30 minutes. 
 
2. Set water bath to 70°C and allow to heat. 
 
3. Remove RNA samples and RNA ladder supplied with RNA 6000 Nano kit from 
the -80C and -20C freezers and thaw on ice.  Always keep RNA samples and the 
RNA ladder on ice. 
 
Preparing the Gel 
1. Pipette 550uL of RNA 6000 Nano gel matrix (red top) into the top of a spin filter 
included in the kit. 
 
2. Place the spin filter into microcentrifuge and spin for 10 minutes at 4000rpm. 
 
3. Aliquot 65uL of filtered gel solution into 0.5mL RNase-free microcentrifuge 
tubes included in the kit.  Label and date the tubes.  Store the aliquots at 4°C.  






Preparing the Gel-Dye Mix 
1. Vortex the RNA 6000 Nano dye concentrate (blue top) for 10 seconds and spin 
down.  Be sure to protect the dye from light at all times. 
 
2. Add 1uL of RNA 6000 Nano dye concentrate to a 65uL aliquot of the filtered gel.  
Close the tube and vortex until dye and gel sufficiently mixed. Return the dye to 
refrigeration at 4°C in the dark. 
 
3. Centrifuge the tube containing the gel-dye mix for 10 minutes at room 
temperature at max speed (14,000rpm).  Use the gel-dye mix within one day of 
preparation. 
 
Loading the Gel-Dye Mix 
1. Before loading the gel-dye mix ensure that the chip priming station is set up 
appropriately; priming station base plate should be in the C position (see page 7 of 
the RNA 6000 Nano Kit Guide for information). 
 
2. Remove a new RNA Nano chip from its sealed bag and place on the chip prim ng 
station. 
 
3. Pipette 9uL of the gel-dye mix into the bottom of the well marked G on the chip.  
 
4. Set the timer to 30 seconds, make sure that the plunger of the syringe is positioned 
at 1mL and then close the chip priming station.   
 
5. Press the plunger of the syringe down until it is held by the clip.  After 30 
seconds, release the plunger.  After 5 seconds, slowly pull the plunger back to the 
1mL starting position. 
 
6. Open the chip priming station and pipette 9uL of the gel dye mix into each of the 
wells marked G.   
 
Loading the RNA 6000 Nano Marker, Ladder, and Samples 
1. Pipette 5uL of the RNA 6000 Nano marker (green top) into the well marked with 
the ladder symbol and into each of the 12 sample wells.  Add 6uL of the Nano
marker to any sample wells that will not be used for a RNA sample. 
 
2. Pipette 1.5uL of the thawed RNA ladder to another RNase-free tube.  H at 





3. Pipette 1uL of the denatured ladder into the well marked with the ladder symbol. 
 
4. Pipette 1uL of each sample into each of the 12 sample wells labeled #1-12. 
 
5. Vortex the chip in the supplied IKA Vortexer for 1 minute at 2000rpm. 
 
6. Analyze the chip within 5 minutes of preparation. 
 
Analysis of NanoChip with Agilent 2100 Bioanalyzer 
1. Start the Agilent 2100 software on the computer. 
 
2. Decontaminate the electrodes on the Bioanalyzer before running chips.   
 
3. Fill one of the wells of an electrode cleaner with 350uL RNaseZAP.  Open the lid 
and place the electrode cleaner in the Bioanalyzer.  Close the lid and leave for 1 
minute.  Open the lid and remove the electrode cleaner. 
 
4. Fill one of the wells of the other electrode cleaner with 350uL RNase-free water.  
Place the electrode cleaner in the Bioanalyzer.  Close the lid and leave for about 
10 seconds.  Open the lid and remove the electrode cleaner.  Wait 10 seconds for 
water to evaporate before closing the lid or inserting chip. 
 
5. Once decontamination of the electrodes is completed, place the chip into the 
cartridge.  The chip will only fit into the instrument one way.  Close the lid. 
 
6. In the software, select Instrument.  Then select Assay  Electrophoresis  RNA 
 Eukaryote Total Nano  
 
7. Click START.  Data will automatically be saved to standard data folder upon 
completion.  Save data in a personal folder before closing software. 
 
8. When the chip analysis has completed, open the lid and remove the chip.  Discard 









Real Time RT-PCR Conditions 
 
Note:  The following RT-PCR conditions are intended for use with the Qiagen 
QuantiFast™ SYBR® Green RT-PCR kit (Qiagen Catalog # 204154) for 
quantitative, real-time, one-step RT-PCR.  
 
 
RT-PCR Reaction Setup 
 
Component Volume/reaction Final Concentration 
2x QuantiFast SYBR Green RT-
PCR Master Mix 
12.5 uL 1x 
Primer A 1uL 1uM 
Primer B 1uL 1uM 
QuantiFast RT Mix 0.25uL  
Template RNA 10ng 100ng/reaction 
RNase-free water 0.25uL  
Total Reaction Volume 25uL  
 
 
Thermal Cycler Conditions 
 
Step Time Temperature  
Reverse Transcription 10 minutes 50°C Hold 
PCR Activation 5 minutes 95°C Hold 
Two-Step Cycling:    
 Denaturation 10 seconds 95°C  
 Combined Annealing/Extension 30 seconds 60°C 
Acquire 
Data  






Lipid Extraction and Transmethylation for Gas Chromatography Lipid Analysi s 
from Cell Samples 
Sample Collection 
• Aspirate culture medium from cells.  Rinse with PBS (Sigma, St. Louis, MO).  
Aspirate PBS from cells. 
• Add 1mL of PBS to each well of 12-well culture plate.  Scrape the cells with pipet 
tip and transfer the cell/PBS solution to a microcentrifuge tube.   
• Freeze sample at -20°C if not to be used immediately.  If frozen, thaw samples at 
room temperature before proceeding. 
 
 Lipid Extraction 
• Transfer PBS and cells from microcentrifuge tube to 50mL-round bottom glass 
centrifuge tube. 
• Add 20mL of 2:1 Chloroform (Fisher): Methanol (VWR) solution to each tube 
(13.4ml/6.6mL). 
• Add 4mL of 0.58% sodium chloride solution to each tube. 
• Vortex samples for 3 minutes using a multi-tube vortexer. 
• Centrifuge sample tubes at 1500 rpm for 5 minutes at room temperature to 
separate the solvent phases. 
• Transfer the lower layer of solution to a 16 or 20-mL round bottom glass tube that 
will fit on the nitrogen evaporator. 
• Discard the upper layer in an appropriate waste container. 
 
 
• Evaporate the lower layer remaining in the tube under nitrogen gas (N-EVAP) 
until completely dry*. 
*Note: If entire sample preparation protocol cannot be finished at the allotted 
time, samples may be stored after this step.  Make sure the samples are 




the screwtop, and store in refrigerator until the next day.  Begin on the next day 
by adding appropriate volume of sodium methoxide. 
 
Transmethylation 
• Add 100uL of methylene chloride (Fisher) and 1mL of 0.5N sodium methoxide in 
methanol (Sigma) to each tube. 
• Flush each tube with nitrogen gas, using the N-EVAP, and cap with Teflon lined 
cap. 
• Heat each tube on dry block heater at 90°C for 10 minutes. 
• Cool each tube to room temperature. 
• Add 1mL of 14% boron trifluoride (BFL3) in methanol (Sigma) to each tube. 
• Flush the tubes with nitrogen gas and cap. 
• Heat at 90°C for 10 minutes. 
• Cool the tubes to room temperature. 
• Add 500ul GC grade hexane (VWR) and 500ul GC grade hexane containing the 
internal standard (ISTD) (Sigma, 1ug/ul C23:0) to each tube. 
• Add 2mL deionized water to each tube. 
• Vortex the tubes for 2 minutes. 
• Centrifuge at 1500rpm for 5 minutes. 
• Transfer the upper layer of solution (hexanes) to a disposable test tub  containing 
anhydrous sodium sulfate (Fisher).  
• Transfer the hexane layer from the disposable test tube to an amber GC vial.   
• Flush each vial carefully with nitrogen gas and cap, crimping the cap to ensure 
seal. 
• Run sample vials on GC for long chain fatty acids 
• Calculate the weight percentages of fatty acids with the following equations: 
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Where: Total Area = area of entire sample plot 
 AreaISTD = area of the internal standard located on the resulting plot 
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